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CHAPTER 1
LITERATURE REVIEW
1.1. THE PROCESS OF LYMPHOCYTE TRANSFORMATION
1.1.1. General considerations
Vertebrates possess a surveillance mechanism, the
immune system which specifically recognises and selectively
eliminates foreign invaders (i.e. antigens). This immune
protection is achieved by the cooperation of two systems 
the humoral and the cellular immune response- each one 
resulting from the activity of two populations of morpho­
logically indistinguishable lymphoid cells; the B-cells 
which initiate the humoral, and the T-cells which initiate 
the cellular immune responses.
There are two fundamentally different forms of cellular 
immune responses depending on the type of T-cells involved.
One type recognises and reacts with antigens on target 
cells. The second type is active in delayed type hyper­
sensitivity reactions (DTH): binding of the antigen on
the surface of T-cells triggers a state of activation 
characterized by cell-enlargement and also increased cellular 
activity, and leads to cell differentiation and division.
I
However, literature data indicate that lymphocyte activation 
does not necessarily lead to proliferation and synthesis of
deoxyribonucleic acid (DNA), i.e. activated lymphocytes
■have to be committed to DNA synthesis. Lymphocytes apart 
from being activated by antigens, can also become activated 
upon interaction with mitogens including plant lectins 
such as phytohaemagglutinin (PHA) and concanavalin A (ConA) 
(chess e_t aT. , 1975; Ling & Kay, 1975), or they can also be 
activated by products of microorganisms (Taranta jet al. , 
1 9 6 9; Greaves & Janossy, 1972; Rodey et al., 1972). Mitogens
are polyclonal and, therefore, they induce a much greater 
response in lymphocytes in vitro than antigens, which 
activate only few clones of cells. Lymphocyte proliferation 
and differentiation is associated with secretion of substances 
(i.e. lymphokines) which attract and activate macrophages 
which, in turn, eliminate the antigen. T-lymphocyte
activation and transformation, therefore, play the key role
in inducing DTH reactions, and factors which affect either
■
process will, in consequence, affect cell-mediated immune 
responses. Many factors have been shown to affect T-cell
activation and proliferation among which is the existence i':of several kinds of accessory cells. These cells are necessary 
to present the antigen to the lymphocytes and also to secrete ,1
substances which enhance T-cell activation. Antigen- or 
mitogen-triggered lymphocyte proliferation also depends on 
factors which affect the degree of transformation-associated 
cellular activity. The elevated activity in proliferating 
cells reflects, primarily, increased synthesis of ribonucleic 
acid (RNA) and DNA and also synthesis of metabolically 
important compounds, proteins and enzymes, which include 
metalloenzymes and cytochromes. An important component for 
the synthesis and activity of these metalloenzymes and 
cytochromes is iron. Availability of iron during the synthesis 
of these molecules will, therefore, affect the rate of their 
production, and inadequate iron-delivery may be reflected 
in impaired proliferation of activated T-lymphocytes. It 
is this aspect of cellular activity, and its role in 
lymphocyte transformation which forms the basis of the work 
reported in this thesis.
rë
■
I
I
1.1.2. Mitogenic activation of T-lymphocytes
Binding of the mitogen on the lymphocyte cell membrane 
is a crucial first step in the activation of lymphocytes 
as demonstrated by the finding that sugars which prevent 
binding of the lectin also inhibit lymphocyte activation 
and transformation (Borberg at al., I9 6 8; Powell & Leon, 
1 9 7 0). This has led to the hypothesis that receptors 
containing an oligosaccharide moiety specific for the lectin 
exists on the lymphocyte membrane (Ling & Kay, 1975)» 
Glycoproteins associated with lectin-binding have been 
isolated from the cell membrane of lymphocytes (Ling & Kay, 
1975; Stobo, 1 9 7 7), and they have been shown to contain
the sequence:. ^galactose — — —^ sialic acid (Novogrodsky,
1 9 7 5)' Since lymphocytes bind similar numbers of lectin 
molecules irrespective of the type of lectin (Stobo et al., 
1 9 7 2; Bold et al., 1975), and glycoproteins isolated from 
the plasma membrane of lymphocytes by affinity chromatography 
with different lectins are essentially the same (Henkart & 
Fisher, 1975), it is concluded that a common receptor 
molecule for the mitogenic lectins may exist. Similarly, 
it has also been reported (Hellstrom _et al. , 1976) that 
T-lymphocytes have a common receptor for ConA and PHA, and 
recently Palacios & Holler (1 9 8I ) have shown that 0KT3 
antibody, ConA and PHA trigger T-lymphocytes through the 
same receptors.
Binding of the mitogen does not necessarily lead to 
lymphocyte activation. A crucial number of mitogen molecules 
must bind to the lymphocyte surface in such a way as to
such as colchicine (de Pétris, 1974; Albertini _et al. , 1977) 
or cytochalasin B (de Pétris, 1974; Yahara & Edelman, 1972),
- 3 - Ï
provide a sufficient surface stimulus, and also there must 
be a linkage between events occurring at the surface and 
inner mechanisms of cell-activation (Stobo e_t ad., 1972 ). 
Literature data indicate that the proliferation of lymphocytes 
in response to mitogens (or antigens) is initiated by the I
cross linking of the receptors exposed on the cell-surface 
(Greaves & Janossy, 1972; Lindahl-Kiessling, 1972; de Pétris,
1974; Rao, I9 8 2). Interaction of ligands with surface
receptors on lymphocytes leads to rapid changes in the I
surface membrane and to "cap" formation, as indicated by 
treating lymphocytes with fluorescein-labelled ConA at 37^C :|(de Pétris, 1974; Rao, I9 8 2). Since "cap" formation is
■found to be affected by cytoskeletal modulating agents
'3it has been suggested that "cap" formation is the result |
of the interaction of receptors with microtubules and micro- |
filaments in the cell cytoplasm, and the disruption of ^
7:these elements leads to alterations in the mobility of the s'
surface receptors (Yahara & Edelman, 1972). Rao (1 9 8 2) 
has shown that adenosine triphosphate (ATP)-dependent sliding 
of membrane-associated actin and myosin filaments was
responsible for the accumulation of ConA-receptor complexes f'%!
into a "cap" on the cell membrane, and they also showed 
that "cap" formation was associated with the degree of the 7
mitogenic response. These results indicate that "cap" 
formation might trigger events which lead to proliferation, f,|
Polymerisation of actin in lymphocytes has also been implicated 7I
'"■"1
as a possible signal for mitogenesis (Rao, 1984). Furthermore^ 
Edelman (1976) has suggested that a signal for initiation 7
of DNA synthesis is mediated by an assembly of interacting 
macromolecules consisting of cell surface receptors,
microtubules and actin-containing microfilaments. However,. i
the exact role of microfilament-formation and actin 
polymerization in the mitogenic (or antigenic) stimulation 7
of lymphocytes remains to be explained.
In an attempt to further elucidate the cellular 
mechanisms involved in mitogen activation, studies of bio­
chemical events associated with mitogen-activation of 
lymphocytes have been performed. These studies demonstrated 
that within minutes of addition of the mitogen, there is a 
marked increase in the membrane transport of small molecules 3;
(van den Berg & Betel, 1971j Ling & Kay, 1975) and ions
(Crumpton e_t al. , 1975; Ling & Kay, 1975) and also an increase
in membrane-lipid turnover (Fisher & Mueller, I9 6 8; Crumpton 1
et al.5 1 9 7 5) and in the levels of cyclic adenosine mono­
phosphate and enzymes (Smith at al., 1970; Ling & Kay, 1975)»
Histone acétylation also occurs (Hirschhorn at al., 1969)»
The rate of protein synthesis is increased, too, as indicated 
by quantitative cytochemical studies in small and activated 
lymphocytes and also by the increase in the rate of incor-
Iporation of labelled precursors into newly synthesised 
protein (Ling & Kay, 1975)» The formation of large protein %
aggregates in stimulated lymphocytes appeared to be generated 
from pre-forraed and newly synthesized proteins (Levy &
Rosenberg, 1973)» These early morphological and biochemical
events are thought to he involved in the activation of 
previously repressed genetic loci (Stobo, 1977)» ;;
■
#1 .1 .3 . Cellular requirement for activation of T~lymphocytes 
Studies on more purified lymphocyte populations have 
suggested that the original idea that a lymphocyte could 
combine with its stimulant and then undergo activation is 
an oversimplification. It is now well established that 
lymphocyte activation by antigens or mitogens requires 
interaction with different cells. Both the direct interaction 
between lymphocytes brought into contact by agglutinating 
stimulants and interactions with adherent cells are involved.
1.1.3•1• Lymphocyte-lymphocyte interaction
The formation of aggregates which occurs after the 
addition of almost any mitogen to lymphocyte cultures has 
been considered to be important in lymphocyte activation. 
Thus, agitation of stimulated cell cultures which prevented 
the formation of aggregates also inhibited the mitogenic 
response especially when the cultures were agitated early
after addition of the mitogen (Peters, 1972). The inliibi ti on 
of lymphocyte activation by hyaluronic acid (Darzynkiewicz 
& Balaz , 1 9 7 1)» and also the decreased rate of incorporation
of labelled uridine into RNA in response to PHA when the 
cells were cultured in medium containing 0.2^ agar (Peters, 
1 9 7 2) indicate that the reduced response of lymphocytes was 
probably the result of inhibition of an interaction between 
the cells in the culture. Cooperation among T-cell subsets 
has been found in synergistic interaction between murine 
thymus and lymph node cells (Piguet et aT., 1975)* The
sresponse of FcR negative T-cells which, were unresponsive
ëto ConA was also increased by the presence of FcR positive -I
cells (stout & Herzenberg, 1975) and la T-cells became |vëresponsive to ConA in the presence of la^ cells (Frelinger, I
1 9 7 7)* B-lymphocytes may also permit a helper effect on 
the response of T-cells to mitogens (Delespesse et aT,,
1 9 7 6; Kasahara e_t aT. , 1979; Kin _et aT. , 1979) or to protein A 
(Kasahara a^., I9 8 0) and they are shown to permit mixed
:':'3lymphocyte reactions between immunocompetent thymus cells
st-;(Dyminski & Smith, 1977)* The consequence of this communication: 
and what information is transferred from lymphocyte to
.lymphocyte remains to be fully elucidated.
- "1 ,1 .3 ,2. Lymphocyte-macrophage interaction IWith the introduction of column filtration techniques
1for routine preparations of lymphocyte cultures with low levels
of contaminating phagocytic cells, it was found that the
response to many of the weaker lymphocyte stimulants such 
as antileucocyte antisera or staphylococcal filtrate was
lost or greatly reduced when purified human lymphocytes were T-cultured dn vi tro (Oppenheim et al., I9 6 8). The activity 
was restored by the addition of phagocyte-rich populations*
Highly purified cultures of lymphocytes also showed a marked.
dependence on the presence of macrophages for their response 7
fto optimum concentration of PHA, and the number of adherent 
cells required to induce the response was very small, often 
no more than 0.3^ of the total number (Levis & Robbins, 1970). 
Similarly, the proliferation of highly purified T-lymphocyte©
■
was also found to be dependent on tlie interaction of 
lymphocytes with macrophages (Waldron _et al. , 1 9 7 3; Unanue,
in response to ConA and PHA (Rosenstreich e_t aT. , 1976) or 
to NalO^ and galactose oxidase (Novogrodsky, 1975) was 
markedly enhanced upon incubation with macrophages. The
blastogénie response of antigen-activated T-lymphocytes
1 9 8 1). Further evidence for the macrophage-requirement in 
.
T-cell proliferation also comes from cytological observations 
which showed that sensitized lymphocytes adhered to macro­
phages in the presence of the PPD (Salvin _et a^ . , 197l)»
The importance of macrophages in T-cell proliferation was 
found to be due to the requirement by the lymphocytes of 
a soluble factor produced by the adherent cells, which 
functions as an essential activating signal (Gery ejb aT. , 
1 9 7 2; Hoessli & Waksman, 1975; Rosenstreich e_t aT. , 1976;
Mizel & Ben-Zvij 1 9 8O; Smith e^ aT., 1980b; Palacios, 1982b;
_Maizel & Lachman, 1984). This lymphocyte-activating factor 
or interleukin-1 (iL-l) has been characterised and its 
function on lymphocyte proliferation (B- or T-cells) is now 
well established (also see 1.1.4). In mitogenic stimulation 
of T-cells, macrophages are essential mainly for the 
production of IL-l. Triggering is initiated by the inter­
action of the mitogen with its receptors on the T-lymphocytes 
(Palacios, 1982a). T-cell activation by antigens, however, 
requires macrophages not only for IL-l production but also 
for the presentation of the antigen to the T-cells as 
indicated experimentally using antibody reactive against 
HLA-DR (or la in mice) antigens (Frelinger et al., 1976;
I
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Albrechtsen _et al. , 1977; Palacios, 1982b)
1.1.4. The "commitment"of lymphocytes to proliferation
It is now well established that maximum commitment of 
lymphocytes to DNA synthesis requires some 18 h exposure to 
the mitogen (Wedner & Parker, 1976). Shorter exposure 
times do, however, result in blastogenesis but cells return 
to their resting stage within a few minutes after the removal 
of the lectin (Sell & Sheppard, 1974). Furthermore, supra- 
optimal doses of ConA which inhibit DNA synthesis, nonetheless 
"prime" T-cells to entry into S phase i.e. stimulate them 
to enter to G_ phase of the cell cycle (McClain & Edelman, 
1 9 7 6). These results indicate that activation of lymphocytes
!is not synonymous with commitment to DNA synthesis, and factors other than the binding of the lectin and the presence 
of the co-stimulator IL-l, are required before cells undergo 
DNA synthesis.
■It has been found that T-cells activated with a mitogen 
or antibody produce interleukin-2 (lL-2), a growth factor 
which is responsible for the maintenance of their continuous
:proliferation (Morgan e_t al. , 1976; Bonnard e_t aT. , 1979; ■
7Larsson & Coutinho, 1979; Smith, I98O). Interleukin-2 
supported the growth of activated T-cells (Larsson & Coutinho,
'1979; Smith, I98O; Palacios et , I9 8 1) although resting 
T-cells became sensitive to IL-2 when they were activated 
(Palacios et aT., I98I). Furthermore, the production of
IL-2 was associated with cell proliferation since 0KT8 
antibody inhibited IL-2 production and proliferation of 
0KT8^ human T-cells (Welte et al.. I9 8 3). It has also been
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reported that in the mouse, the production of IL-2 is 
associated with Lyl^2 3 T-cells, while Lyl 2^^^ cells 
respond to it by proliferation (Smith, I9 8 0). The production 
of IL-2 by stimulated T-cells has been associated with the 
expression on the cell membrane of IL-2 receptors and this 
has been confirmed biologically as activated T-cells 
effectively absorb IL-2 from conditioned media preparation 
(Bonnard ejb al. , 1979; Robb e_t al. , I98I). In addition, 
using a recently described monoclonal antibody, anti-Tac, 
that specifically recognizes the IL-2 receptor (Leonard et al., 
1 9 8 2; Depper et al., I9 8 3) it has been shown that acquisition 
of the receptor depends on lectin stimulation (Depper ejb al. , 
1 9 8 3)» The literature data therefore indicate that production
of IL-2 receptors is associated with activated lymphocytes 
and that their acquisition by T-cells may be one of the 
functions of lectin interaction with the cells. However, 
given a central role of macrophages and IL-l in immuno- 
regulation, a question of importance concerns what role 
these cells play in the expression of IL-2 receptors. There
,are no data so far suggesting that concomitant IL-l exposure
'may change the kinetics of acquisition or the density of 
IL-2 receptors. It is known, though, that IL-l promotes 
the production of IL-2 by activated T-cells (Smith at al.,
1 9 8 0a;Hunig et al., I983) and that both these factors play 
a crucial role in T-cell proliferation. Thus two different 
models have been postulated to describe the T—cell cycle.
.,7
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1 ) Wagner jet al. (1 9 8 0) postulated that Lyl^2^3" cells 
produce IL-2 in response to the combined action of antigen 
or mitogen and IL-l, and then IL-2 induces DNA synthesis 
in precursors of Ly|.”2"^ 3'^  cells which have been activated 
by the antigen to express receptors for IL-2.
2 ) An alternative model is provided by Lafferty e^ al. (1 9 8O)
according to which there are two stages:
1. Resting T-cells (either Lyl*'*2"3" or Lyl™2^3^) are 
stimulated by the combined action of antigen or mitogen and 
IL-l derived from accessory cells.
2. The above sensitize the cell to progress to a stage
where the specific requirement for antigen or the mitogen 
remains but a signal is provided by IL-2 which causes the 
activated cell to be committed to DNA synthesis.
In conclusion, the lymphocyte stimulation by antigens or 
mitogens can be divided into two stages, the■activation stage 
(Gq to G^; Fig. 1 ) and the commitment stage (G^ to S ). 
Immunological specificity is preserved in the initial 
activation event, while clonal growth and differentiation 
can then be maintained by IL-2, which acts in G^ phase from 
which cells are committed to enter the phase of DNA synthesis
( s) .
1 .1 .5 * DNA synthesis by activated lymphocytes
The nature of the signal for the initiation of DNA 
synthesis is not yet fully understood, but it is thought to 
be a cytoplasmic function. The DNA synthesis observed after 
activation of lymphocytes is due simply to the normal replication
- 13 -
Figure 1: Cell-cycie control in T-cells.
(1) Lectin + IL-l
M
Antigen + IL-l (1)
IL-2 (2)
G2
Resting T-cell (G^ ) is activated into by signal (l), and it will 
arrest somewhere in unless further stimulation by IL-2 (signal (2)) 
induces commitment to DNA synthesis.
(From Klaus & Hawrylowicz, 1^84).
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of the chromosomal DNA required for mitosis, and follows
the normal semi-conservative replication. DNA synthesis
is accompanied by synthesis of ribosomes since low concentrations
of actinomycin which inhibit synthesis of rRNA also inhibited
DNA synthesis (Kay e_t al. , 1 9 6 9)* The induction of several
enzymes is also associated with the initiation of DNA
synthesis. Thus increased DNA-polymerase activity was
observed after PHA stimulation and it was followed by
3increased incorporation of H-thymidine by the stimulated 
cells (Loeb & Agarwal, 1971)* Increased activity of other 
enzymes involved in DNA synthesis has also been reported 
(Ling & Kay, 1975)'
The initiation of DNA synthesis in lymphocytes also 
seems to have some requirement for certain metals which are 
involved in enzyme activity. These metals include zinc 
(Chesters, 1972) and iron (Wrigglesworth & Baum, I9 8 0), 
and the requirement for iron is dealt with in detail in 
the following section.
1.1.6. The role of iron in DNA synthesis
Although iron is required for many enzymes and coenzymes, 
the most important requirement as far as lymphocyte trans­
formation is concerned appears to be linked with an iron 
requirement for DNA synthesis. Iron is essential 
component of the enzyme ribonucleotide reductase (Brown 
et al,, 1 9 6 9; Moore at aT., 1970)* This enzyme is a component 
of a cytoplasmic enzyme system which catalyses the reaction 
of the four ribonucleotides to their corresponding deoxy-
— 15
ribonucleotides which are essential for the synthesis of 
DNA. Thus !
Ribonucleotide deoxyribo--, - ,  - . - - . - nucleotideRrbonucleoside reductase  ^ deoxyribonucleoside ^di-phosphates " s y s t e m ^  di-phosphates ' ... - \ . T^ ^ phosphokinase
deoxyribonucleoside DNAtri-phosphates ' - ^polymerase
In mammalian tissues the reductase system consists of three 
major protein components; a ribonucleotide reductase, a 
thioredoxin polypeptide and a thioredoxin reductase. The 
reduced form of thioredoxin provides the source of electrons 
for the ribonucleotide reaction. Ribonucleotide reductase 
comprises two non-identical protein subunits. One subunit 
contains two iron atoms probably both in high spin ferric 
form. An electron spin resonance signal can be detected 
in the subunit but the characteristics are those of an 
organic free radical. This may be the site for thioredoxin 
interaction, which is not yet known. Iron seems not to 
participate as an electron carrier in the reaction but it 
is necessary for the activity of the enzyme,and Atkin et al.
(1 9 7 3) have suggested that the function of the iron is to 
help to generate and stabilize the organic radical inter­
mediate during catalysis. The other subunit binds to the 
substrate (i.e. the ribonucleotides).
The importance of ribonucleotide reductase in DNA
synthesis was shown by Brockman et al. (l97l) who reported
3impaired incorporation of H-thymidine into DNA by a 
leukaemia cell-line when the cells were cultured in medium
16
transferrin are discussed in the following section.
‘ I:
.
containing inhibitors of ribonucleotide reductase enzyme.
In addition, it has been shown that iron taken up by HeLa 
cells was transferred to the nucleus and embedded into 
the chromosomes during cell division (Robbins & Pederson, I9 7 0) 
and also desferrioxamine (DFO) which is an iron chelator, 
inhibited DNA synthesis. Hoffbrand e_t al. (1976) have 
described the mechanism by which DFO inhibits DNA synthesis, 
and this is discussed in detail in Section 1.3*3*
In conclusion, availability of iron affects the activity
I
of the iron-containing ribonucleotide reductase enzyme 
which is essential for the synthesis of DNA. Since iron 
is normally delivered to cells by the iron-transport protein 
transferrin, it seems likely that the increased iron 
requirement to rapidly diving cells will lead to an increased 
need for transferrin-bound iron, hence the importance in
cell proliferation. This aspect has been the subject of 
the work reported in this thesis, and the properties of
I
'i
I
'.i
■: !■j;.
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1.2. TRANSFERRIN
1.2.1. General considerations
Iron is essential to all forms of life. The flow of 
electrons through the biosynthetic pathways, the activation 
of molecular oxygen, hydrogen and nitrogen, the binding of 
oxygen to haemoglobin, myoglobin and haemerythrins and the 
decomposition of noxious derivatives of oxygen, are all 
reactions requiring iron (Wrigglesworth & Baum, I98O).
;However, although iron is important in life, it can also 
present hazards to organisms. In aqueous solution iron has 
access to two different oxidation states; ferrous 
and ferric (Fe^^). Under physiological conditions the more 
stable form is the ferric, while ferrous iron is readily 
oxidised by molecular oxygen to ferric iron. Since ferric 
iron is insoluble, organisms have evolved specific iron- 
sequestering molecules to maintain the element in a soluble
form which is readily available for transport and biosynthetic
reactions. In vertebrates, these iron-binding functions 
are met by transferrin, whose main function is iron transport, 
and ferritin which is essentially an iron-storage protein 
(Jandl & Katz, I9 6 3; Aisen & Lis towsky, I98O)
Transferrin is a glycosylated ^-globulin which has 
the ability to bind two iron atoms reversibly. In Man, 
serum contains 2-4 mg/ml transferrin of a saturation with 
iron of about 30%» The transferrin concentration and iron 
saturation vary, however, with pathological conditions 
(Morgan, I98I). In vertebrates, transferrin is synthesized 
mainly in hepatocytes, although lymph nodes, peripheral
III
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of the overall organisation of the molecule, as revealed by-
blood lymphocytes and other tissues have also been 
implicated (Morgan, I9 8 1).
1.2.2. Structure of transferrin
Recent elucidation of the amino acid sequence of human 
transferrin showed that the molecular weight including the 
carbohydrate chain is 79,550 (MacGillivray _et aT. , I9 8 2).
Physical studies have given similar values for the plasma 
transferrins of other vertebrates (Morgan, I98I). The
'shape of the molecule has the form of prolate ellipsoid
-a
with axial ratio of 1 ; 2 for iron-saturated transferrin 
(Rosseneu-Montreff al.,1 9 7 1) and 1:2.5 (Rosseneu-Montreff 
et aT., 1 9 7 1) or 1:3 (Bezkorovainy & Rafelson, 1964) when 
the protein is iron-free.
Human transferrin consists of a single polypeptide 
chain together with two glycan moieties attached to the 
C-terminal region of the peptide chain. The striking feature
3
I
X-ray studies of transferrin crystals (Gorinsky afc al., 1979), 
is that the polypeptide chain is folded into two globular 
sub-structures or domains each one containing a cleft 
which corresponds to the iron binding site of each molecule 
(Morgan, I98I). Within each domain there are disulphide
i:bridges (Elleman & Williams, I97O; Williams, I9 8 2), and a 
bridging region limited to a maximum of seven residues 
join the two domains together (MacGillivray _et aT. , I9 8 2).
These domains, as indicated by studies of iron-binding 
fragments of bovine transferrin (Brock & Arzabe, 1976) or
ovotransferrin (Williams, 1974; 1975) differ from each other
7
■
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physically and antigenically. Although there is a difference 
in the physical properties of the two domains,(Aisen &
Listowsky, I98O), the functional significance of the presence 
of the two domains with separate iron-binding sites is 
uncertain. There might, however, be an evolutionary 
advantage of the two-domain structure, which would reduce 
loss of protein through glomerular filtration (MacGillivray 
e t al., 1 9 8 2). The polypeptide chain of human serum trans­
ferrin consists of 678 amino acids (MacGillivray e;b aT. , 1 9 8 2), 
There is an internal hO^o homology between residues 1-336 
and 3 3 7-6 7 8, each range representing an iron binding site, 
suggesting gene duplication of an ancestral protein with 
a single domain (MacGillivray et al,, I9 8 2). Amino acid 
sequence is also known for chick transferrin (Jeltsch &
Chambon, I9 8 2; Williams e^ aT., 1982a)which also shows 
internal homology (Jeltsch & Chambon, I9 8 2).
Human transferrin contains approximately 6^ carbo­
hydrate disposed on two identical and nearly symmetrical 
branched heterosaccharide chains each terminating in one 
or more sialic acid residues attached to a galactose residue 
(Borland et aT., 1977; Morgan, I98I). The carbohydrate 
moieties are attached to the polypeptide chain by a ^-1 
glycosidic linlcage via an asparagine residue (Aisen, I9 8 0).
This most frequent structure is a biantennary glycan 
structure although a triantennary structure has also been 
reported (Krusius & Finne, I9 8 1). Transferrins isolated 
from other species also contain a single (Heaphy & Williams, 
1982a)or two glycan chains (Hudson ejb aT. , 1973; Iwase &
II
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Hotta, 1977)» Despite the considerable knowledge of the 
structure of the carbohydrate moieties of transferrin, 
little is known about their function. The glycan chains 
may be important in determining the rate of elimination 
of the protein from the circulation since removal of 
sialic acid in many glycoproteins leads to rapid uptake 
and catabolism in the liver. However, there is no conclusive 
evidence for the involvement of the glycan in the catabolism 
of transferrin (Aisen, I9 8 0).
1 .2 .3 . Metal binding
1,2.3*1* Iron binding
Iron free molecule of transferrin (i.e. apotransferrin) 
reacts with ferric ions to produce a salmon pink complex 
which has maximum absorbance at 467-470 nm. Each iron 
atom binds to and occupies each site of the polypeptide 
chain (i.e. domain) so strongly that it is effectively 
"locked in". The domains become more compact when iron is 
bound (Bezkorovainy & Rafelson, 1964) and the molecule 
becomes less susceptible to proteolytic degradation and 
dénaturation (Brock _e^  sT. , 1976; I9 8 0), Iron binds as 
the ferric form although there have been reports that 
ferrous iron can also bind but with lower affinity, and 
in the presence of oxygen it is converted to the ferric 
iron-complex (Kojima & Bates, I9 8 1).
The affinity of iron binding by transferrin is pH- 
dependent and it is maximal above pH 7»0 (Morgan, I9 8 1),
s
::4
,1
21
When the pH is reduced, the affinity becomes lower, the 
iron starts to dissociate from the molecule at about pH 6 .5 , 
and it is completely released at pH 4.5 (Morgan, I98I).
In human transferrin, the iron is dissociated from the 
molecule in a biphasic manner depending on the pH, and half 
of the iron is released at about pH 5*^, whereas the remainder 
is lost when the pH drops below 5*0 (Princiotto & Zapolski, 
1 9 7 5)* This biphasic release of iron suggests that there 
might be a difference in the iron-binding properties of 
each site. Cannon and Chasteen (l975) a-'cd Zweier (1978)
showed that ferric ions have a tendency to bind preferentially
at one site of the transferrin molecule at a pH above
7 . 2  thus referred to as the acid labile site, the other 
acid stable site, becomes occupied at pH 6.0-7*1' These 
sites are shown to correspond to N- and C-terminal sites 
of the molecule (Evans & Williams, 1978). The removal of 
iron from one site over the other also depends on salt 
concentration, and it has been reported that chloride
facilitates removal of iron from the C-terminal site but 
retarded its removal from the N-terminal site (Van Eijk 
et al.. 1 9 7 8). Addition of chelating agents du vitro as 
a source of iron also revealed preferential binding to one 
site depending on the pH of the medium (Brock & Arzabe,
1 9 7 6; Williams ejt al• , 1978). The use of EPR spectroscopy 
revealed quantitative differences between the C- and N- 
terminal site of ovotrans f errin (Keung _e_t al. , 1 9 8 2).
These investigators reported that the a-helical content 
of the C-site was twice that of the N-site, and that
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major differences in the content of histidine, alanine 
and methionine also existed.
The binding of each iron to transferrin requires the 
synergistic binding of an anion (Aisen ejt al. , 1 9 6 7, Price & Gib­
son, 1 9 7 2; Bates & Schlabach, 1975? Gelb & Harris, I9 8 0) which 
is usually either a carbonate or bicarbonate; the exact 
nature of the anion is still in dispute (Gelb & Harris,
I98O; Zweier ejt ai. , I9 8 1). In the absence of a synergistic 
anion, the iron does not bind specifically, and non-specific
binding in the form of ferric-hydroxide polymers has been 
reported (Bates & Schlabach, 1975)* Release of the anion
3
destabilizes the complex of iron-transferrin allowing 
release of iron. A large number of anions may be substituted 
for(bi)carbonate in the specific binding of iron to 
transferrin (Young & Perkins, I9 6 8; Aisen ejb al. , 1973;
Egyed, 1973; Schlabach & Bates, 1975)* These anions which
'include oxalate, malonate, pyruvate, giycolate, lactate, 
malate and gluconate, form complexes with transferrin that 
are less stable than those containing (bi)carbonate.
Chelating agents such as nitrilotriacetate (NTA) can also 
substitute for (bi)carbonate. It has been reported that 
binding of Ee(NTA) to apotransferrin results in the
■formation of a ternary iron- and chelate-containing.complex 
of transferrin, in which the iron is more labile than when
■(bi)carbonate is used. Addition of (bi)carbonate does not 
displace the chelate immediately but induces the formation 
of a quaternary complex of transferrin with iron, chelate 
and (bi)carbonate from which the chelate is later released 
(Bates, 1 9 8 2).
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Iron-binding by transferrin does not involve any
■ ;specific prosthetic groups. The metal-binding sites are §
the consequence of folding of the polypeptide chain to 
produce two spatial domains which are stabilized by di-
9sulphide bonds and other secondary interactions (Feeney j
involvement reflects binding to the synergistic anion 
rather than binding to iron (Zweier & Aisen, 1977)'
& Komatsu, I9 6 6). The iron, when bound to transferrin 
possesses an octahedral configuration with six ligands, f
one of which is bound to the synergistic anion and another y
to a molecule of water (Zweier & Aisen, 1977)* The remaining 
ligands bind to the protein. Controversial data exist 
concerning the identity and the number of protein ligands.
Thus, it has been suggested that either three (Warner &
Weber, 1953; Windle ejfc ai., I9 6 3; Gelb & Harris, I98O) or two 7 
(Tan & Woodworth, I9 6 9) tyrosine residues are involved in 
each iron-binding site. There is also evidence that either 
one (Zweier & Aisen, 1977) or two (Rogers e_t ai., 1977 )
'4histidine residues are involved as iron-binding ligands. 4)
Arginine and lysine have also been implicated, but their iÎ
1.2.3*2, Binding of metals other than iron
Transferrin can bind metals other than iron, although 
iron is probably the only metal bound to transferrin in vivo. 
Specific binding of these metals should fulfil the following 
criteria (Aisen, 1980):
1 . Only two metal ions should bind per molecule of transferrin.
2. One (bi)carbonate (or other anion) should bind for each metal.
II
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3. Binding of the metal to iron-saturated transferrin 
should not occur.
Metals which bind to transferrin and fulfil most of 
the above criteria include; Zn^^, Cu^^, V Cr^^, Co^^,
Ga^^, Mn^’*' (Feeney & Komatsu, I9 6 6; Aisen e_t ai., I9 6 9;
Tan & Woodworth, 1 9 6 9? Woodworth e_t ai., 1970; Harris et ai., 
1974; Zweier, 1978). Lanthanide ions such as Tb^^, Fu^^,
Nd^^, Ho^ **' (Mears & Ledbetter, 1977; O'Hara jet ai., I98I) and 
actinides Th^ "*", Pu^* (Pecoraro ejb ai., I9 8 1) also bind with 
the same stoichiometry as iron and probably occupy the same 
sites. Metal displacement studies and relative binding 
affinities of metal complexes of transferrin showed that 
the order of binding was Fe^^ >Cr^^ and Cu^^>Mh^^, Co^ "** and 
Cd^^>Zn^^>Ni^^ (Tan & Woodworth, 1 9 6 9)* Feeney & Komatsu 
quoted unpublished work of Inman (1 9 5 8) according to which 
Co^^ had a greater binding affinity for transferrin than 
Fe^^ and, therefore, Co^^ could displace Fe^ "** in the 
transferrin molecule. However, recent work using NMR 
spectroscopy (Zweier et al., I98I) showed that Fe^^ will 
displace Co^^, and therefore the earlier observation of 
Inman probably was incorrect.
Thus, although binding of metals other than iron to 
transferrin is probably non-physiological, it has served ' 
as a useful tool in spectroscopic studies of the transferrin 
molecule.
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1.2.3*3* Binding and release of iron from transferrin du vitro
In the presence of (bi)carbonate, iron binds to either
site of transferrin. Kinetic rather than thermodynamic
factors govern the distribution between the sites (Van
Eijk at ad., 1978). The distribution of iron between the
sites is affected by the pH and salt concentration of the
solution (williams _et al. , 1978; Chasteen & Williams, I98I;
Williams et al., 1982b), In vi tro, loading of transferrin
with iron may create problems. Although the association
constant of iron and transferrin is high (lO^^ M ^) so
3 +that iron binding can easily occur, Ee ions can exist in 
solution at neutral pH only at very low concentrations 
and in excess of 2.5 x 10 are insoluble. At higher
concentrations, the iron is hydrolysed and polymers are 
formed which react slowly with transferrin (Bates & Schlabach, 
1 9 7 3), and furthermore they can react with hydroxyl groups 
of the transferrin molecule, thus causing non-specific 
binding (Bates & Schlabach, 1973)* The problem of non­
specific binding of iron, when ferric salts are used, can 
be avoided by using iron chelators such as nitrilotriace- 
tate or citrate. When using citrate to ensure absence 
of polymers, the reactive species should be of low molecular 
weight, and this is achieved by using a 20-fold excess of 
citrate ions. Nitrilotriacetate, when used at neutral pH 
at a 1:4 ratio of iron to chelate, also results in rapid 
iron-binding (Schlabach & Bates, 1975)» However NTA can 
also occupy the anion-binding site (see 1.2.3 * 1) and this 
can be avoided by adding (bi) carbonate which will slowly 
displace the NTA.
■■"ill■•|4Ï
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of transferrin is the transport of iron among the sites
Iron removal from transferrin iu vitro is usually 
achieved with low pH to destabilize the iron-protein bond 
and an iron chelator such as citrate to accept the released 
iron. Even at physiological pH, however, iron can be |
Ieliminated from the protein when a more powerful iron-binding 7
molecule such as desferrioxamine is available to bind the 
released iron (Aisen, I9 8 0). However, since the iron- |
transferrin bond is so strong that spontaneous dissociation 
of iron from the protein is difficult, mediating agents 
have to be used to facilitate the transfer of iron from
-i'.protein to DEO. Effective mediating agents include NTA 
and ketomalonate (Aisen, I9 8 0).
1.2.4. Function of transferrin  — —      -
1.2.4.1. Introduoti pn "IThe most important and certainly the most studied role
Iof absorption, storage, utilisation and excretion, most
'Iiron being delivered to erythroid precursors for the synthesis
Iof haem. Small but significant quantities of iron are also 
delivered to non-erythroid cells, especially the rapidly
dividing cells. During pregnancy, transferrin also acts
IIas an iron transport molecule to the placenta for transport 
to the foetus. The mechanism by which transferrin accepts 
and donates iron has been extensively investigated, but is 
still not fully understood. Most of the original investigations .
3concerning the donation of iron to cells by transferrin 
were carried out using reticulocytes, but it is now known
I3
%
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tîie cell membrane
2. entry of transferrin into the cell by endocytosis
4. release of apotransferrin from the cell into the 
surrounding medium.
These are discussed in more detail below.
It;
that most of the features apply to non-erythroid cells 
such as lymphocytes.
Another important function of transferrin is associated 
with antimicrobial activity. By restricting the availability 
of iron for microbial metabolism, transferrin may have an 
important role in the defence against infection (pearson & 
Robinson, 197^).Intracellularly, transferrin may also function 
in the killing of phagocytosed bacteria via a catalytic 
pathway involving the generation of hydroxyl radiais from 
superoxide and peroxide (Motohashi & Mori, 1 9 8 9).
1.2.4.2. Events in the transferrin-cell interaction
It is now generally considered that several steps are 
involved in the uptake of transferrin-bound iron by erythroid 
and non-erythroid cells. These are:
1. binding of transferrin to specific receptor sites on
3» removal of iron from transferrin
1.2.4 .3 . Interaction of transferrin with membrane receptors
The existence of receptors on reticulocyte cell membranes 
was first noted by Jandl et al. (1959) vho found that
trypsinised red cells could no longer bind transferrin or 
take up iron from transferrin. They inferred that a receptor 
specific for transferrin existed on the cell membrane which
*
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was degraded by proteolysis. Later Garrett e_t al. (l973) 
demonstrated transferrin-binding activity in detergent- 
solubilised reticulocyte stroma, probably due to receptors 
Since then, many studies have been reported describing 
methods for the isolation and characterisation of the 
transferrin receptor, but results have been controversial.
Thus, first estimates of the molecular weight have ranged 
from 18,000 - 450,000(Aisen, 1983)» Discrepancies in the 
exact values of the association constants for transferrin- 
receptor have been reported, too. Most of these controversial
results arose due to using transferrin and cells from
different species, different methods for isolating the 
receptors, or heterogeneity of cell suspensions. Studies, 
on non-erythroid cells have generated less controversial 
results. These reports indicate that the receptor is a 
glycoprotein (Omary & Trowbridge, I98I; Newman _et ad., 1982; 
Schneider al., I98 2) of molecular weight 170,000 - 200,000
and that it exists as a disulphide-bonded dimer, each subunit
containing three glycan chains of molecular weight 95,000 
(Seligman et al., 1979; Goding & Burns, I98I; Goding 
& Harris, I98I; Sutherland _et al. , I98I; Trowbridge &
Omary, I98I; Schneider ejb al. , I9 8 2), and consisting of 
galactose, N-acetyl glucosamine and sialic acid (Newman 
et al., 1 9 8 2). The transferrin receptor has been shown to 
contain palmitic acid covalently attached close to the 
cell membrane-associated part of the receptor molecule 
(Omary & Trowbridge, I98I; Newman _et al. , I9 8 2) and it is
■} a
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also phospîiorylated, predominately on serine residues 
(Schneider _et al. , 1982). Part of the receptor can also
a fragment of molecular weight 7 0 ,0 0 0 which retained the
be cleaved from the cell surface by proteolysis yielding
;i :transferrin-binding sites, suggesting that the receptor is
embedded in the cell membrane and the major part is exposed 
to the extracellular environment (Schneider _et al. , 1982). 
Transferrin receptors have been isolated from different 
cells including placenta cells, reticulocytes, kidney tissue 
and tumour cells, and so far no structural differences
between them have been reported.
The expression of receptors on the cell membrane is 
associated with increased requirements for iron. The rate 
of iron uptake from transferrin during erythroid cell 
development was found to correlate closely with the number 
of transferrin receptors expressed on the cell membrane 
( lacopetta e_t al. , 1 9 8 2), and this number decreased on cell 
maturation (Nunez ejb al. , 1977; Frazier ejb al. , 1982;
Parmley ej6 al. , I9 8 3). In non-erythroid cells, the transferrin 
receptor has also been associated with increased need for 
iron during cell proliferation. Thus the cell membrane 
antigen associated with proliferation and recognised by 
monoclonal antibody 0KT9 is the transferrin receptor 
(Sutherland et ^ . , I98I; Trowbridge & Omary, I9 8 1). In 
addition, transformed lymphoid cell lines (Larrick &
Cresswell, 1979^; Galbraith ejb al. , 1980a; Makino al. ,
1 9 8 3) and lymphoblasts (Brock & Rankin, I9 8 1) express a
■— 3 0 —
higher number of transferrin receptors than normal resting 
lymphocytes. The percentage of cells to which transferrin ‘ 3
binding was detected was found to correlate with the 
degree of lymphocyte DNA synthesis in response to mitogens 
(Galbraith et al«, 1980b). Increased expression of 
transferrin receptors is also associated with malignancies.
Thus, expression of a large number of receptors in leukaemic 
cells (Larrick & Logue, 1 9 8 0) and in carcinomas, sarcomas 
and samples from cases of Hodgkin's disease (Gatter e_t al. ,
1 9 8 3) has been reported. Additionally, Mus grove e_t al.
(1 9 8 4) observed large numbers of transferrin receptors in 
human tumour cells in culture , and showed that the 
expression of the receptors was related to the cell cycle
phase thus reflecting the proliferative activity of the cells.
The association of the expression of transferrin receptors 
.with an increased requirement for iron by the proliferating
.cells is also justified by the observation that during 
differentiation when there is a decreased requirement for 
iron, the number of receptors on the cell membrane also 
decreases (Makino et al., 1 9 8 3)»
The binding of transferrin to the receptor is normally 
essential for the uptake of iron by the cells. Evidence 
that cellular iron uptake from transferrin is dependent on 
transferrin binding to the receptor comes from the observation 
that proteolytic digestion of reticulocytes leads to a 
reduction in the rate of iron uptake by the cells (Hemmaplardh 
& Morgan, 1976) and monoclonal antibodies to the transferrin 
receptor which inhibit binding of transferrin also inhibit
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iron uptake and cell growth vitro (Trowbridge et al.,
1 9 8 2; Trowbridge & Lopez, I9 8 2). Monoclonal antibodies 
which do not affect transferrin binding do not affect 
uptake of iron (Sutherland at aT., I98I; Trowbridge & Lopez,
1 9 8 2). However, iron uptake not involving transferrin 
binding to the receptor, has also been reported (see 1.2.4,4).
The reaction between transferrin and detergent-solubilised :
receptor is dependent on pH, presence of Ca^* and the iron 
content of transferrin (Morgan, 198I). The receptor is 
specific for transferrin, since binding of iron-saturated
transferrin was competitively inhibited by iron-saturated
yunlabelled transferrin but not by other proteins (Larrick 
& Cresswell, 1979^). Studies with a number of different 
cell types show that diferric transferrin has a higher 
affinity for the receptor than apotransferrin at neutral 
pH (Jandl & Katz, 19 63 ; Young & Aisen, I98I; Hasegawa &
Ozawa, 1982; Kohgo ejb aT. , I9 8 3; Ward e_t al. , 1 9 8 3). The
functional advantage of the greater affinity of iron- 
containing transferrin than apotransfex'rin for the receptor 
is that apolrwill not greatly interfere with the iron uptaker
process by the cells. However, apo might sometimes interfere 
with the iron uptake process if the saturation of transferrin 
with iron were very low.
It is not yet known what part of the receptor is 
important in the binding of transferrin. However, recent 
studies showed that transferrin binding to the receptor 
was decreased when the receptor was treated with galactosidase 
or in the presence of carbohydrates such as galactose and
the iron uptake process has not yet been fully elucidated.
One possibility is that a kind of interaction of the
I
transferrin-iron complex with the receptor may be required 
for iron release from the protein, although no experimental 
data are so far available to support this hypothesis. Another 
function, which has been extensively investigated, is that 
the receptor plays an essential role in the internalisation 
of transferrin-bound iron. This function as well as the 
actual process of endocytosis will be discussed in more 
detail below.
.
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N-acetyl galactosamine (Steiner, I9 8 0) indicating that 
the glycan moiety of the receptor is implicated. Even 
less is known about the moiety of transferrin which binds 
to the receptor. The carbohydrate part of the molecule is 
probably not involved since ovotransferrin and chicken 
serum transferrin which have different carbohydrate contents 
donate iron at the same rate to chick erythroid precursor 
cells (Keung & Azari, I9 8 2). A factor which has been found 
to be important in the binding of transferrin and iron 
donation is the integrity of the transferrin molecule, 
since monoferric fragments of ovotransferrin and bovine 
transferrin had little ability to bind and donate iron to 
chick embryo cells or rabbit reticulocytes, respectively 
(Esparza & Brock, I98O ; Brown-Mason & Woodworth, I9 8 2).
It is now known that the transferrin receptor is 
required for the uptake of iron, although the exact way of
33
1.2.4.4. Internalisation of transferrin
Receptor binding of compounds which exhibit capping 
or patching is a phenomenon which leads to internalisation 
of these compounds via coated pits. This phenomenon which 
is observed in many systems such as in the binding of mitogens 
on the surface of lymphocytes during cell activation (Stobo,
1977; Rao, 1 9 8 2) or in the binding of antigens to the 
surface immunoglobulin on B-lymphocytes (Raff & de Pétris,
1 9 7 3)» requires multi-subunit membrane receptors as well 
as binding of divalent ligands. Receptor-bound transferrin 
exhibiting patching or capping in mitogen stimulated 
lymphocytes (Galbraith & Galbraith, I98O) or in reticulocytes 
(Harding ejt al. , 1983; lacopetta e_t al. , I9 8 3) has been 
reported. Furthermore, Goding & Harris (1 9 8 1) using 2- ^
■'4dimensional electrophoresis showed that the transferrin 
receptor is the major multi-subunit component in the cell 
membrane in murine T-lymphocytes. Transferrin also acts 
as a divalent ligand since monoferric fragments do not
donate iron (Brock, 1 9 8 1). These observations suggest that 
transferrin-bound iron is taken into the cell by receptor- 
mediated endocytosis, the iron is released from the 
transferrin and apotransferrin is then recycled to the 
exterior by the reverse process. Morphological data using 
colloidal gold bound to transferrin (bight & Morgan, I9 8 2) 
or studies on the subcellular localisation of transferrin 
labelled with ferritin (Hemmaplardh & Morgan, 1977), 
peroxidase (Hemmaplardh & Morgan, 1977; Hopkins, I9 8 3) or
;v;
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Iodine-125 (Lamb at al., 1983; Nunez & Glass, I9 8 3) showed 
that transferrin in various cell-types in internalised 
by endocytosis. Treatment of cells with pronase or metabolic 
inhibitors or heating at 46^0, processes which inhibit 
endocytosis, caused a reduction in the number of intra­
cellular gold particles (Light & Morgan, I9 8 2). Furthermore, 
Enns at aT. (1 9 8 3) studied endocytosis of transferrin in 
human erythroid cell lines using rhodamine-labelled transferrin 
and fluorescein-labelled Fab fragments of goat antireceptor 
IgG, and showed that transferrin and its receptor were 
internalised as aggregates and comigrated to the same 
structures within the cell. Hopkins and Trowbridge (1 9 8 3) 
also showed that transferrin and the transferrin receptor 
were internalised and the complexes were transferred from 
coated pits on the cell surface to a system of cisternae in 
the peripheral cytoplasm and finally to small lysosome-like 
vesicles. Extraction of complexes using Triton-x and 
purification through a Sepharose-transferrin column, showed 
that the internalised transferrin remained bound to the 
transferrin receptor during the intracellular process. 
Additionally, Ciechanover et al. (1 9 8 3) showed that exposure
of the transferrin-receptor complex to medium of pH less 
than 5*0 resulted in dissociation of iron but that apo- 
transferrin remained bound to the receptor. When the pH 
was raised to 7»0, as would occur when an acidic intracellular 
vesicle fuses with the plasma membrane, apotransferrin 
rapidly dissociates from the receptor. Taken together 
these observations indicate that iron-containing transferrin
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enters the cell by receptor-mediated endocytosis, the 
transferrin remains bound on the receptor throughout the 
endocytic cycle and the transferrin is exocytosed in a 
reverse process after the release of iron. Whether such 
internalisation is absolutely necessary before transferrin- 
bound iron is available to the cell remains unclear, and 
there have been studies indicating that iron may be taken 
up without being endocytosed. Thus, Woodworth ejt al. (1982 )
reported that the highly-specific microtubule inhibitor 
nocodazole did not affect the rate of iron uptake from 
transferrin by reticulocytes suggesting that endocytosis 
of transferrin is not essential for iron uptake. Similarly, 
Fielding & Speyer (1977) using a different approach found 
that low concentrations of sulphydryl inhibitors which 
act by reducing cell membrane permeability depressed 
removal of iron from transferrin by reticulocytes by 50%*
Since this inhibitor is thought to act on the cell surface 
without penetrating the cell, they considered that iron 
was dissociated from the transferrin at the cell surface 
and was then transferred into the cell, probably by a 
membrane component acting as an iron recipient. No such 
component was identified at the time. However, Glass et al. 
(1 9 8 0) isolated transferrin- and iron-binding proteins from 
the membrane of reticulocytes and postulated that transferrin 
first binds to the cell membrane and then donates its iron 
to an iron acceptor membrane moiety that subsequently 
delivers iron to the cytosol. An iron-binding membrane 
protein in human melanoma cells which exhibits primary 
sequence-homology with transferrin has recently been
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identified (Brown ad., I9 8 2) and may correspond to
the component described by Glass et al. (1 9 8 0).
In conclusion, there are data which indicate that 
transferrin is taken up by receptor-mediated endocytosis. 
However, there is also evidence indicating that there may 
be a plasma membrane—mediated release and transfer of iron 
to the interior of the cells. The relative importance 
of these mechanisms still remains to be resolved, although 
it has been suggested that both processes may operate 
(Zaman et al.. I9 8 0), the extent to which each process 
operates depending on the type of cell involved.
1.2.4.5' Release of iron from transferrin
Several mechanisms for iron-release from transferrin 
have been postulated, but the exact mechanism has not yet 
been fully understood. The elucidation of the mechanism 
involved in the removal of iron from transferrin has been 
complicated by the controversy about whether endocytosis is 
a requirement for the release of iron. Thus, it has been 
proposed that conformational changes in transferrin while 
bound to the cell membrane result in iron release to a 
membrane iron-binding component (see 1.2.4.4). In vitro. 
the iron-transferrin complex can be destabilised by attack 
upon the synergistic anion, or protonation and probably 
these mechanisms are involved in the release of iron from 
transferrin in vivo. There have been several reports 
demonstrating the' release of (bi)carbonate from transferrin 
simultaneously with iron during iron uptake by reticulocytes 
(Egyed, 1973; Schulman _et al. , 1974). Furthermore replacement 
of (bi)carbonate in iron-transferrin complexes with oxalate
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leads to a reduced rate of iron uptake (Egyed, 1973;
Williams & Woodworth, 1973)* These results are consistent 
with the hypothesis that the iron—release from transferrin 
involves the initial attack of the anion. However, the 
results do not prove the hypothesis as whatever mechanisms 
are involved in the release process, the anion will be 
released as well.
There is much evidence, however, that iron-release 
from transferrin may result from protonation of the iron- 
transferrin complex. The reaction of iron with transferrin 
involves the displacement of protons from the complex, and 
since this reaction is reversible, iron-release may involve 
addition of hydrogen ions. Evidence for this comes from 
the observation that the rate of iron release from transferrin 
is directly correlated to hydrogen-ion concentration and 
that iron is released from the transferrin-receptor complex 
only at low pH such as 4.8 - 5*5 (Dautry-Varsat, I9 8 3; dt dl* 
Ciechanover ejk al. , 1983; Klausner e^ aT. , 1983; Morgan, I9 8 3)* 
Further evidence for the importance of protonation in the 
release comes from studies in which treatment of cells 
with NH^Cl, which neutralizes intracellular acidic compartments,, 
blocks segregation of iron from transferrin after endocytosis 
while the reagent does not affect internalisation of 
transferrin (Ciechanover ejb aT. , 1 9 8 3; Harding & Stahl, I9 8 3;
Loh, 1 9 8 3; Rao ejt aT. , I9 8 3). Since NH^Cl, by causing an 
increase in intravacuolar pH, inhibits release of iron from 
transferrin, it seems reasonable that removal of iron may 
take place within the endocytic vacuole. The iron is released
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■when the pH is reduced by the action of a proton pump, 
which would account for the requirement for metabolic energy 
during the iron-uptake process. Alternatively, a lysosome 
may fuse with the endocytic vacuole thus reducing the 
intravacuolar pH to about 4.5 (Ohkuma & Poole, 1978). The 
apotransferrin-receptor complex which is stable at pH 4.8 
(Klaunser ejt aJL. , I9 8 3) could escape digestion, and be 
recycled back to the exterior.
Agents such as pyrophosphates and organic phosphates 
have also been implicated in the removal of iron from 
transferrin vitro (Cowart at al., I9 8 3) and it may be 
that ATP acts both as a source of energy and competing 
chelator (Morgan, 1979)»
Literature data concerning functional differences
I
«
It has been suggested that iron from one site is preferentially
between the two iron-binding sites have been controversial.
taken up by cells. Fletcher & Huehns (1 9 6 7) reported that 
transferrin in the plasma preferentially delivers iron to 
immature red cells from one site, and that the other site 
was orientated towards the hepatocytes and intestinal mucosal 
cells. Further experiments, though, revealed no functional
difference between the sites in homologous systems (Harris 
& Aisen, 1975; Harris, 1977; Huebers at , 1981b;
Heaphy & Williams, 1982b;Young, I9 8 2). For heterologous 
systems, reports have been contradictory, and some authors 
have shown functional differences between the sites 
(Princiotto & Zapolski, 1976) while others did not (Esparza 
& Brock, 1980 ; Huebers ^  , 1981b). Generally, evidence
39 -
suggests that the two iron-binding sites of transferrin 
are functionally the same with respect to iron donation to
■cells, although studies both iri vitro(Huebers et ad., 1981b) 
and vivo (Huebers at ad., 1978; 1981a,b,c) revealed 
preferential utilization of iron from diferric transferrin.
The released iron probably enters the labile pool 
present in the cell (Jacobs, 1977) from which it can be 
taken up by mitochondria for haem synthesis. The mechanism 
by which iron is delivered to the mitochondria has not yet 
been elucidated, although transferrin has been implicated
I
in the direct transport of iron to the mitochondria (Romslo,
1 9 8 0). Intracellular iron transport, however, is beyond 
the scope of this study and further information can be 
obtained from the review of Romslo (1 9 8O).
1.2.4.6. Release of apotransferrin
Little attention has been directed to the mechanism
.
of return of iron-depleted transferrin from the cell to its 
surrounding medium. However, there are reasons to suppose
that apotransferrin leaves the cell by exocytosis. The 
kinetics, metabolic requirements and response to many 
cellular poisons of transferrin release in reticulocytes are 
similar to those of iron uptake. The differential effects 
of pH on the binding of apotransferrin and diferric trans­
ferrin to the receptor probably play an important part in 
the recycling process. At acid pH in the intracellular 
vesicles apotransferrin retains its high affinity for 
receptors and remains bound to them as explained in Section
1.2.4.5. However, once carried to the cell surface,
4
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apotransferrin would be readily exchanged with diferric 
(or monoferric) transferrin because of their higher affinity 
for the receptor at neutral pH of the cell exterior. Both 
transferrin and receptor recycle with little evidence of 
degradation. However, in fibroblasts some degradation of 
transferrin occurs probably as a result of fluid phase 
endocytosis (Octave e_t al. , I98I).
In conclusion, although some details still remain to
be worked out, it is now clear that transferrin acts as a 
specific iron donor to immature erythroid and proliferating 
cells. Uptake probably occurs by receptor-mediated endo- 
cytosis, a mechanism in which the transferrin molecule is 
conserved while iron is acquired by the cell.
r)
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1.3. EFFECTS OF IRON DEFICIENCY ON CELL-MEDIATED IMMUNE 
RESPONSES AND LYMPHOCYTE TRANSFORMATION
1.3*1. General considerations
As previously described, transferrin is important 
because of its ability to transport iron from the sites
of iron absorption and catabolism to cells. Apart from 
erythroid precursors which need iron for the synthesis of
haemoglobin, fast dividing cells also may require iron to 
meet their increased need for the synthesis of metabolically 
important enzymes and cytochromes. The expansion of clones 
of lymphocytes, characterised by an increased cellular 
metabolic activity and cell division, is associated with 
increased expression of transferrin receptors (see 1.2.4.3)» 
which probably reflects an increase in iron requirement.
Inadequate delivery of iron, therefore, may prevent lymphocytes
from proliferating at optimum rate. Evidence to support this 
concept comes from literature data, which indicate that 
iron deficiency can result in decreased DNA synthesis, 
which could impair the cell-mediated immune response.
1 .3 .2 . Iron deficiency
Iron deficiency is the most widespread nutritional 
deficiency recognized throughout the world. The deficiency 
state arises through a variable combination of inadequate
dietary intake, increased metabolic requirements and blood 
loss. Three steps are identifiable in the development of 
iron deficiency (Dallman, I9 8 1). The first is characterised
I
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by depletion of iron stores. If the iron deficiency 
progresses, the second phase appears. This phase is 
characterised by decreased saturation of transferrin with 
iron, and increased total iron binding capacity (TIBC) of 
transferrin. Depletion of both iron stores and transport of 
iron inhibits production of metabolically active compounds
requiring iron either as a constituent or as a cofactor.
Such deficiencies may lead to systemic manifestations.
The final stage in iron deficiency is characterised by 
hypochromic, microcytic anaemia.
1 .3 .3 . Cellular iron requirement
Iron is important for the activity of many enzymes 
(Wrigglesworth & Baum, I98O). Recently increased attention 
has been focused on the association of iron deficiency with :
inhibition of DNA synthesis and cell division. Hershko e_t al.
(1 9 7 0) observed a decrease in the nucleic acid content of
3bone marrow and also a marked drop in the rate of H-thymidine
■
incorporation into DNA associated with chronic iron deficiency. 
Hoffbrand et al* (1976) offered evidence for a mechanism by
which iron deficiency may reduce DNA synthesis. They 
observed that DFO produced an imbalance between DNA precursors 
and concluded that the removal of iron inhibited the iron- 
containing enzyme ribonucleotide reductase, since DFO inhibited
the enzyme in vitro and the imbalance of deoxyribonucleotides 
paralleled. the effects of hydroxyurea, a known inhibitor 
of reductase activity. Retardation of cellular and tissue 
development associated with iron deficiency, probably the
I
I
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result of reduced DNA synthesis (Kochanowski & Sherman,
1 9 8 2) has also been reported. Rothenbacher & Sherman (1 9 8O) 31t-3
observed that 18-day old rat pups from iron-deficient 3
3pregnant dams showed severe fatty degeneration of the liver
1.and lesions in the spleen and thymus. In addition iron 
deficiency may impair the development of the central nervous 
system and cause behavioural changes, as indicated by low 
behavioural responses and low mental scores in young children 
(Seshadri e_t al. , I9 8 2) or low mental development scores 3?
in infants (Lozoff _et a^ . , 1982; Walter e_t al. , I9 8 3). The 33
impaired development of the central nervous system in iron If
deficiency may be the result, in part, of decreased neuronal |
-5,growth and myelinization due to impaired DNA synthesis and ;
also decreased activity of an iron-dependent enzyme involved |
in neurotransmission (heibel et al., 1 9 7 9)*
4In conclusion, literature data indicate that DNA synthesis
gis impaired in iron deficiency. The reduced DNA synthesis 
in iron deficiency can be reflected in reduced cell-mediated !immune responses in man and in animals.
1 .3 *4 . Iron deficiency and cell-mediated immunity
Since it is well documented that iron deficiency in Man
is associated with increased incidence of infectious disease, 
attempts have been made to study the capacity of iron- 
deficient subjects to mount immune response. Cell-mediated
33immune responses, as assessed by in vivo delayed type
hypersensitivity reactions to various antigens or vitro $
3by the proliferative response of lymphocytes, were impaired 4
■ 'j:Ai:
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in iron deficiency, both in Man and in animals. Joynson et al« 
(1 9 7 2) studied cell-mediated immunity in adults with iron 
deficiency anaemia. Delayed hypersensitivity and lymphocyte 
transformation in response to purified protein derivative 
(PPD) of Mycobacterium tuberculosis and Candida antigen 
were impaired in iron deficient anaemic adults compared with 
a control group. In addition, the production of macrophage- 
migration inhibition factor was significantly reduced when 
lymphocytes were stimulated with Candida but only slightly 
reduced when PPD was used. Macdougall ejk ai. (l975) evaluated 
CMI responses in children with latent iron deficiency, iron 
deficiency anaemia and healthy controls. Delayed type
hypersensitivity reactions iri vivo and DNA synthesis vitro 
by stimulated lymphocytes were impaired in the anaemic and 
latent iron-deficient children. Similar observations have 
been reported by others (Chandra & Saraya, 1975), who in 
addition, showed that the proportion of T-lymphocytes was 
slightly but significantly reduced in the iron-deficient 
group in comparison with the control group. Fletcher et al. 
(1 9 7 5) found lymphopaenia and depressed lymphocyte mitogenic 
responses in iron-deficient subjects which returned to 
normal after iron therapy. Bhaskaram & Reddy (l975) reported 
irreversible in vitro reduction in the proliferation of 
lymphocytes isolated from iron-deficient patients. They 
also reported decreased T-cell numbers in the iron-deficient 
group which increased after correction of the iron status. 
Depressed lymphocyte function as assessed by DTH test in 
response to PHA and in vi tro by leucocyte migration inhibition
I
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tests have also been reported in association with iron 
deficiency anaemia (Talwalkar et al.» I9 8 2). Morphological 
abnormalities in lymphocyte mitochondria in iron-deficient 
patients have also been observed. Swelling, vacuolation 
and rupture of the cristae of peripheral blood lymphocytes 
in iron-deficient anaemic patients have been reported 
(jarvis & Jacobs, 1974). Similar mitochondrion abnormalities 
in iron-deficient anaemic subjects have been observed by 
Jimenez et eM. (1 9 8 2), who, in addition, showed that the 
mitochondrion modifications were proportional to the degree 
of iron deficiency. Abnormalities in mitochondria in 
lymphocytes in iron deficiency may result in a defective 
activity of the mitochondria which then may affect cellular 
metabolic activity, resulting in reduced cell proliferation. 
However, an association between abnormalities in lymphocyte 
mitochondria and cell proliferation has not yet been 
demonstrated. Taken together these reports indicate that 
CMI responses are impaired in iron deficiency. However 
normal CMI responses in iron deficiency have also been 
reported. The number of T-cells and the proliferation 
of peripheral blood lymphocytes in response to mitogens 
in iron deficiency were not statistically different from 
the values obtained from control groups (Van Heerden et al.,
1 9 8 1). Furthermore, normal fn vitro proliferation of 
lymphocytes isolated from iron-deficient (Gross et ai., 1975?
Srikantia ejfc ai. , 1976; Krantman e_t al. , I9 8 2) or iron-
deficient anaemic patients (Kulapongs et al., 1974; Sawitsky 
et al. , 1 9 7 6; Gupta _et al. , I9 8 2) have also been reported.
..
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3:!There are, therefore, controversial literature data on 
whether iron deficiency can result in depressed lymphocyte 
transformation and CMI responses in Man, which, in turn, 
may result in increased susceptibility to infections. Firm 
conclusions, therefore, cannot be drawn regarding cell- 
mediated immunity in patients with iron deficiency. Infections 
characteristically seen in immunodeficient states due to 
severe defects of cell-mediated immunity such as disseminated 
viral or fungal diseases, have not yet been reported in 
association with iron deficiency. Certainly patients with 
iron deficiency may escape such infections, but it is then 
difficult to implicate the deficiency of iron as a causative 
mechanism for any infection that may occur. Oral candidiasis 
(Fletcher al., 1973) and chronic mucocutaneous candidiasis, 
(Higgs & Wells, 1 9 7 2) in association with iron deficiency
have been reported before, but candidiasis is classically
.found in patients with impaired cell-mediated immunity.
However, other factors may also predispose the iron-deficient
patients to candidiasis, since not all iron-deficient
■
patients with documented decreased CMI responses have
candidiasis (Higgs & Wells, 1972; Fletcher at ai., 1973)*
.On the contrary, leukaemic patients which have increased
plasma iron and increased transferrin saturation also have
'
problems with mucocutaneous candidiasis. Obviously, factors 
associated with iron balance but unrelated to cell-mediated :
immunity may also be important. In animal models, though, 
it has been shown that impaired host responses associated 
with iron deficiency may contribute to increased susceptibility
;3:
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to the above findings, Soyano e_t al. (1 9 8 2) demonstrated
increased proliferation of splenic lymphocytes in response 
to optimum doses of mitogen, but a decreased response of
to gut parasites. Thus pat\combe et al. (1979) have shown 
that iron deficiency suppressed resistance to reinfection 
with Nlppostrongylus brasiliensis in the rat and that iron 
repletion effectively restored the protective immunity. 
Other defects of cell-mediated immunity in iron deficiency 
in animals have been reported. Kuvibidila e_fc ai. (1 9 8 2) 
reported a decreased proportion of T-cells in the spleens 
of iron-deficient mice. Decreased numbers of T-cells may 3
result in a reduced proliferative response of the lymphocytes
in vivo. Impaired vitro blastogénie response of splenic 
lymphocytes isolated from iron-deficient mice has also been 
reported (Kuvibidila ai., 1 9 8 3a,b), which was corrected 
by iron supplementation, showing that the defect in iron 
deficiency can be corrected after iron therapy. In another 
study, delayed cutaneous hypersensitivity of mice to 
dinitrofluorobenzene was reduced in association with iron 
deficiency (Kuvibidila at a^ . , I9 8I.), this being the result
of reduced DNA synthesis as assessed by incorporation of■ Ilabelled DNA-precursors into the sensitised area. Furthermore, 
the DTH reaction returned to normal on administration of 
iron dextran prior to the recall dose of dinitrofluorobenzene.
"■3Taken together these observations indicate that in iron 
deficiency some function of lymphocytes associated with 
the ability of cells to proliferate is defective, and that 
this defect is corrected after iron therapy. In contrast
:
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thymic lymphocytes isolated from iron deficient rats.
Their results might be explained by either an alteration 
or imbalance of the population of cells in various lymphoid g
compartments, or alteration in the migration pattern of 
lymphocytes due to iron deficiency.
g
In conclusion, literature data on the effect of iron
deficiency on cell transformation showed that vivo the 
proliferative response of lymphocytes is impaired both in s
Man and in animal. However, data arising from the in vitro 
studies contradictory and some investigators found 
reduced mitogenic or antigenic responses of lymphocytes 
while others reported normal proliferation. The exact 
effect of iron deficiency on cell proliferation, therefore, 
remains to be elucidated, and forms the subject of part of 
the work reported in this thesis.
:;3:'1
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CHAPTER 2
PRELIMINARY EXPERIMENTS
4
-4
I'-4'
3
=Lf
A
i
I
%
■S'
5 0
2.1 INTRODUCTION
The work presented in this thesis involved the study 
of the effect of iron and transferrin on mouse lymph node 
cells in vi tro. The proliferative response was estimated 
by measuring the degree of incorporation by Con A-stimulated 
lymphocytes of labelled thymidine into newly synthesized 
DNA.
Since incorporation of labelled thymidine into 't.Ke. cells 
may not reflect proliferation, parallel morphological 
evaluation or autoradiography may be necessary to assist in 
the estimation of proliferative responses. However, parallel 
studies using autoradiography as well as estimation of DNA 
synthesis by measuring the degree of labelled thymidine 
incorporation indicates that it is the transformed cells 
which incorporate the label (MacKinney ejk al. , I9 6 2).
Furthermore, lymphocyte proliferation in vitro measured 
by the technique of incorporation of labelled thymidine has 
been used for a long time to provide insight into the 
pathogenesis of disease involving immune mechanisms (Aisenberg, 
1 9 6 5; Bjune e_t al. , 1976; Bjune, 1979), and also to study 
the effects on cell-mediated immunity of iron deficiency 
with or without anaemia ( Joynson e_t al. , 1972; Bhaskarom & 
Reddy, 1975? Fletcher _et al. , 1975; Cross e_t al. , 1975? 
Macdougal e_t ad., 1975? Srikantia _et al. , 1976; Van Heerden 
et al. , 1981 ; Krantman e_t ed. , 1982; Soyano et al. , 1982; 
Kuvibidila ejb al. , 1983a,*b ) , Additionally, the technique
has been used to investigate the effect of certain drugs on
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cell-mediated immune responses (Bonnet aJL. , 1984; Pay an iet ad., 1984). The study of the effects of growth factors 
involved in T-cell proliferation (Phillips & Azari, 1975;
Andersson ejb ad., 1979; Coutinho ejb ad., 1979; Brock, I98I; 
Novogrodsky e_t , 1982; Lipkowitz e_t ad., 1984; Malek &
Shevach, 1984), or accessory-cell cooperation (Smith et ad.,
I
1980b ; Sunshine ejb al. , I98O; Fitzgerald ejb ad., I9 8 3) has 
also been achieved by measuring proliferation as the degree
,.S"S'of incorporation of labelled thymidine into newly synthesized A"4
DNA. 4
In the present investigation, the experimental technique, AA
in particular the use of serum-free medium to culture the 
cells, was developed by Brock (I98I) using 1 ml cultures in d
test tubes, and since the technique needed to be adapted to 
a microculture method, some preliminary work was essential 4
,33
in order to find the exact conditions to perform the 
experiments.
One of the important factors which may affect the 
estimation of the proliferative response of the lymphocytes 
is the period for which the cells are cultured before 
proliferation is measured. At certain times, measurement 4
33of incorporation of labelled thymidine into newly synthesized %
DNA may not reflect the actual degree of cell-proliferation ;
as some cells may undergo transformation without having 
entered the S phase of the cell cycle. It was therefore 4
important to find the time for which lymph node cells should 
be cultured in order to get maximum thymidine incorporation.
I
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The degree of response to ConA of mouse lymph node cells 
in serum-free and serum-containing media was therefore 
estimated at different time intervals. Furthermore, since 
the degree of lymphocyte proliferation after mitogenic 
stimulation depends on the amount of the mitogen used (Stobo 
et al. , 1972; Ling# Kay , 1975? Wang al , 1976) y it was 
also essential to find the concentration of ConA which induced 
maximum proliferation. As previous work in this laboratory 
(Brock, personal communications) showed that in test-tube 
cultures optimum transformation of mouse lymph node cells 
in serum-free and serum-containing culture medium was achieved 
at concentrations of ConA of 1 and 8 pg/ml, respectively, 
in the present investigation a range of values of 0 .0 2 5 - 
4 pg/ml for serum-free and 1 - l6 pg/ml for serum-containing 
medium was used.
It has already been established that when lymphocytes 
transform in serum-free conditions, their response depends 
on the availability of transferrin and iron (Phillips & ■
Azari, 1975? Brock, 1981; Brock & Rankin, I98I). Since
different saturations of transferrin with iron have different
■effects on the proliferation of lymphocytes (Brock, 1 9 8I), 
it was essential in the present work, to find the saturation 
of transferrin with iron which induced a good proliferative 
response in order to use it in the subsequent experiments 
as a standard positive control. Additionally, as large
.amounts of transferrin were needed to complete the studies, 
it was important to determine whether human transferrin
53
which has the advantage of being commercially available 
in a highly purified state, could be substituted for the 
homologous mouse transferrin in the in vitro mouse lymphocyte 
cultures.
Lymph node cells contain a small percentage of cells 
other than lymphocytes such as monocytes or macrophages.
The degree of incorporation of labelled thymidine into new 
DNA might, therefore, also reflect replication of these 
adherent cells. Thus, an experiment was performed in which 
the incorporation of labelled thymidine by lymph node cells 
was studied in the presence and absence of adherent cells.
I
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2, 2 MATERIALS
2.2.1. Animals « Unless otherwise stated, female C^H/Bi
inbred mice, 12-17 weeks old were used throughout, and 
obtained from the departmental animal house stock.
a
I
2.2.2. Reagents, When necessary, media were prepared in 
iron free apparatus (see 2,3*1*2).
2.2.2.1. Phosphate buffered saline (PBS). This consisted of 
NaCl (8 g/l), KCl (0.2 g/l), NaHPO^ (I.I5 g/l) and KH^PO^ 
(0.2 g/l) (Analar grade, BDH Chemicals Ltd., Poole, Dorset, 
England), Solutions were made in de-ionised distilled water 
(d-DW) and when appropriate sterilised by filtration.
2.2.2.2. Ferric nitrilotriacetate solution Fe(NTA)^10 mM . 
This solution was prepared by mixing one volume of a freshly
prepared solution of FeCl„ (20 mM; BDH) and one volume of3
NaNTA (80 mM; pH 7; Sigma Chemical Co., Poole, Dorset, England).
1
The FeCl^ was added to the NaJSTTA dropwise with constant 
stirring, adjusting the pH to 5 as required with 1 M NaOH 
to prevent the NTA-free acid precipitating. The final pH 
was 5 •
2.2.2.3' Scintillation fluid. This solution was prepared by 
mixing one volume of Triton-X-100 to two volumes of a 
solution of 2,5 diphenyloxazole (5 g/l) and l,4-di(2( 
5-phenyloxozolyl)benzene) (0*3 g/l) in toluene at 56°C (all
chemicals obtained from BDH).
2.2.2.4. Concanavalin A solution. Concanavalin A was obtained 
from Miles Laboratories, Stoke Poges, Slough, Bucks, England
I
j
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and solutions of the appropriate concentrations (see 2.4.2) 
were prepared in PBS, sterilised by filtration and stored
o ■#'in aliquots of 100 pi at -20°C. Each aliquot was used once
only. ■ ir
2.2.2.5» Human serum albumin solution. A solution of 1%
f(w/v) human serum albumin (HSA; Behringwerke, Hoechst, Hounslow,
,Middlesex, England) was prepared in RPMI-l640 culture medium 
(Flow Laboratories, Irvine, Strathclyde, Scotland). The 
solution was sterilised by filtration and stored at 4°C.
The albumin contained no detectable transferrin (j.H. Brock, f
personal communications).
.2.2.2.6, Human apotransferrin solution. Iron free (apo-) 
transferrin was obtained from Behringwerke. A stock solution 
(lO mg/ml) was prepared in PBS containing 1^ (w/v) NaHCO„
(Analar grade, BDH) to ensure iron binding, sterilised by 
filtration and stored at 4°C. It was used within a month.
For 20 or 25^ iron saturated transferrin preparations, 3*0
or 3*75 pg/ml, respectively, of iron as ferric nitrilotriacetate « 
complex (see 2.2.2.2) was added, Tor other saturations of 
transferrin with iron, the appropriate amount of Fe(NTA) was 
used.
2.2.2.7» Standard culture medium. The standard culture medium
Iconsisted of RPMI-l640 (without Hepes: Flow) supplemented 1
with penicillin (lOO lu/ml) and streptomycin (lOO pg/ml) i
(Flow) and 0.3 mg/ml L-glutamine (BDH). To this 2-mercapto- 
ethanol (2-Me; final concentration 50 pM; BDH) and 10% 
final concentration of foetal calf serum (FCS; Gibco, Paisley, 
Scotland) were added. For serum-free conditions, HSA (1 mg/ml
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final concentration) and human transferrin (usually 50 pg/ml 
final concentration and 3 0% saturated with iron including 
the iron present in the culture medium; see section 2.4.3) 
were used instead of FCS.
2.3 METHODS
2.3*1• Estimation of iron
2.3'1'1' Estimation of iron in the culture medium.
The iron content of the serum-free culture medium (see 
2.2.2.7) was determined by Dr D. Halls, Department of 
Biochemistry, Glasgow Royal Infirmary, Scotland, using carbon 
furnace atomic absorption spectroscopy. Two different 
batches of RPMI-l640 without Hepes culture medium were used
during this work. The iron content of the first batch was 5
1 2 .5 ng/ml and that of the second 5 ng/ml. These levels of
iron were enough to saturate 8 .9% and 3*4%, respectively of |
the added transferrin, and these figures were.rounded off
to 10% and 5% respectively, in subsequent experiments.
2. 3• 1 • 2. Estimation of the iron contamination of plasticware -i
used to prepare media or culture cells.
Iron free plastic bijou, test tubes and pipette tips 
were used throughout this work and were selected from a 
number of items purchased from different suppliers after %
estimating their contamination with iron spectrophotometrically,. 
using the reagents prepared for serum iron estimation (see 
Section 3*2.3)' The reagents were left in contact with 
the item for 30 min and an aliquot was then aspirated and 
the absorbance was measured against a reagent blank in a
I
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1 cm cuvette. Usually ten articles of the same kind were 
tested, and the iron-free were selected on the basis of 
low absorbance (zero - 0.002).
The following items were found to be iron-free and used 
in the subsequent experiments:
1. Sterile 7 ml plastic bijou (Sterilin, Teddington, Middlesex, 
England).
2. Sterile 20 ml plastic universal bottles (sterilin; not 
tested but informed of suitability by Dr D. Halls).
3* Plastic 10 ml conical bottomed test tubes (sterilin).
4. Polypropylene test tubes (Falcon, Beeton-Dickinson, Oxnard 
Ca, U.S.A. )*
5. Plastic 50 ml tissue culture flasks (Gibco).
6. Sterile 96V - well microtitre tissue culture plates 
(Linbro Chemical Co., New Haven, Conn., U.S.A.).
7* Plastic 1.5 ml Eppendorf reaction vials (Anderman & Co.
Ltd., East Molesey, Surrey, England).
8. Treff yellow plastic pipette tips (0.200 pi; Scotlab 
Instruments Ltd., Carluke, Lanarks, Scotland).
9 . Volac blue plastic pipette tips (O-IOOO pi; A & J.
Beveridge Ltd., Edinburgh, Scotland).
Glassware was rendered iron-free by washing in 10%
HCl solution for 10 h and then rinsing in d-D¥ three times. i';
2 .3 *2. Preparation of cell suspension and culture conditions*
Cell suspensions were prepared from the peripheral 
(brachial, axillary and inguinal) and mesenteric lymph 
nodes of the mice. The lymph nodes were removed from freshly
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killed mice under sterile conditions and the cells were 
teased into RPMI-164-0 with Hepes (Gibco) culture medium 
supplemented with penicillin, streptomycin and L-glutamine 
as described in Section 2.2.2.7* The cell suspension was 
mixed well, transferred into a sterile universal bottle 
and left to stand for 1-2 min to allow any pieces of tissue 
to settle to the bottom. The cell suspension was then 
carefully aspirated into a clean universal bottle and the 
cells were washed once at 1200 r.p.m, for 45-60 sec in the 
culture medium. The suspension contained 90-95% lymphocytes 
as demonstrated by Leishman stain and were 85-95% viable as 
measured by eosin exclusion. The cells were finally suspended 
in the culture medium (see 2.2.2.7) at a concentration of
2 .3  X 10^ viable cells/ml and, unless otherwise stated, 
were cultured in conical bottomed microtitre culture plates 
(see 2.3*1* 2 ), each well containing 2 x 10'^  cells and ConA 
at the appropriate concentration (see 2.4.2) in a total 
volume of 100 pi. The importance of adding ConA last should 
be noted. Preliminary experiments showed that the addition 
of ConA to the medium before adding the cells prevented 
transformation particularly in serum-free medium. The cells 
were cultured at 37°C in an atmosphere of 10% CO^, 90% air 
using a New Brunswick humidified CO^ incubator, for 2-3 days, 
as required. Proliferative responses were assayed by 
pulsing cells for 4 h with 50 pl/well of ^"^C-thymidine 
containing 12.5 nCi (Specific activity 5C-6O mCi/mmol;
Amersham International, England) before the cells were
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harvested on a Skatron cell harvester (Flow), The cell- 
associated radioactivity was measured for 5 min in a Packard 
liquid scintillation counter (Model 3320). Unless otherwise 
stated, the cultures were set up in heptuplicates with quadru­
plicate ConA-negative controls.
2.3*3* Preparation of mouse serum transferrin
Mouse transferrin was prepared from pooled mouse serum 
using the method described by Brock ejb al. (l9?6) for the 
preparation of bovine transferrin except that the initial 
step of rivanol (6,9-di-amino-2-ethoxy acridine lactate) 
precipitation step was omitted. Mouse serum was prepared 
by centrifugation of clotted blood, and after aspiration of 
the serum enough iron from Ib^TA)(see 2.2.2. 2) was added to 
fully saturate the transferrin. The ^-globulin of the 
serum was precipitated at for 2k h with 2M(NH^)2S0^
(BDH) and the supernatant containing the transferrin was 
aspirated after centrifugation in a MSE-high speed-18 centri­
fuge for 20 min, at 12,000 rpjm. Crude transferrin was 
precipitated from this solution at 5°C for 2k h by increasing 
the (NH^)2S0  ^ concentration to 2.8 M and recovered by 
further centrifugation. The precipitate was dissolved in 
distilled water (D¥) and dialysed against 0.05 M Tris- 
(hydroxymethyl) methylamine (Tris) pH 7*6 for 20-24 h.
Further purification of the transferrin preparation was 
achieved by chromatography on DEAE-Sephadex A50 (Pharmacia, 
Uppsala, Sweden). The column was equilibrated with 0.05 M
'■l:;NaCl/0 .0 5 M Tris, pH 7*6, and the transferrin was eluted
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first with equilibrating buffer and then by stepwise increase 
of NaCl concentration from O.O5 to 0.10 M in O.O5 M Tris, 
pH 7 .6. Transferrin eluted at 0.10 M NaCl but still contained 
a contaminant (presumed to be haemopexin) which was removed 
by chromatography on SP-Sephadex C50 (Pharmacia) equilibrated 
with citrate buffer, 0.02 M, pH 5*1» and eluted with citrate 
buffer by a stepwise increase of the pH from 5*1 to 5*55»
value; E. ^ = 11.2 for human transferrin (Feeney & Komatsu, ’ icm ^
The transferrin was eluted at pH 5» 55» Removal of any 
remaining iron was achieved by dialysis against 0.02 M sodium 
citrate pH 5»1* The transferrin solution thus obtained was 
concentrated by ultrafiltration and the purity was tested 
by zonal cellulose acetate electrophoresis^barbitone buffer 
(pH 8.6) and mouse transferrin preparation as a standard.
The barbitone buffer consisted of Tris (4.8 g/l), barbitone 
(2.06 g/l) and sodium barbitone (8 .I3 g/l). The samples 
were applied at the cathode and run under a constant current 
(20 mA) for 1 h. The concentration of the transferrin in 
the solution was estimated spectrophotometrically by measuring 
the absorbance at 280 nm and using the extinction coefficient
1% nm
1966). Finally the preparation was dialysed against three 
changes of D¥ at 5^C for 24 h and freeze-dried.
2.3 *4 . Leishman stain
About 6 X 10^ cells were deposited on to clean slides 
in a Shandon cytocentrifuge at 1200 r.p.m, for 90 sec. The 
preparations were air dried and then fixed and stained by 
immersing the slides in undiluted Leishman stain for 2 min 
and then in diluted stain (1 in 3 in D¥) for 10 min. The
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slides were then washed in tap water, air-dried and examined 
in a Leitz-¥etzlar light microscope (x 200). The number of 
large blast like cells and total cell counts in different 
fields taken at random were obtained and the percentage of 
blasts was calculated. About 300-350 cells were counted 
each time.
I
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2.4 RESULTS
2.4.1. Time-course of the proliferative response of mouse 
lymph node lymphocytes to Concanavalin A in vitro 
Mouse lymph node cells were cultured in serum-free and
serum-containing medium as described in Section 2.3*2. At 
different time intervals cells were pulsed, harvested and 
their radioactivity was measured (see 2.3*2). Controls 
without ConA were also included. The maximum proliferative 
response in both media was obtained between 46-71 h with 
the peak at 56 h (Fig. 2a), and therefore, in the subsequent 
experiments, the cells were cultured for 5 5 -6 9 h. Although 
in this experiment the degree of transformation of the cells 
when cultured with ConA in medium containing serum was not 
very much higher than the response when serum-free medium 
was used (Fig. 2a), serum-containing medium sometimes induced 
better transformation than the serum-free conditions (Fig. 3, 
and other preliminary experiments not reported here). This 
was probably due to the fact that the serum-containing medium 
contains nutrients and growth-promoting factors other than Ialbumin and transferrin, hence the enhanced proliferation of
the lymphocytes. In the absence of ConA the degree of 
transformation in both media was very low (Fig. 2b), However, 
there was some transformation observed which might have 
been the result of non-specific stimulation of some lymphocytes 
due to a few mesenteric lymph node cells having been
.antigenically stimulated prior to culturing. Furthermore, 
the background transformation of lymphocytes in serum-containing 
medium was very much higher than when the cells were cultured 
in serum-free conditions.
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In vitro transformation of mouse lymphocytes in 
serum-containing (• - u) and serum-free (o - o) medium.
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(b) Cells cultured without concanavalin A.
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batch of ConA was used, maximum transformation vas obtained
2.4.2. The effect of different concentrations of concanavalin A 
on the proliferative response of mouse lymph node cells 
Lymph node cell suspensions were prepared as described 
in Section 2,3.2. The cells were cultured in serum-free 
medium (see 2.2. 2.7) containing 0*25 f O.3 , 1, 2 and 4 pg/ml
of ConA, or in serum-containing medium (see 2.2. 2*7) containing <’
.1, 2, 4, 8 and I6 p,g/ml of ConA. The cells were cultured
for 61 h and proliferative responses were assayed as described S;
in Section 2.3*2. Two different titration experiments were 
performed using different batches of RPMI-l640 medium and 
ConA. In the first experiment, culture medium containing
1 2 .3  tî-g iron/ml was used. When a new batch of ConA was ÿ
required, it was titrated using a new batch of culture medium
in which the endogenous iron was 3 ng/ml. Figure (3a,b) shows 
the responses of lymphocytes to ConA in serum-containing and i
serum-free medium, respectively using the first batch of ConA,
The concentrations of ConA which induced optimum transformation 
were 4 and 1 ^g/ml, respectively. However, when the new 1
at concentrations of 2 and 0.3 ^g/ml for serum-containing 
or serum-free medium, respectively (Fig. 4). The reason 
that higher concentrations of ConA were needed to induce 
optimum transformation in serum-containing than in serum-free 
medium was probably that some of the ConA binds to serum 
proteins in the medium. In the subsequent experiments the 
concentrations of ConA used were 1 or 0 .3 ^g/ml for serum- 1
free medium and 4 or 2 pg/ml for serum-containing medium for 
the first and second batches of ConA, respectively.
I
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Figure 3: The effect of concanavalin A (batch 1) on the
in vitro transformation of mouse lymphocytes in 
serum-containing (a) and serum-free (b) medium.
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Figure 4 ; The effect of concanavalin A (batch 2) on the
in vitro transformation of mouse lymphocytes in 
serum-containing (a) and serum-free medium (b).
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2 .4 .3 * The response to concanavalin A of mouse lympli node 
cells in serum-free media containing different 
saturations with iron
Lymph node cells were cultured with ConA 1 pg/ml 
(see 2.4.2) in serum-free medium containing transferrin 
of total saturation with iron of 10, 30, 5 0? 70 and 100 per
cent (see 2.2.2.6). Negative controls without ConA were 
also included. The cultures were set up in quadruplicate 
with duplicate ConA-negative controls. Two-way analysis of 
variance (Two-way AN0VA)of all observations (excluding those 
when lOO^ o—iron-saturated transferrin was used) showed that 
in medium containing 10%—iron-saturated transferrin the
proliferative response of the lymphocytes was significantly
lower than when transferrin 30 to 70 per cent saturated with 
iron was used (Fig. 5)* In subsequent experiments, therefore,
the effect of restriction of iron on lymphocyte transform-
.ation was investigated by using lO^ o—iron-saturated trans- Iferrin in the culture medium. The degree of transformation 
of lymphocytes in^  medium containing 100%—iron-saturated 
transferrin was also very much reduced. This suggests that 
at very high saturation of transferrin with iron, the iron 
may be toxic to the cells. Nevertheless, in subsequent 
experiments the cells were cultured in medium containing 
30^—iron-saturated transferrin for a positive control response. 
This saturation of transferrin was chosen for the reason 
that it may be more appropriate to conditions in a responding 
lymph node (see Discussion, p.78 ). Furthermore, a difference a
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in lymphocyte transformation-promoting activity between 
10 and 30 per cent iron-saturated transferrin was consistently ; 
observed in this set of experiments as well as in other 
experiments (see Chapter 3 )®
2.4.4. Effect of mouse and human transferrins on the response 
of mouse lymph node cells to concanavalin A 
Mouse lymph node cells were cultured as described before 
(see 2 .3 *2 ) in serum-free medium containing ConA (0*5 
see 2 .4 .2 ) and 309 —^iron-saturated human or mouse transferrin. 
Experiments using 10%—iron-saturated transferrins were also g
included. The degree of transformation of lymphocytes in ?medium containing 3 0%—iron-saturated mouse transferrin was
■-i"
not statistically different from tlie response in medium 
containing 30%-iron-saturated human transferrin (Table 1).
Further, the mitogenic response of lymphocytes in medium 
containing 10%—iron-saturated mouse or human transferrin
did not differ from each other, and were reduced compared it
with the responses when 3 0%-iron-saturated transferrins were
used. These results indicate that human transferrin does 
not differ from mouse transferrin in its ability to promote 3
lymphocyte proliferation and that human transferrin can 
be substituted for mouse for the dm vitro lymphocyte cultures 
in serum-free conditions.
2 .4 .5 * Effect of adherent cells on the transformation of 
mouse lymph node cells 
Mouse lymph node cells (2 x 10^ viable cells/ml) were 
cultured in serum-free or serum-containing medium in flat-
7 0
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bottomed 24-well plates (Linbro Chemical Co.), each well 
containing 1 ml of cell suspension and ConA at 1 or 4 pg/ml 
(see 2.4.2), respectively. The cells were cultured as 
described before (see 2 .3 .2 ) for 65 h before being pulsed 
with 50 nCi of ^^C-thymidine for 4 h. However, before the 
cells of each well were pulsed, they were mixed and the 
medium containing the cells was transferred to a clean well 
in the plate in order to separate the adherent cells from 
the lymphocytes. Controls consisting of cells cultured 
but not transferred before being pulsed, as well as negative 
controls without ConA were included. The cultures were 
set up in quadruplicate with duplicate ConA-negative controls.
l4Incorporation of C-thymidine into cells which were trans­
ferred into clean wells before being pulsed with the 
labelled thymidine was the same as cells which were not 
transferred (Table 2), in both serum-containing or serum-free 
medium. Microscopic observations with a Nikon phase contrast 
microscope (x200) of the wells from which cell suspensions 
were removed revealed macrophage-like cells adherent to 
the bottom of the wells. These results indicate that the 
cell-associated radioactivity was due to activity of lympho­
cytes and not due to that of monocytes or macrophages.
The degree of transformation in the absence of.ConA 
was higher in experiment I than in experiment II. The 
reason for this was not clear, but in neither case was 
shown any difference between cultures with or without 
adherent cells. 3
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2. 5 DISCUSSION
Measurement of incorporation of radiolabelled precursors 
into DNA by mitogen stimulated lymphocytes has been used 
extensively to follow proliferation in vitro. The method 
measures an increased amount of biosynthetic activity 
following stimulation and therefore reflects directly the 
increased numbers of transformed cells. Proliferation also 
depends on the activity of macrophages; IL-1 production by 
macrophages and also antigen presentation during antigenic 
stimulation, play a crucial role in the proliferation of 
lymphocytes (Larsson ejb al. , 1982; Rock & Benacerraf, 1983; 
1984; R e s k e — hunz ejk al, , 1984). However, as seen in the 
present investigation, macrophages did not incorporate 
labelled thymidine (Table ^), indicating that the accumulation 
of ^^C-thymidine by stimulated mouse lymph node cells was 
the result of lymphocyte activity alone and not due to 
activity of these adherent cells.
In this study, it was found that maximum incorporation 
of ^^C-thymidine in response to ConA by mouse lymph node 
cells in serum-free or serum-containing media occurred in 
46-71 h cultures with a peak at 56 h (Fig. 2). In many 
cases lymphocytes have been cultured for a longer time 
before the degree of proliferation was assessed by measuring 
the incorporation of labelled thymidine into newly synthesized 
DNA (joynson ejk aT. , 1972; Kulapongs et al. , 1974; Phillips 
& Azari, 1974; Fletcher e_t al. , 1975; Gross et , 1975; 
Sawitsky et al. , 1976; Brock, I98I; Van Heerden et al. , 1 9 8I 
Krantman et al., 1982; Novogrodsky et al., 1982; Soyono et al.,
74 -
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I9 8 2; Kuvibidila jet ad., 1983a ; Bonnet e_t ad. , 1984; LipKovntx.
et ad., 1984; PayairL ejk ad., 1984). However, most of
these workers used peripheral human blood lymphocytes
(Joynson e_t ad. , 1972; Kulapongs _et ad. , 1974; Phillips &
Azari, 1974; Fletcher e^ ad. , 1975; Gross jejb ad., 1975;
Van Heerden ejfc ad., 1981; Krantman e_k a^ . , 1982; Novogrodsky
et ad., 1 9 8 2; Pay an ejt ad. , 1984), while mouse lymph node i
cells were used in the present investigation. Others have
used lymphocytes from the spleens of rats ( Soyano ejt ad.,
1 9 8 2) or mice (Kuvibidila jejb ad. , 1983a, b ).Brock (1 98I) used
mouse lymph node cells, but test-tube cultures were used
rather than the microculture method employed in the present
investigation. In general, there is heterogeneity in the
proliferative response of lymphocytes iu vitro depending
.on the species, type and concentration of the mitogen (or 
antigen), and age of the animal from which the cells are 
isolated (Ling & Kay, 1975)* Despite this heterogeneity
it has been shown that the first period of DNA synthesis 
by stimulated lymphocytes occurs 48-72 h after addition of 
the mitogen (Soren, 1973; Ling & Kay, 1975), although a 
small proportion of cells may be early (24 h) or late (above 
100 h) responders (Soren, 1973)* Furthermore, Sasaki & 
Norman (1 9 6 6) showed that 48-70 h cultures of lymphocytes 
consist of cells which are in the first cycle of division 
and that after 72 h stimulated cells are in the second or 
third metaphase. However, despite the fact that 72 h 
cultures have been more often used, in the present investi­
gation, the cells were cultured for 55" '89 h since maximum
I:
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:éproliferation of mouse lymph node lymphocytes occurred at 
this time (Fig, 2a. )• In the absence of ConA the
/Iproliferative response in both media was very much lower j
4than when it was present. However, there was still some
1 kincorporation of C-thymidine by the cells (Fig. 2b).
This might have been due to repairing of DNA by some cells, 
or the result of non-specific stimulation of some lymphocytes.
A few mesenteric lymph node cells might also have been 
antigenically stimulated prior to culture. The incorporation 
of labelled thymidine by unstimulated cultures was greater 
when the cells were cultured in medium containing FCS 
(Fig. 2b). Foetal calf serum has also been found to produce 
a considerable ’’background" stimulation of human lymphocytes, 
which in 7-day cell cultures, affected from 5-48% of the 
lymphocytes (Joynson & Russell, I9 6 5). However, the 
"background" stimulation observed in both media was always 
very much lower than the response of the mitogen-containing ■
samples. Serum-free medium, therefore, has an advantage
over serum-containing medium in always giving low "background".
The incorporation of ^^C-thymidine by lymph node cells
cultured with ConA depended on the concentration of ConA 
used (Figs, 5,4). It is well established that the degree 
of lymphocyte proliferation vitro depends on the.strength 
of the stimulus received which in turn will depend on the 
number of molecules of mitogen bound to the cell surface 
receptors (stobo _et al. , 1972; Ling & Kay, 1975)» At 
concentrations of ConA above the optimum, however, the 
effect of the mitogen on the cell proliferation and
i
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differentiation is inhibitory rather than stimulatory as 
indicated by the decreased incorporation of thymidine
(Figs. 3,4). Concanavalin A is an agglutinin (Ling & Kay, 
1975)9 so that at higher concentrations it may cause some 
agglutination of lymphocytes, and hence decreased responses.
In addition, the binding of the mitogenic lectins has a 
distinctive effect on the mobility and distribution of all 
receptors on the lymphocyte cell-membrane (Yahara- &
Edelman, 1972; Cunningham et al., 1976). Depending on the 
conditions of cell-cultures, ConA has two antagonistic
:■ !.effects on the mobility of the cell receptors, and at 
high concentrations, it causes inhibition of cap formation 
by both its own receptors and other receptors, thus affecting 
receptor-cytoplasm interaction, and therefore mitogenesis 
(Yahara & Edelman, 1972; Wang ejb al. , 1976). This typical 
unimodal dose-respouse curve seen in the mitogenic 
stimulation of lymphocytes has been also observed by other 
investigators (Ling & Kay, 1975; Cunningham e_t , 1976;
Stobo, 1 9 7 7) and indicates the need to accurately :
determine the dose of ConA for optimum response. It was 
found, in the present investigation, that higher concentrations- t 
of ConA were needed to induce optimum transformation in 
serum-containing medium than when serum-free conditions 
were used (Figs, 3,4). This was probably because some 
ConA binds to serum proteins in the medium. It has been 
shown that mitogens such as PHA and ConA can react with 
a -macroglobulin, ^-lipoprotein and IgM and to a lesser 
extent with IgA (Morse, I9 6 8; Powell & Leon, 1970; Ling &
7 7
Kay, 1975 )• Bindiiig, therefore, of the mitogen to these 
molecules will cause a reduction in the total number of 
mitogen molecules available for lymphocyte activation.
Since lymphocyte proliferation initially depends on the 
strength of mitogenic stimulus, higher concentrations of 
mitogen will, therefore, be needed to induce a proliferative 
response when serum proteins are present. In earlier 
experiments it was found that optimal transformation was 
obtained using k pg/ml and 1 p,g/ml in serum-containing and 
serum-free media, respectively (Fig. 3)* However, variation 
in the proliferative response of lymphocytes cultured in 
both media was observed when a second batch of ConA was 
needed later on (Fig. 4), and thereafter optimal transformation 
required concentrations of 2 pg/ml and O . 5 ^g/ml, respectively.
The degree of proliferation of mouse lymph node cells 
cultured with ConA in serum-free conditions also depended 
on the saturation with iron of the transferrin present 
in the medium. Maximum proliferation was observed at a 
saturation of transferrin with iron of 7^% (Fig. 5)» Since, 
in vivo, saturation of mouse transferrin with iron is 
6^-80% (Puschmann & Ganzoni, 1977; Kuvibidila ejb a^ . , 1983a; 
also Chapter 3), the above result may indicate that the 
saturation with iron of the transferrin added to the medium 
required to induce optimum proliferation of mouse lymphocytes 
in vitro may correspond to normal in vivo transferrin 
saturation. At lower saturations of transferrin, the 
proliferative response of lymphocytes was progressively 
reduced (Fig. 5)« Brock (1 9 8I) also showed that the degree
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of proliferation of mouse lymph node cells cultured in 
serum-free conditions depended on the saturation of trans­
ferrin with iron, and that maximum proliferation was observed 
at 30-70% saturation of transferrin with iron. However, 
he found no significant difference in the lymphocyte response 
when 30 or 50 per cent iron-saturated transferrin was used 
which is different to the results observed in the present 
investigation. This might have been due to the different 
experimental conditions employed. However, 30%-iron- 
saturated transferrin was subsequently used as a positive 
control for the reason that in a lymph node the saturation 
of transferrin with iron may be lower than that in the serum 
especially when a local response causes a rapid uptake of 
transferrin-bound iron, resulting in .a local reduction of 
the saturation of transferrin.
The initial step in the uptake of iron involves the 
binding of the transferrin to specific cell membrane receptors 
and in rat hepatocytes (Young & Aisen, I9 8 1) and in rabbit 
reticulocytes (Young et al.. 1984b)the strength of interaction 
of transferrin with the receptor decreases from diferric 
to monoferric to apotransferrin. Furthermore, in human 
reticulocytes iron from diferric transferrin is more rapidly 
taken up by the cells than iron from monoferric transferrin 
(Huebers e_b aT. , 198lb; 1 9 8 3)* In consequence the degree 
of transformation of lymphocytes in medium containing 
partially saturated transferrin will most likely depend 
on the proportions of monoferric, diferric and apotransferrin 
molecules, hence the increased proliferation associated 
with increased percentage saturation of transferrin with
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iron observed in the present investigation. From the data 
of Williams e_t ad. (1978) it can be calculated that for 
ovotransferrin to which iron as Fe(NTA) in O.IM - NaHCO^ 
is added to saturate the transferrin by 7 0%, 3 0% of the
molecules are expected to be in the diferric form and 4-0% 
and 10% would be monoferric and apotransferrin, respectively. 
However, at lower saturations of transferrin with iron the 
number of diferric molecules decrease and the number of 
monoferric and apotransferrin molecules will increase 
accordingly. Thus, the results suggest that the amount of 
iron bound to transferrin may be important in determining 
the degree of proliferation. However, at 100% saturation
■
of transferrin with iron, the degree of transformation of 
mouse lymphocytes was lower than when the cells were cultured 
in medium containing 50 or 70 per cent iron-saturated 
transferrin (Fig. 5)« Brock (1 9 8I) also reported similar 
results. It seems, therefore, that with mouse lymph node 
cells, the higher the saturation of transferrin with iron 
the better the vitro proliferation until iron-saturation 
of transferrin reaches a level which corresponds to the 
in vivo situation. Above this level, the effect is reversed 
and transformation is reduced. Several explanations are 
possible. It has been suggested that transferrin-bound zinc 
is also important for lymphocyte proliferation (Phillips,
1 9 7 8) and since iron binds to transferrin with higher affinity 
than zinc (Fraenkel-Conrat & Feeney, 1950; Warner and Weber,
1953) Tan & Woodworth, I9 6 9) saturation with iron will
I
prevent the binding of zinc. However, Chesters and Will
•i=a
Ï
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(1 9 8 1) found that albumin was the major transport protein 
for zinc in the plasma and not transferrin, and they showed 
that zinc-binding to transferrin was quantitatively in­
significant. Another possible explanation arises from the 
observation that lymphocytes, unlike many other types of 
cells, do not synthesize ferritin in response to increased 
levels of iron (Summers et al. . 1975; Summers and Jacobs, I9 7 6; 
Lema & Sar'cione, I98I,). At high transferrin saturation 
with iron, uptake may, therefore, proceed too rapidly to 
allow adequate intracellular processing, with possible 
toxic effects and a consequent reduction of transformation.
In the present investigation, it was also found that 
the degree of proliferation of mouse lymph node lymphocytes 
cultured in serum-free medium containing either mouse or 
human transferrins of the same iron-saturation was not 
statistically different (Table l). This indicates that 
human transferrin is as good as mouse transferrin in 
promoting proliferation of mouse lymphocytes and that the 
transferrin receptor in mouse lymph node cells could interact 
equally well with either human or mouse transferrin. Human 
transferrin can, therefore, be substituted for mouse for 
in vitro lymphocyte cultures in serum-free conditions.
Brock (1 9 8 1) also showed that human transferrin induced 
similar proliferative response as mouse transferrin when 
lymph node cells were cultured in serum-free conditions.
'Slj
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CHAPTER 3
THE EFFECT OF IRON DEFICIENCY ON THE 
IN VITRO TRANSFORMATION OF MOUSE ■I,
LYMPH NODE LYMPHOCYTES
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3.1 INTRODUCTION
Iron deficiency has often been associated with decreased
cell-mediated immune responses. Clinical studies have 
demonstrated impaired delayed type hypersensitivity to 
PHA (Talwalkar _et aT. , lp82) and PPD of Mycobacterium 
tuberculosis, Candida antigens (joynson e_t al. , 1972), 
diphtheria toxoid and streptokinase-streptodornase (Macdougall 
et al.4 1 9 7 5) and to Trichophyton antigens (Chandra &
Saraya, 1975) ia humans with iron deficiency anaemia.
Furthermore, impaired in vitro blastogénie activity of 
peripheral blood lymphocytes to PPD and Candida antigens 
(Joynson e^ al., 1972), pokeweed mitogen (PWM; Sawitsky 
et al,, 1 9 7 6), PHA (Bhaskaram & Reddy, 1975; Chandra and 
Saraya, 1975; Fletcher et al., 1975; Macdougall et al.,
1975; Sawitsky ejb al. , 197&; Van Heerden e_t al. , I9 8 1) or 
ConA (Van Heerden at al., I9 8 1) have been reported in iron 
deficient anaemic adults and children. Children with latent 
iron deficiency also showed reduced skin test responses to 
diphtheria toxoid and streptokinase-streptodornase, and 
reduced blastogénie responses to PHA (Macdougall at al.,
1 9 7 5)" Lymphocytic function as assessed by leucocyte 
migration inhibition test was also impaired in iron deficient 
anaemic adults (Talwalkar et al., 1982)4 The proportion of
circulating T-lymphocytes has also been found to be reduced 
in iron-deficient anaemic adults (Bhaskaram & Reddy, 1975;
Chandra & Saraya, 1975; Fletcher et al., 1975) und in 
children with latent iron deficiency with or without anaemia
I:
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(Sx’ikantia jet al., 1976). Iron therapy increased the
proportion of T-lymphocytes (Bhaskaram & Reddy, 1975;
Fletcher et al., 1975) and lymphocyte proliferation in vitro
(Fletcher e_t al. , 1975» Macdougall e_t al. , 1975; Sawitsky
et al. , 1 9 7 6) back to normal values, although in one study 
3no change in H-thymidine uptake was observed after iron 
therapy (Bhaskaram & Reddy, 1975)» la addition, iron 
repletion in vivo caused an increase in delayed hypersensitivity 
to PHA and also improved secretion of migration inhibition 
factor by lymphocytes (Talwalkar _et al • , I9 8 2). Animal 
studies have also shown that cell mediated immune responses 
may be affected in iron deficiency. Delayed cutaneous 
hypersensitivity reactions of iron-deficient anaemic mice 
to dinitrofluorobenzene, measured as the rate of incorporation 
of iodinated DNA-precursors in the sensitised area was 
markedly decreased when compared to control or pairfed 
groups (Kuvibidila e_t al. , I98I). Injection of iron prior
to the recall dose restored the rate of DNA-synthesis in 
the anaemic mice but had no effect on either the control or 
pairfed groups. Furthermore, the response of splenic 
lymphocytes from iron-deficient mice to PHA, ConA and 
lipopolysaccharIde (LPS) was significantly impaired when 
compared with control mice (Kuvibidila et al., 1 9 8 3a, b) 
and there was also a small but significant decrease in the 
number of peripheral blood lymphocytes (Kuvibidila ejb , 
1 9 8 3a). Addition of mouse transferrin (unspecified saturation) 
or ferric chloride to the culture medium partially restored
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the response of the cells to PHA but not to ConA and LPS, 
while haemin restored responses to both PHÀ and ConA 
(Kuvibidila _et al_. , 1983b). However, no explanation was 
offered by the authors of the different responses of the 
lymphocytes under the different conditions employed. 
Furthermore, the ini vivo repletion of iron levels of the 
iron-deficient group resulted in the in vitro restoration 
of the blastogénie response of lymphocytes to PHA, while 
the response to ConA and LPS was improved but not fully 
restored (Kuvibidila _et al. , 1 9 8 3a). In contrast to the 
above findings Soyano e_t al. (1982) found a marked increase 
in the proliferative responses to PHA, ConA and PWM of 
splenic lymphocytes from iron-deficient rats whereas the 
response of thymic lymphocytes was very much impaired. It 
was suggested that this difference could have been the 
result of an alteration of the cell populations in the 
various lymphoid compartments.
It appears therefore, that iron deficiency may affect 
cell-mediated immunity in vivo or Ln vitro in both man and 
experimental animals. However, there have also been 
reports of normal cell-mediated immune responses and 
blastogénie activity of lymphocytes in iron deficiency. 
Delayed type hypersensitivity reactions to dinitrochloro- 
benzene in iron-deficient patients were found to be the 
same as in the control groups (Gross ejb al. , 1975)» Further­
more, the proliferative responses of peripheral blood 
lymphocytes to PHA or ConA in iron-deficient patients 
(Gross ejb al. , 1975; Srikantia e_t al. , 1976; Van Heerden
I
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et al., 1 9 8 1) and in children with iron deficiency anaemia, 
before and after iron therapy (Kulapongs ejb al. , 1974) did 
not significantly differ from that of the control groups. 
Krantman ejb al. (1 9 8 2) and Gupta ejb al. (1 9 8 2) also found 
that the response to PHA of lymphocytes from iron-deficient 
anaemic children were within the normal range. However, 
there was an increased responsiveness of the cells after 
iron therapy (Krantman ejb , I9 8 2). The proportion of 
T-lymphocytes has also been reported to be within normal 
range in iron deficiency alone (Van Heerden et al., I98I) 
or with anaemia (Van Heerden et al. , I98I; Krantman e_t al. . 
1 9 8 2), which conflicts with reports cited earlier indicating 
a decreased proportion of T-cells. Furthermore, Srikantia 
et al. (1 9 7 6) found that children with anaemia and normal
transferrin saturation had an unexpectedly lower T-cell 
count than children who had evidence of both anaemia and 
latent iron deficiency.
The precise cellular or molecular defects in lymphocytes 
that may be induced by or associated with iron deficiency 
remain unclear. One of the reasons for this may be the 
lack of control of other factors which may affect the 
immune status. The presence of infections (Mendes _ejb al. , 
1 9 7 1? Mendes & Raphael, 1971) or the use of anti-inflammatory 
drugs (Tormey ejb al. , I9 6 7) or immunosuppressive agents 
(Baxter & Harris, 1975; White _ejb al. , 1979) have been 
known to depress cell-mediated immunity. Deficiencies 
of other nutritional factors such as zinc (Cunningham- 
Rundles et al., 1979; Gross ab al. , 1979; Pekarek ejb al. .
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1979; Beisel, I9 8 2) or copper (Beisel, I9 8 2) or deficiency 
of vitamin A (Krishnan ejt , 1974; Bhaskaram & Reddy,
1 9 7 5; Levis & Emden, 1976) and vitamin B^^ (MacCuish e_t al. ,
1974; Das & Herbert, 1978) have also been shown to depress 
cell-mediated immune responses. In some reports on the 
in vitro or ha vivo cell-mediated immune responses in iron 
deficiency in humans, existence of infections, malignancies, 
usage of immunosuppressive agents by the patients or signs 
of protein or vitamin deficiencies were not excluded 
(Bhaskaram & Reddy, 1975; Chandra & Saraya, 1975)® In 
other studies, although clinical signs of infection and 
chronic illness (MacDougall ejt ad. , 1975; Srikantia al. ,
1 9 7 6; Krantman e_t al. , I9 8 2) were excluded, vitamin or 
other biochemical deficiencies were not looked for and 
could affect interpretation of their findings. Since 
infections and other nutritional factors which affect cell- 
mediated immunity are difficult to control in human studies, 
it may be preferable to study the in vi tro or iri vivo 
cell-mediated immune responses in an experimental animal 
model in which infections and presence of deficiencies 
other than iron are better controlled, and age and sex 
matching more easily achieved. Although animal studies 
have been carried out before (Soyano _ejfc al. , 1982; Kuvibidila 
et al., 1 9 8 3a, b) these studies have not provided an adequate 
explanation for the observed changes in lymphocyte trans­
formation resulting from iron deficiency.
iÏ
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The biochemical basis of reduced cell-mediated immune 
responses and vitro lymphocyte transformation which may 
be associated with iron deficiency has not been elucidated.
A factor which may be significant is the reduction in 
levels of iron available to lymphocytes for mitosis and 
DNA synthesis. Hershko ejb al. (l970) showed that DNA 
synthesis by bone marrow cells is reduced in iron deficiency, 
and it is known that iron is required for the activity of 
the enzyme ribonucleotide reductase which is involved in 
the reduction of ribonucleoside diphosphates to deoxyribo- 
nucleotides (See 1.1.6). It is possible that the reduced
synthesis due to inadequate levels or activity of ribo-
Ilymphocyte proliferation may result from defective DNA i
nucleotide reductase. It is therefore critical in elucidating 
the effect of iron deficiency on lymphocyte responses in 
vitro to use an experimental system which allows limitation 
of iron supply in the culture of lymphocytes. The contro- 
versial nature of the data on the correlation of iron 
deficiency and lymphocyte proliferation vitro reported 
in the literature may therefore have arisen due to the 
fact that while most investigators used normal serum or 
foetal calf serum in their lymphocyte cultures, others used 
autologous serum. The iron content of these sera would 
undoubtedly vary. However, it is now possible to study 
the vitro mitogenic response of lymphocytes using serum 
free conditions (Dillner-Centerlind et al. , 1979; Brock,.
1 9 8 1) which allow iron levels to be accurately controlled.
1?
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This study was carried out in an attempt to define 
more closely the effect of iron deficiency, and in particular 
the role of circulating (i.e. transferrin-bound) iron 
on lymphocyte transformation. To ensure the absence of 
environmental or other nutritional factors which might 
influence results, an experimental animal model consisting 
of mice fed on defined diets of known iron content was used. 
Furthermore, iron levels in the culture media were controlled 
using both serum-free and serum-containing media, in order 
to relate lymphocyte transformation to the availability 
of transferrin-bound iron.
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3-2 MATERIALS
3*2,1. Mice. Unless otherwise stated, female 7-8 weeks old 
mice were used throughout the experiments described in 
this chapter.
3*2.2. Diet. Information for the formulation and preparation 
of the semisynthetic diet was kindly provided by Dr C.F. 
Mills, Department of Inorganic Biochemistry, Rowett Research 
Institute, Aberdeen. Table 3 lists the ingredients of the 
complete diet. Table 4 lists the resulting concentrations 
of the essential elements. To prepare the diet, the casein 
and methionine were mixed with two-thirds of the sucrose.
The remaining sucrose was put aside for pre-mixing the other 
supplements. To the basic diet, finely ground mineral 
supplements (elements l4-l8, Table 4) were added. The 
metasilicate was powdered in a coffee-mill in a fume-hood 
and mixed with sucrose before being added to the diet.
Major trace elements (Cu, Zn, Mn and when necessary, Fe) 
were powdered and mixed with another portion of sucrose 
before addition to the diet. The minor trace element mix 
(Table 3) which was made in a sucrose carrier (4.97 g 
sucrose) was prepared in bulk and stored at 4°C in a 
tightly stoppered polythene jar. The sucrose/minor trace 
element mix was ground with more sucrose before being added 
to the diet. The water soluble vitajnins were first 
dispersed in sucrose (0 . 5 g) and inositol, then ground to 
a fine powder in a mortar and mixed with more sucrose before
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Table 3: Complete diet (1 kg)
Ingredient Weight of ingredient
Casein (60 mesh)
Methionine (Sigma)
Commercial sucrose 
Inositol (Sigma)
Arachis oil (Pharmacy, Gartnavel 
General Hospital, 
Glasgow)
CaCO 
Na H^PO 
KH,PO ^
KCI
MgS0,.7H G 
(Na SiO ,5H 0 
(NaIG„.R.O ^ "n 
(NaF ^ '(U GCNfsB^
Minor trace element mix(SnCl (K Cr;o 
(Na Seo'
CnS0,.5H 0 FeSOT.THyO*
MnS0:.4H,0 ZnSO^.TH^O 
Thiamine (Sigma)
Pyridoxins (Sigma)
Riboflavine (Sigma) 
p-aminobenzoic acid (Sigma)
Nicotinic acid (Sigma)
Ca-pantothenate (Sigma)
Folic acid (Sigma)
Biotin (sigma)
Tocopherol acetate (Uit.E; Sigma) 
Retinylacetate (Uit. A; Sigma) 
Calciferol (Vit. D; Sigma)
Choline chloride (BDH Chemicals Ltd.) 
Vitamine (Sigma)
Menadione fvit. K„; Sigma)
20G.GG 9
5.80 9
648.00 9
0.40 9
100.00 9
15.00 9
6.60 9
15,70 9
1,10 9
5.10 g
0.76 9
1.70 mg
5.50 mg
0.27 mg
2.60 mg
3.20 mg
14.00 mg
0.23 mg
19.70 mg
249.00 mg
203.00 mg
176.00 mg
10.00 mg
10.00 mg
10.00 mg
10.00 mg
30.00 mg
20.00 mg
5.00 mg
5.00 mg
0.20 9
0,80 mg
0.27 mg
1.00 9
25.00 P9
5.00 mg
* Added as appropriate.
' i
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Table 4; Essential elements and their dietary concentrations,
No. Element DietaryConcentration
(mg/kg)
1 Cu 5.0
2 F B* 50.0
3 Mn 50.0
4 Zn 40,0
5 Si 100,0
6 I 1.0
7 F 2.5
8 V 0.2
9 Ni 1.0
10 Sn 2.0
11 Be 0.1
12 Cr 5.0
(g/kg)
13 Ca 6.0
14 K 5.1
15 Mg 0.5
16 Na 2.3
17 P 5.0
IB Cl 0.5
Added as appropriate.
addition to the diet. Choline chloride was mixed with 
vitamin and the remainder of the sucrose before being
added to the diet. The water insoluble vitamins consisting 
of vitamins A, D, and E were dissolved in chloroform
(l ml) and mixed with the arachis oil before addition to 
the diet. The complete diet was thoroughly mixed and stored 
at -4°C in portions of 500 g. Enough diet was prepared to 
allow 5 g diet per mouse per day. The diet was used within 
6 weeks. Two diets were prepared, one containing EeSO^ 
and the other without iron. The iron-content of the iron- 
deficient diet was kindly estimated by Dr D, Halls using
■■■carbon furnace atomic absorption spectroscopy and was found
to be 820 pg/kg. The diet supplemented with FeSO^ contained 
an iron level of 50 mg/kg.
All glassware used for the preparation of the iron- 
deficient diet were rendered iron-free prior to tlSS ( see 2.3*1.2)
3*2,3' Reagents for estimating the iron status of mice
3.2,3'!' Acid digest solution. This solution, used for the 
extraction of non-haem iron from the mouse liver samples, 
was prepared by dissolving 10 g of trichloroacetic acid (tCA' 
Analytical reagents grade, M & B Ltd., Dagenham, Essex,
England) in d-DW (70 ml) and adding 29*7 ml of concentrated 
HCl (Analar grade, BDH ) .
■'V3 .2*3'2. Protein precipitant solution. This contained 10% 
(w/v) TCA, 3% (v/v) thioglycolic acid (BDH) and 2M HCl.
It was stored in the dark in an iron-free glass universal
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and used diluted 1Z 3 iii d-DW.
3.2.3 .3 . Ferrozine chromogeia. This was prepared by dissolving 
105 mg of ferrozine (3-(2~pyridyl)-5,6-bis(4-phenylsulphonic 
acid)-l,2,4-thiazine, BDH) in a drop of d-DW and then adding 
100 ml of saturated sodium acetate (Analar grade, BDH) made 
in d-DW.
3 .2 .4 . Reagents for estimating haemoglobin levels 
A kit was supplied by Sigma (Kit No, 525)*
3 .2 .4.1. Reagents supplied in the kit
3 .2.4.1.1. Drabkin's reagent (Stock No. 525-2). This was
a dry mixture consisting of sodium bicarbonate (lOO parts), 
potassium ferricyanide ( 20 parts)and potassium cyanide 
(5 parts).
3 .2.4.1.2. Brij-35 solution (Stock No. 430 Ag-6 ). This 
solution contained Brij-35, 30 g/lOO ml#
3 .2.4 .1 .3 . Haemoglobin standard (Stock No. 525-18). This 
contained lyophilized human haemoglobin equivalent to I8 g 
(- 1%) haemoglobin per 100 ml whole blood when reconstituted 
with Drabkin’s solution. •|
3 .2.4,2. Materials prepared using reagents supplied in the kit
3 .2.4.2.1. Drabkin's solution. This was obtained by re­
constituting Drabkin•s reagents with 1000 ml water. To 
this, 0 . 5 ml of 30% Brij-35 solution was added and mixed 
well. The solution was filtered and stored in the dark at 
room temperature.
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3* 2. 4. 2. 2. Cyanmetl'iaemoglo’bin solution. This solution was 
obtained by reconstituting the haemoglobin standard with 
50 ml Drabkin*s solution. The solution was mixed well and 
left to stand for 30 min at room temperature before use.
3 .2 .5 . Reagents for estimating protein synthesis
Minimum essential complete medium. Minimum essential medium 
without leucine (Flow) was supplemented with penicillin, 
streptomycin, L—glutamine and 2-Me as described for the 
RPMI“1640 culture medium (see 2.2.2.7)* To this were added 
10 pCi/ml of tritiated leucine (specific activity I60 Ci/mMol; 
Amersham) and 40 jiM (final concentration) cold leucine (BDH) . 
Apotransferrin or 20%—iron-saturated transferrin (50 pg/ml) 
or foetal calf serum (2%) (Gibco) were added as appropriate.
3.2.6. Reagents for estimating numbers of T-cells and T-cell 
subsets.
3 .2.6.1. Formol calcium solution. This solution (pH 6 .7 ) 
contained 10% formaldehyde and 1% CaCl^ in D¥.
3 .2.6 .2. Phosphate buffer (0.06m). This was prepared by 
mixing 1 , 5 ml of NaHP0..2H 0 (II. 8 8 g/l) with 9 8 . 5 ml 
KHgPO^ (9 . 0 8 g/l).
3 .2.6 .3 . Hexazotised pararosaniline. This solution was 
formed by mixing equal volumes of solution A and solution B 
as below:
Solution A - 4% NaNO^ in D¥, freshly prepared.
Solution B - Ig pararosaniline (Sigma) was dissolved in 20 ml 
warm DW and 5 ml of concentrated HCl were added. 
This solution was allowed to cool and was 
filtered before use.
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3 ,2 . 6 .4. g-'aaph.tliyl acetate esterase (ANAE) reagent* This 
consisted of 40 ml of 0.06m phosphate buffer (pH 5*0)»
2.4 ml of hexazotised pararosaniline solution and 10 mg of 
g-naphthyl acetate (Sigma) which was dissolved in 0.4 ml 
acetone prior to addition to the buffer-pararosaniline 
mixture. The pH of the complete reagent was adjusted to 
5 . 8  with 2M NaOH. The solution was filtered before use.
Ï
I
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3*3 METHODS
3 .3 .1 . Induction of iron deficiency
Twenty mice were assigned to four groups and housed 
individually in grid-bottomed cages. The mice were fed 
for six weeks on either laboratory diet (ND) (Rat and Mouse 
No.l Maintenance Expanded Diet; Special Diet Services,
Witham, Essex, England), iron-supplemented semisynthetic 
diet (SD), low-iron semisynthetic diet (DD) or pairfed with 
the iron-supplemented semisynthetic diet (PF). All animals 
were given diet ad libitum except the PF group which received 
an amount equal to the average amount consumed by the DD 
group the previous day. This group was included in order 
to allow for the possible effects of protein-calorie 
malnutrition. Tap water was given to ND, SD and PF groups 
while the DD group received d-DW. Glass feeding dishes 
used for the DD group were acid-washed before use. The mice 
were weighed weekly and the diet was replaced daily.
.,9.i
3*3*2. Iron repletion
For iron repletion studies, the mice were assigned to 
three groups (l to 3)» and fed either on iron-supplemented 
diet (group 1) or low-iron diet (groups 2 and 3 ) for six 
weeks, after which group 3 was put on iron-supplemented diet. 
The mice were fed on corresponding diets for a further four 
weeks. Mice receiving low-iron diet at any time were given 
d-D¥, while tap water was used for mice fed on iron- 
supplemented diet.
1
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3 .3 .3 . Sacrifice of mice
At the end of the feeding period, a blood sample was 
drawn by heart puncture and the mice were then immediately 
killed by cervical dislocation. Lymph nodes (see 2.3*2) 
and livers were removed. The blood samples were used, 
after clotting, for determination of serum iron and total 
iron binding capacity (TIBC), while unclotted samples were 
used for estimating haemoglobin levels. The livers were 
used for determining storage iron and the lymph nodes to
prepare the lymphocyte suspensions (see 2.3*2). One mouse 
per group was killed per day over a period of the required
■number of consecutive days.
3 .3 *4 , Culture conditions and mitogen stimulation
Cell suspensions were prepared as described in Section 
2.3 *2 . The cells were cultured in either serum-containing 
culture medium or serum-free medium containing HSA and 
human transferrin (see 2 .2 .2.7 ) either as apotransferrin 
or 20%-iron-saturated transferrin (see 2.2*2.6 ). However, 
taking into account the iron content of the serum-free 
medium which was 1 2 .5 ng/ml (see 2 .3 *1 *1 )? the final 
saturations of transferrin with iron were 10% and 3 0% 
respectively. The cells were cultured as described in 
Section 2.3*2 with ConA at a concentration of either 4 or 
1 pg/ml for medium containing FCS or transferrin, respectively,, 
and for a period of 5 1 -5 2 h before pulsing with labelled 
thymidine for 4 h. Assaying of proliferative responses was 
carried out as described elsewhere (see 2 *3 *2 ).
'9#
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3*3*5« Determination of serum iron
Serum was prepared by centrifugation (twice) of the 
clotted blood samples in a MSE Cent^aur 2 centrifuge at 
3000 r.p.m. for 10 min. The serum iron was estimated by 
a method based on that of Brittenham (l979)* The method 
which was used because it is designed for small volumes of 
serum, is a colorimetric one and involves precipitation of 
serum proteins, dissociation of iron from transferrin and 
formation of a complex of reduced iron with a chromogen.
Mouse serum (lOO pi) and protein precipitant (see 3*2.3*2)
(300 pi) were pipetted into 1.5 ml Eppendorf micro tubes 
(Anderman & Co.). The tubes were capped, thoroughly vortexed 
and, after standing for 5 min, centrifuged for 10 min in a 
microhaematocrit centrifuge (Hawksley, England). Supernatants 
of 320 pi were removed into clean microtubes and 80 pi of 
ferrozine chromogen solution (see 3*2.3*3) vere added. The 
tubes were vortexed and after standing for 5 min the 
absorbance at 562 nm was determined using microcuvettes 
in an ultrospec 4050 spectrophotometer (LKB, Cambridge,
England). The microcuVettes were rinsed in diluted protein 
precipitant before use. Iron standard solutions (70 - 280 pg/lOO 
ml) were prepared using /Fc(NTA) solution and d-D¥, and also 
d-DW was used instead of serum for the reagent blank. The 
straight line was fitted to the absorbance versus iron 
levels plot by the method of least squares and the serum 
values were calculated from the regression line. All assays 
were performed in duplicate.
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3«3*7. Estimation of haemoglobin levels
Total haemoglobin levels were estimated colorimetrically 
by the cyanmethaemoglobin method using a kit (Section 3*2.4). 
The method involves oxidation of haemoglobin to methaemoglobin 
at alkaline pH and in the presence of potassium ferricyanide. 
Methaemoglobin when reacting with potassium cyanide forms 
cyanmethaemoglobin which gives maximum absorption at 540 nm. 
Cyanmethaemoglobin standards were prepared by diluting the 
cyanmethaemoglobin solution (Section 3*2.4.2.2.) with 
Drabkin's solution (Section 3.2.4.2.1) to get preparations 
containing 6, 12 and 18 g haemoglobin per 100 ml of whole
3*3*6. Determination of total iron binding capacity
To a serum sample (300 pi) in an iron-free polypropylene 
test tube (see 2*3*1*2) 300 pi of 100 pM Fe(NTA) solution 
was added. The mixture was thoroughly vortexed and after 
standing at room temperature for 15 min, the excess unbound
iron was removed using hydrated MgCO (0.045 g; BDH) which 
was added with a previously calibrated scoop. The test 
tubes were stoppered and mixed on a rotating shaker (Hoechst) 
for 45 min. The samples were then centrifuged for 15 min 
at 2500 r.p.m. and thereafter the supernatants were treated 
as in serum iron assays (Section 3*3*5)* Reagent blank 
and iron standard solutions were prepared as in the serum
assays. Since insufficient serum could be obtained from 
individual mice for both serum and total iron binding 
capacity, TIBC values were obtained using pooled sera of 
mice of the same group. I
3
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blood. The absorbance of the standard solutions were 
read at 5^0 nm against Drabkin’s solution as a reagent 
blank in the Ultrospec 4050 spectrophotometer and a 
calibration curve constructed. For the test samples, 20 pi 
of whole blood were mixed well with Drabkin's solution (5 ml) 
and, after standing at room temperature for 15 min, they 
were read against Drabkin's solution. Total haemoglobin 
concentrations of the test blood samples were determined 
directly from the calibration curve. Samples were assayed 
in duplicate. Due to the small volume of blood available, 
it was not possible to assay for both haemoglobin and serum 
iron/TIBC on samples from the same animal.
3 .3 .8 . Determination of liver iron
To extract non-haem liver iron, liver samples (0.2 g) 
were cut into small pieces and heated for 20 h at 65^0 in 
1 ml of acid digest solution (Section 3*2.3*i)« After 
cooling to room temperature, 50 pi of the extract was 
transferred to an Eppendorf micro tube and d-DW (5 0 pi) 
and diluted protein precipitant solution (3OO pi) were 
added. Thereafter, the serum iron procedure was followed.
All samples were prepared in duplicate using two different 
samples of liver for each mouse. The standard solutions 
were prepared as described elsewhere (see 3*3*5)•
3 .3 *9 * Determination of protein synthesis by transformed 
lymphocytes
Mouse lymph node cells were cultured for 55-56 h with 
ConA in serum-free media containing apotransferrin or 20%—
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iron-saturaied transferrin (see 2.3*2). The transformed 
cells were washed twice (l200 r.p.m., 45-50 sec) with
warm (37^0) Hanks balanced salts solution (Gibco) containing 
either FCS (2%), or 10%- or 30%-iron-saturated transferrin 
(5 0 pg/ml), as appropriate. After washing, the cells were 
resuspended at a concentration of 5 % 1 0  ^viable cells/ml
3in ^H-leucine-containing minimum essential complete medium
s(Section 3*2.5). Aliquots (lOO pi) of the transformed 
cell suspensions were cultured in microtitre plates for 1 h, 
after which 100 pi of ice-cold PBS containing 1 mM L-leucine
was added to each well and the plates were chilled at O^C 
for 15 min. The cells were then harvested by suction through
2 .5 cm diameter glass microfibre filters (Whatman). Each
'7,well was rinsed with PBS and the cells were washed twice with S
PBS. The DNA was extracted from the cells with 5% tri- ip
chloroacetic acid. The filter mats were finally f
owashed with methylated spirit and, after drying at 50 C
i
irfor 1 h, the tritium activity was measured in the liquid scintillation counter. The number of replicates depended 
on the initial density of the transformed cells and varied 
between 2 and 12.
3 .3 *1 0 . g-naphthyl acetate esterase staining
About 6 X 10^ lymph node cells were deposited on to 
clean glass slides in a Shandon cytocentrifuge at 1000 r.p.m. 
for 90 sec. The preparations were air-dried and fixed in 
formol calcium (pH 6.7 ) at 4^0 for 10 min. The slides were 
then washed in running water for 20 min and finally stained 3with ANAE-reagent (see 3*2.6.4) for 90 min at 37°0. After
:
102
staining, the slides were washed in gently running water 
for 10 min and, after being dried, counterstained with Z^ o 
methyl green for 30 sec. The slides were then rinsed in 
tap water, dried, mounted with DPX and finally examined 
using a Leitz~¥elzlar microscope (x 400). Using this 
stain, T-lymphocytes are characterised by small brown spots 
in their cytoplasm, monocytes and macrophages show a 
diffuse brown staining throughout the whole cell, and B- 
lymphocytes (and null cells) do not stain (Fig. 6). At 
least three fields chosen at random were examined and the 
percentage of T-lymphocytes was calculated.
3 .3 .1 1 » Immunefluoréscent staining of T-cells
T-cells and T-cell subsets can be recognized with ■
monoclonal antibodies to cell markers. In mice, monoclonal
antibodies to “fby^  ^cell antigens distinguish T-lymphocytes
from B-lymphocytes and macrophages or monocytes, while
a-Lyi and a-Ly^j probably recognize T-helper and T-suppressor
cells, respectively. Fluorescein-labelled monoclonal
antibodies to Thy_ , Ly. and Ly. T-cell antigens wereJL • ^  J .
obtained from Becton-Dickinson (Sunnyvale, Ca., U.S.A.) 
and used diluted in PBS at 1:20, 1:20 and 1:4 respectively.
Cytocentrifuge preparations of cells were obtained as 
described in Section 3*3*10. The slides were fixed in 
freshly made formalin (2 .3 '^ i^ i DW) for 10 min and washed 
in PBS for the same time before staining with I5 of 
the appropriate dilution of the monoclonal antibody for 
30-40 min in a moist box in the dark at 4°0. After staining
 ^ I
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Figure 6 ; A population of cells from mesenteric and peripheral 
lymph nodes of mice stained with &-naphthyl acetate 
esterase stain.
\ # A
%
Cells indicated by one arrow are T-lymphocytes, double 
arrows point to an ANAE-stain negative cell (B-lymphocyte 
or null cell) and triple arrows to a monocyte or macrophage 
(x 900).
i o 4
the slides were washed three times (lO min each time) in 
cold PBS containing 0.02^ azide and then mounted in PBS- 
glycerol (4 parts PBSil part glycerol). More than 300 
cells from different fields chosen at random were counted 
under phase contrast and U.V. using a Leitz Ortholux 
microscope. The percentage of positively-stained cells 
was calculated for each antibody and finally the number 
of cells positive for ly^ and ly^ surface antigens was 
calculated as a percentage of cells positive for thy^J- , 2
antigen.
'
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3 . 4  RESULTS
3 .4 .1 . Mouse weights
The weight gain at the end of the feeding period of
all mice fed on different diets (apart from mice used for 3
the iron repletion studies) was analysed using two-way 
analysis of variance (two-way AJMOVA ).
The mean weight gain of mice fed on laboratory diet 
was significantly lower than the mean weight gain of mice 
fed on the semisynthetic diet (Fig. 7j Table 5 )® This was 
probably the result of the different carbohydrate content 
of the laboratory diet in comparison with that of the 
semisynthetic diet (see 3*5)* However, there was no 
significant difference in mean weight gain among the mice 
fed on any semisynthetic diet (Fig. 7, Table 6) indicating 
that the low-iron diet did not cause weight loss. There
■ a
was also an experiment-to-experiment variation of statistical 
significance in weight gain in mice fed on different diets 
(Tables 5 and 6), which was not the result of the effect 
of the diet on the mice (Table 6). The small but significant 
effect seen in the interaction of diet and experiment (Table 
5 ) was probably due to the difference observed between 
laboratory and semisynthetic diet (Fig. 7, Table. 5 )*
The weight gain of mice which were used for iron 
repletion studies were analysed using Scheffe’s method of 
multiple comparisons (see Appendix). Two analyses were 
performed of:
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Figure 7; Weight gain observed in mice fed on different diets. 
(Results of eight experiments pooled).
:W
No. 8 Mean = 3.2
o f 4
mice 0 p—” — 11 2 3 4 5 6 7
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No. 
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(b) Mice fed on
iron-containing 
semisynthetic diet
No.
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No. 8 ■ synthetic diet
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Table 5: Two-way analysis of variance of weight-gain of
all mice fed on laboratory diet, iron-containing 
semisynthetic diet, low-iron diet and pairfed.
Due to F ratio Significance
Day-to-day variation 11.141 p < 0.001
Diet 3.376 p <0.05
Interaction of diet
and experiment 1.734 p <0.05 ■ I
:S.
I
■5
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Table 6; Two-way analysis of variance of weight-gain of 
mice fed on iron-containing diet, low-iron diet 
and pairfed.
Due to F ratio Significance
Day-to-day
variation 9,569 p <0.001
Diet 0.534 ns
Interaction of 
diet and 
experiment 1.490 ns
I
!
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i1. the weight gain during the first 6 weeks feeding period and
2. the weight gain during the period between 6th and 10th week* 
Both analyses showed that there was no significant difference 
in weight gain between mice fed on different diets (Table 7)*
3•4.2. Effect of iron deficiency on the transformation of 
mouse lymph node lymphocytes cultured in serum-free
medium and in medium containing foetal calf serum
■3*4.2.1, Transformation of lymphocytes in serum-free medium
3*4.2.1.1. Iron status
The serum and liver iron levels of the DD group were 
significantly lower compared with the other three groups
of mice. TIBC values of the DD group were higher than in
the other groups so that the percentage saturation of serum
transferrin with iron in the DD group was very much reduced 
.(Tables 8 and 9)* These results indicated that iron deficiency
'was established in the DD group at the end of the six-week 
feeding period.
3.4,2,1.2. Mitogenic response of lymphocytes
The degree of transformation of lymphocytes in culture
medium containing 10^-iron-saturated transferrin was
,significantly lower in all groups compared with the responses
s
of the cells cultured in medium containing 309 ‘^-i3Ton-saturated 
transferrin (Table lO). These results indicated that the 
iron content of the culture medium was an important factor 
controlling the degree of mitogenic response. However, 
although there was a lower mitogenic response of lymphocytes 
of the DD group in medium containing 10%—iron-saturated
ii'
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Table 7: Analysis by Scheffe’s method of multiple comparisons
of the weight gain of mice used for iron-repletion 
studies.
Groups
compared*
Simultaneous 95% 
confidence limits
Week 1 - 6  6 - 10
Significant 
1 — 6
difference 
6 - iQ
1 & 2 1,50,-2.51 1.90,-1.20 ns ns
1 & 3 2.10,-1.92 2.80,-0,35 ns ns
2 & 3 2.75,-1.30 2.41,-0.62 ns ns
* 1: mice fed on iron-containing semisynthetic diet for lO weeks;
2: mice fed on low-iron diet for 6 weeks and then on iron-containing 
diet for à weeks;
3: mice fed on low-iron diet for lO weeks.
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transferrin compared with, other groups of mice (Table lO), 
the difference was not significant (Table 11) and the 
effect was not reproducible in the subsequent experiments. 
The iron content of the medium, therefore, did not affect 
the cells of the DD group very differently from those of 
the other groups (Tables 10 and 11). This indicated that 
the lymphocytes from the iron-deficient mice responded 
normally to ConA and had not lost their ability to transform 
due to intrinsic defects caused by iron deficiency. 
Statistical analysis also showed that there was a day-to-day 
variation probably as a result of minor changes in the time
of the day during which the experiments were performed or
variations in the mice, and cell populations during each
experiment (Table 11)• The day-to-day variation might
have caused the large standard deviations seen in Table 10, 
so it was possible that some small intrinsic difference in 
lymphocyte function in the DD group might not have been 
apparent. Since preliminary studies (not reported here) 
have shown that media containing FCS generally gave less 
variation in the mitogenic response than serum-free medium 
the experiment was repeated using medium containing FCS 
as well as serum-free medium containing transferrin.
3 .4 .2,2. Transformation of lymphocytes in serum-free medium 
or in medium containing foetal calf serum
3 .4.2.2.1. Iron status
The serum and liver iron levels and the TIBC of mice 
(Table 12) were similar to the previous groups of mice 
(Table 8 ).
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Table 11: Three-way analysis of variance of the mitogenic response
of lymphocytes from mice on different diets cultured in 
serum-free medium (data from Table 10).
F ratio Significant difference
Due to I II I II
Day-to-day
variation 8.87 0.73 P < 0.001 ns
Diet 1.12 0.61 ns ns
Medium 29.26 21.31 p < 0,001 p <0.01
Interaction 
of medium 
and diet 0.58 0,08 ns ns
I
I
:
a
116
3.4.2.2.2. Mitogenic responses of lymphocytes
As before, the degree of mitogenic response of lympho­
cytes in serum-free medium containing lO^ o—iron-saturated 
transferrin was very much lower in all groups compared
:
IS
with the proliferation of cells cultured in medium containing I'i
30 0^—iron-saturated transferrin or 10^ FCS (Table l4).
Furthermore, no significant difference in transformation 
was observed between cells cultured in media containing 
30^-iron-saturated transferrin or FCS (Tables l4 and I5 )*
The iron content of FCS was I .8 9 pg/ml and the saturation 
of serum transferrin with iron was 41^ 0. Although the
experiment using FCS in the culture medium was performed 
to account for the large variation in the proliferative
activity of lymphocytes cultured in serum-free medium, the 
variation still persisted when cells were cultured in either 
medium. This result indicated that variation in mice or 
cell population was probably the cause of the large 
difference in lymphocyte proliferating activity rather than 
the serum-free conditions. Furthermore, three-way ANOVA 
(Table I5 ) showed that there was a slight but statistically 
significant effect of diet (p < O.O5 ). However, this 
effect could have been a false positive since there was no 
significant effect when the interaction of medium and diet 
was considered, and furthermore, the effect of diet did not
'iIs.-
JÎI
persist when the results of "309^  FeT^" versus "lO^ c FCS "
'%d
were analysed (Table I5 ).
3 .4 .3 * Effect of mouse serum on the transformation of 
mouse lymphocytes
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Table 12: Iron status of mice on different diets used for
lymphocyte-transformation experiments performed in 
serum-free medium or in medium containing foetal 
calf serum.
Diet Normal
(ND)
Semisynthetic 
+ Fe (SD)
Semisynthetic 
-Fe (DD)
Pairfed
(PF)
4-Liver iron 
( /*9/g)
2.44 i 0.27 
(5)
2.26 ~ 0.13 
(5)
0.68 i 0.07 
(5)
2.52 i 0,36 
(5)
Serum iron"^ 
(jAg/lDO ml)
230 i 23 
(5)
246 i 20 
(5)
84 i 9
(5)
280 i 21
(5)
TIBC"^
(^g/100 ml)
285 i 5 280 i 2 375 i 5 300 i 10
% saturation 
of trans­
ferrin with 
iron 81 88 22 93
______
Figures in parentheses are number of animals. For statistical analysis 
see Table 13.
■’■flean ± SEM.
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3.4.3.1. Preliminary experiments
It has been reported (¥. Hasten, personal communications) 
that the mitogenic responses of mouse lymphocytes cultured 
in autologous serum for approximately three days is very 
low. In these experiments, different concentrations of ConA 
and times for culturing the cells were, therefore, used in 
order to determine whether different conditions from those 
used in previous experiments were necessary for optimum 
transformation. Pooled cells of the l4- to 15-week old
mice of the same litter and pooled mouse sera which had
been heat-inactivated (56^0 for 10 min) were used in each 
experiment. Since medium containing either 2.5^ or 59° 
mouse serum allowed the same degree of transformation 
(Table I6 ), medium containing 2*59° mouse serum was used in 
subsequent experiments. Also, there was no significant 
difference in the mitogenic response when cells were cultured 
for 44 or 54 h (Tables 17 and 18) and, therefore, the cells 
were cultured for 44 h in the subsequent experiments. 
Similarly, medium containing 1 pg/ml ConA did not induce 
as good proliferative response as 2 or 4 ^g/ml ConA was used
(Tables 17 and 18). Since there was no significant difference
in the mitogenic when 2 or 4 ]ag/ml of ConA were used (Table 
1 8 ), ConA. was used at concentrations of 2 ^g/ml, in the 
subsequent experiments,
3 .4 .3 .2. Effect of iron-sufficient, iron-deficient and iron- 
supplemented iron-deficient mouse sera on the 
transformation of mouse lymphocytes
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Table 16; The effect of mouse serum on the transformation of mouse 
lymphocytes.
^^C-thymidine incorporation (c.p.m.)
Culture medium 
containing +ConA* -ConA*
2*5% mouse i2963 ~ 300 66 i 9serum"^
5% mouse serum"** + t2865 - 221 6 9 - 9
Cells cultured for 56 h.
Mean - au.
*+ConA, 4 |tg/mlj n = 14; -ConA, n 
t^p > 0.1.
8.
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Table 18: Analysis by Scheffe’s method of multiple comparisons
of results of the effect of different concentrations 
of concanaualin A and culturing time on the 
transformation of mouse lymphocytes (data from Table 17)
Groups
compared*
Simultaneous 
95^ confidence 
limits
Significant
difference
1 and 2 -232.4,-889.6 S
1 and 3 -193.4,-850.6 S
2 and 3 367.6,-289.6 ns
4 and 5 -162.4,-1729.6 S
4 and 6 -629.4,-2196.6 S
5 and 6 316.6,-1250,6 ns
7 and 8 -2.0,-1150.0 S
7 and 9 -174.0, -1322.0 S
8 and 9 402.0,-746.0 ns
1 and 4 -126.0,-1426.0 S
1 and 7 -174.0,-1474.0 s
4 and 7 602.0,-698.0 ns
2 and 5 -740.2,-1581.8 S
2 and 8 -418.2,-1259.8 S
5 and 8 742.8,-98.8 ns
3 and 6 -1311.0,-2023.0 S
3 and 9 -1294.0,-2006.0 S
6 and 9 373.0,-339.0 ns
*1,4,7: 1 p,g/ml ConA; 2,5,8; 2 jjg/ml ConA; 3,6,9: 4 -p,g/ml ConA.
1,2,3: cells cultured for 30 h; 4,5,6: cells cultured for 44 h;
7,8,9: cells cultured for 54 h.
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3. 4. 3» 2. 2. Mitogenic response of Ivmp-hocvtes
Two mice of each group were killed per day over a
of mice of the same groups killed each day were pooled. 
Different combinations of "cells** - "Serum** were used; 
cells from mice fed on iron-containing semisynthetic diet 
(SD) were cultured in media containing;
Ï
Since the previous experiments showed no significant 
difference between any control groups with respect to 
either iron status (see 3*4.2.1.1. and 3*4.2.2.1) or 
lymphocyte transformation (3*4.2.1.2. and 3*4.2.2.2) the
ND and PF groups were omitted in this experiment. Mice 
were therefore fed on either iron-containing semisynthetic 
diet (SD; 10 mice) or low-iron diet (DD; 10 mice) as 
described in Section 3*3*1*
% I3*4.3*2.1. Iron statusSince mouse serum was used in the culture medium and 
as inadequate amounts of serum could be obtained from each 
mouse to perform all assays individually, serum iron and 
TIBC were estimated using pooled sera of all the mice of 
the same group. Again, the serum iron levels of the DD 
group were much lower and the TIBC much higher than the SD 
group (Table 19)* Liver iron was estimated in all mice 
individually, and was significantly lower in the DD group 
than the SD group (Table 19)* Again the results indicated 
that mice fed on low-iron diet were iron deficient. a
isiperiod of five consecutive days. Sera and lymph-node cells
À
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Table 19: Iron status of mice on different diets used for lymphocyte- 
transformation experiments performed in medium containing 
mouse serum.
Diet Semisynthetic 
+ Fe (SD)
Semisynthetic 
- Fe (DD)
Liver*
3.24 - 0.32 0.68 i 0.12
Serum**" 
(jAg/lOO ml) 289 i 7 108 i 3
TIBC"*"
(jAg/lOO ml) 330 i 10 520 i 2
%) Saturation 
of trans­
ferrin with 
iron 88 21
*p < 0,001; Mean of readings from 10 mice; 2 readings/mouse - SEM 
"^Mean of two readings of pooled sera from 10 mice - SEM.
:ï
II
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to transform in response to mitogens, and in addition
1, iron-sufficient mouse serum (SS)
2. iron-deficient mouse serum (DS)
3* iron-deficient mouse serum supplemented with. 1.8 pg/ml 
iron (dS + Fe).
Similarly, cells from mice fed on low-iron diet (DD) 
were cultured in media containing SS or DS or DS + Fe, 
Addition of iron to DS serum was based on the difference 
between the average level of iron in the iron-deficient
'mouse sera and in the sera from the control groups of mice 
calculated from Tables 8 and 12. This was found to be 
172 pg/lOO ml serum which was rounded off to I80 pg/lOO ml 
and it was added as Fe(NTA) solution. Cells from iron- 
sufficient and iron-deficient mice were also cultured with 
ConA (1 pg/ml) in serum-free media containing either 10^ — 
or 30%-iron-saturated transferrin.
Transformation of lymphocytes from iron-sufficient 
or iron-deficient mice was lower in media containing serum 
from iron-deficient mice than when serum from iron-sufficient 
mice was used (Tables 20 and 21). Addition of iron to the
3
deficient serum significantly improved its ability to
:promote transformation. These results again show that the i;
Jflymphocytes from iron-deficient mice have a normal capacity I
demonstrated that serum from iron-deficient mice has in­
adequate iron levels to permit optimum vitro transformation. 
However, although deficient serum with added iron was as good 
as iron-sufficient serum in supporting transformation of 
lymphocytes from iron-deficient mice, it was still somewhat
I
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Table 20; Effect of iron-sufficient, iron-deficient mouse sera 
and iron-deficient mouse serum supplemented with iron 
on the transformation of lymphocytes from mice on 
different diets.
^^C-thymidine incorporation (c.p ,m. )
Diet Semisynthetic 
+ Fe (SD)
Semisynthetic 
- Fe (DD)
Medium supplemented 
with^
+ConA* 5559 i 377 5068 + 777
Iron-sufficient
mouse serum (SS) -ConA* 44 - 23 52 4- 32
■tConA 3655 - 601 3752 + 601
Iron-deficient
mouse serum (DS) -ConA 51 - 22 55 i 30
Iron-deficient +ConA 4619 - 522 4969
+ 846
mouse serum
supplemented 
with 1.8 )^g/ml 
Fe (DS + Fe) -ConA 44 - 18 ■ 45 10
i
.
3
I
,i
For statistical analysis, see Table 21.
Mean - SiQ.
* n = 10 mice, 7 observations/mouse for 4-ConA; 4 observations/mouse for -ConA
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inferior when used with cells from iron-sufficient mice 
(Table 20), This indicates that serum from iron-deficient 
mice may lack other growth factors unrelated to iron content.
The mitogenic response of the cells from these mice 
was also tested using serum-free conditions, and as before, 
proliferation was significantly lower in medium containing 
10%—iron-saturated transferrin when compared with the 
responses in media supplemented with 30%—iron-saturated 
transferrin (Table 22). Again, no significant difference 
was observed between responses of cells from iron-sufficient 
and iron-deficient mice (Tables 22 and 23)*
3.4.4. Protein synthesis by transformed lymph-node 
lymphocytes from mice fed on different diets
In the previous experiments it was found that the iron-
content of the culture medium is important in controlling
the mitogenic responses of mouse lymphocytes. The aim of
these experiments was to find whether the iron level in 
the culture medium also affects protein synthesis by 
lymphocytes vitro.
Twenty mice were fed on diets as described in 3*3.1, 
and lymph-node lymphocytes were cultured in serum-free 
medium containing 1 0%—or~»3 0% iron-saturated transferrin 
(see 2 .3 .2 ). Protein synthesis by transformed cells was 
determined as described elsewhere (see 3.3*9). Two 
experiments were performed using two different sets of 
four groups of mice, one group for each diet (ND, SD, DD, PP) 
In the first experiment the transformed lymphocytes were
- 1 3 1  -
Table 22: Transformation 
diets cultured
of lymphocytes from 
with concanavalin A
mice on different 
in serum-free medium.
^^C-thymidine incorporation (c.p.m.)
Diet Semisynthetic 
+ Fe (SD)
Semisynthetic 
-Fe (DD)
Medium supplemented 
with'*'
10% FeTf +ConA* 1818 - 425 1793 i 410
-ConA* 161 i 53 110 i 15
30% FeTf +ConA
-ConA
3539 i 212 
187 i 97
3279 - 640 
150 ~ 23
For statistical analysis see Table 23.
Mean - S.D,*
* n ~ 10 mice, 3 observations/mouse for +ConA; 2 observations/mouse for -ConA.
132 i
Table 25; Analysis by Scheffe^s method of multiple comparisons 
of the results of transformation of lymphocytes from 
mice on different diets cultured with concanavalin A 
in serum-free medium (data from Table 22).
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 328.7,-278.7 ns
1 and 3 -1417.3,-2024.7 S
3 and 4 563.7,-43.7 ns
2 and 4 -1182.3,-1789.7 S
*1,3; cells from mice fed on SD diet and cultured in medium 
containing 10% FeTf or 30% FeTf, respectively.
2,4; cells from mice fed on DD diet and cultured with 10% 
FeTf or 30% FeTf, respectively.
1
.:;ViiI
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washed and protein synthesis determined in media containing 
PCS. However, in the second experiment protein synthesis 
was assessed in medium containing 10%-or 30%-iron-saturated 
transferrin as appropriate.
3 .4.4.1. Experiment I; transformed cells cultured in media 
containing foetal calf serum
3 .4.4.1.1. Iron status
Haemoglobin levels were estimated on this occasion to 
determine whether the iron-deficient group of mice develop 
anaemia in addition to iron deficiency under the feeding 
conditions employed throughout this work. Since inadequate 
amounts of blood could be obtained from each mouse by 
heart puncture to permit other assays to be carried out as 
well, serum iron and TIBC were not estimated in this group. 
The haemoglobin levels of the iron-deficient group were 
lower but not statistically different from the other groups 
(Tables 24(a) and 2 3). These results indicate that the 
mice of the DD group were not anaemic. The liver iron levels 
of the DD group were significantly lower than iron levels 
of the other groups (Tables 24(a) and 25)* Furthermore, 
the liver iron values were similar to those in previous 
experiments (Tables 8 , 12, 19), and it was assumed that 
serum iron levels would also have been similar. Since the 
mice were not anaemic, but the low liver iron levels show 
that a state of latent iron deficiency existed.
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3 . 4. 4.1. 2. Proteiii synthesis
Estimation of protein synthesis by lymphocytes which 
had been transformed in serum-free medium containing 10%~ 
or 3 0%“l3ron-saturated transferrin revealed no significant 
difference between any group of mice (Table 26(a)). It
appeared, therefore, that iron deficiency or iron-availability
'in the medium did not affect protein synthesis by transformed
lymphocytes. However, since the transformed lymphocytes
'
were washed and cultured in media containing ECS, the iron 
level in the ECS might have been large enough to eliminate 
any effect on protein synthesis of the low-iron content of 
the medium to which apotransferrin was added. The experiment 
was, therefore, repeated but the transformed lymphocytes 
were washed and cultured in medium to which apotransferrin 
or 20%-iron-saturated transferrin were added as appropriate.
3.4.4.2. Experimentll; transformed cells cultured in media 
containing transferrin 
Eor technical reasons, the mice in this experiment 
were fed on the different diets for seven weeks instead of 
six weeks as in previous experiments.
3 .4.4.2.1. Iron status
The haemoglobin level of the iron-deficient group was
significantly lower compared with the levels in any other
group (Table 24(b)), indicating that the mice of the iron-
deficient group had developed anaemia. It appears, therefore,
that an extra week of feeding on low-iron diet may have been
,long enough to convert the latent iron deficiency state 
into anaemia.
%
■I'
138
GOHGACD0q-01 C •H C
-PC0 □
1•H1
C•H
XG-PI-PGG
GG-P
Ü0
t>\A
X1Gq-GgAA
X
G•HGGX4^c>\G
C»HG
4JOADu
XCM
•g
LD en • WX O enG CM o Gq- ^ CA Lu + I 4-1•H CLG w LO LD ACL A en IDO LDm ID CM
H
A GCE U A•H CM GCL A A O «r4 LDG CD CO X CO□ X  %-' CTi AA  a CDc Q + 1 LD 4-1 LDC G IO G O CM C•H •H G LO AA E Lu CD XG G CD CD enA CO 1 A AO GCL A «HA XQ Iü XC ü A C•H •H GA CDG G LO CD C EC X  z-' i> <C O 3•H A  Q A •H Aü C en A X3 4-1 4-1 Mf G GG G •H E.A A  G A A A1 E Lu CM C- GX G en r- > CCQ CO + sf # O>. •HG AX O1 Go O ALD A GI—1 m o G 1 AG » en CM A >» CE Q G G l—!A Z 4-1 LO 4-1 LD E Xo 'u-' •HZ LD en CCM LD Gen CD A G•ÿj- LO A A CO GAA enG enX OE CD A3C G IA >G G A•H f4 AQ G AG EG A 3G •HG 'BR. XG o GX A E4*^cG ceA =3G OG  X Ê 4- 4- CL zG  G 3 oi A A ceA  E 1 •A C H A C C3>- A E X •H G G •H >> Cri0 0 3 G C A A GO A  A E A G 3 4-1X  G G G "BR. 'fe^ G 1CL C G G A O O A G CE G G C 1—1 CD 3 G G>% A C A O en A GA  A  A A ü A X E:A A 4-
139
The liver iron in the DD group was significantly lower 
compared with the other groups (Tables 24(b) and 25)*
3 .4.4.2.2. Protein synthesis
Lymphocytes from any group of mice transformed in 
serum-free medium containing either 10%-or 30%—iron-saturated 
transferrin synthesized similar levels of protein (Table 26(b)) 
These results confirmed the earlier observation that neither 
iron deficiency nor iron availability in the culture medium’ 
affects protein synthesis by transformed lymphocytes 
indicating that once DNA has been synthesized translation 
and protein synthesis proceed normally irrespective of iron 
availability.
3 .4 .5 * Effect of in vivo repletion of iron-deficient mice 
on lymphocyte transformation in vitro 
The aim of these experiments was to determine whether 
repletion of mice fed on low-iron diet restores lymphocyte 
responses to normal values and whether this is associated 
with re-establishment of normal iron status,, particularly 
serum iron levels.
3 .4.5*1* Preliminary experiments
Since Kuvibidila _et aT. (1 9 8 3a) had shown that iron 
repletion could be established within two weeks, four mice 
were fed on low-iron diet for six weeks after which the 
mice were put on iron-supplemented diet for three weeks to 
determine whether this was long enough to restore iron levels* 
Another group of four mice were fed on iron-deficient diet 
for the period of the nine weeks.
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At the end of the feeding period, haemoglobin levels 
and serum and liver iron were estimated. The iron status 
of the iron-deficient group (serum iron: 75 “ 11 pg/lOO ml; 
liver iron; 0.80 - 0.04 pg/g; haemoglobin; 7»2 - 0.5 g /
100 ml; mean - SEM) was similar to values obtained for 
the DD group in the previous experiments, and in the 
iron-repleted mice, the serum iron (23O - 18 pg/lOO ml) 
and liver iron (2.2 - O .3 V-ë/ë) were similar to values 
obtained for the Nd, SD and PF groups in the previous 
experiments. The haemoglobin levels of the iron-repleted 
mice (1 1 .4 i 1.4 g /lOO ml) were very near to figures 
obtained in Section 3»4.5*1«1» These results indicated 
that, as found by Kuvibidila e_t al. (1 9 8 3a), iron repletion 
had been established in iron-deficient mice after feeding 
on iron-supplemented diet for three weeks. However since 
haemoglobin levels were slightly below normal values obtained 
in Sections 3*4.4.1.1. and 3*4.4.2.1, the iron deficient 
mice were fed on iron-supplemented diet for four weeks, 
in the subsequent experiments.
3*4.5»2. The effect of serum from iron-sufficient, iron-
repleted and iron-deficient mice on the transformation 
of mouse lymphocytes vi tro 
Nine mice were assigned to three groups (three mice 
per group) and fed on different diets as described in 
Section 3«3«2. After the feeding period the mice were 
killed (see 3*3*3)*
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3•4.5•2.1. Iron status
The serum and liver iron levels of the repleted group 
of mice were very much the same as that of the group fed 
on iron-containing semisynthetic diet (Table 27), while 
there was a significant difference between the repleted 
mice and the iron-deficient group (Tables 27 and 2 8). These 
results confirmed the observations of the preliminary 
experiment (see 3*4.5*l) that supplementation of iron in 
the low-iron diet brings the liver and serum iron levels 
of the iron-deficient mice back to normal values.
supplemented with serum from iron-deficient mice than when
I3*4.5*2.2. Mitogenic responses of mouse lymphocytes from
iron-sufficient, iron-deficient and iron-repleted 
mice
Lymph-node lymphocytes were cultured for 43 h in medium 
containing 2.5% mouse serum and 1 pg/ml ConA (batch 2).
Cells from iron-repleted mice were cultured in serum from 
iron-sufficient, iron-deficient and iron-repleted mice and
■also in iron-deficient serum supplemented with iron and :
serum from repleted mice was used to test cells from all 
three groups. Additions of iron to DS serum was carried 
out as described in Section 3*4.3*2.2. Cultures containing 
cells from deficient mice in iron-deficient serum, and 
cells from mice fed on iron-supplemented diet in normal 
serum were also set up. The transformation of lymphocytes 
from iron-deficient or iron-repleted mice was lower in media
%
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Table 27; Iron status of iron-sufficient, iron-repleted and iron- 
deficient mice.
Mice Iron-sufficient Iron-repleted Iron-deficient
Serum iron"^ 
(pg/lOO ml)
229 i 29 (3) 220 i 10 (3) 7 0 - 6  (3)
Liver iron’*' 
(lig/g)
2.31 i 0.30 (3) 2.40 i 0.26 (3) 0.52 i 0.03 (3)
Figures in parentheses are number of animals. For statistical analysis 
see Table 28.
"^Mean - SEM.
Table 28; Analysis by Scheffe’s method of multiple comparisons of
results of the iron status of mice used for iron-repletion 
studies (data from Table 27).
LIVER IRON SERUM IRON
Groups
compared*
Simultaneous Signifi- 
95% confidence cant diff- 
limits erence
Simultaneous 
95% confidence 
limits
Significant
difference
1 and 2 0.14,-0.05 ns 72.80,-86.80 ns
1 and 3 0.21,0.09 S 248.80,89.25 S
2 and 3 0.25,0.05 S 255.83,96.21 S ■
I
■«
V
III
*l! iron-sufficient mice; 2: iron-repleted mice; 3s iron-deficient.
s
i
AI
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serum from iron-sufficient or iron-repleted mice was 
used (Table 29)* As before, addition of sufficient iron 
to bring the iron level of the deficient serum to that of 
iron-sufficient serum significantly improved its ability 
to promote transformation. Cells from iron-repleted mice, 
transformed as well as the cells from normal mice, and 
serum from iron-repleted mice was as good as serum from 
iron-sufficient mice and/or iron-supplemented iron-deficient 
serum in promoting transformation. The degree of transform­
ation of lymphocytes was, however, generally reduced in 
comparison with previous experiments (Table 20), this probably 
being associated with changing the batch of ConA. The 
results presented here indicated that repletion of iron 
deficiency brings about a restoration of normal lymphocyte 
responses to ConA, this being the result of an increase in 
serum iron levels, and confirm the earlier observations 
that iron deficiency in mice does not cause intrinsic 
defects in lymphocytes associated with ability to transform*
3 .4 .6 . Mouse T-cell populations and subpopulations
In the previous experiments it was shown that iron 
deficiency affects T-lymphocyte transformation in vitro, 
this being associated with a decrease in the level of 
circulating iron. However, it might be possible that iron 
deficiency affects immune responses by altering the 
relative populations of T-lymphocyte populations and sub­
populations. In order to find whether this was true, 
experiments were performed to study T-cell and T-cell sub­
sets in populations of cells from mouse lymph nodes.
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3.4.6.1. Estimation of T-lymphocyte populations using 
ANAE stain
Twenty mice were assigned to four groups and fed on 
different diets as described in Section 3-3-1* Iron status 
and the percentage of ANAE-positive T-cells of the four 
groups of mice are shown in Tables 30 and 34, respectively. 
The liver iron levels (Table 30) were similar to values 
obtained from previous groups of mice (Tables 8, 12, 19)
observation that when mice are fed on low-iron diets for 
six weeks, the haemoglobin levels do not fall much below 
those of the control groups. The percentage of T-cells
1,2
results were obtained with a-ly^ and a-ly^ antibodies. As 
before, liver and serum iron levels in the iron-deficient 
group were significantly lower than in control groups 
(Tables 32 and 33)» The proportion of cells positive for
■V.
i
and furthermore, the haemoglobin levels were similar to 
values obtained in Section 3*4.4.1.1, thus confirming the
■sI
s'in the iron-deficient group was not statistically different S:
from that of the other groups of mice (Tables 34 and 35). îÏ-s
3 .4.6 .2. Estimation of T-lymphocyte population and sub­
populations using monoclonal antibody to T-cell
surface antigens 
Using fluorescein-conjugated a-thy^ a-ly^ and a-lyxJ- y J-  ^ i
monoclonal antibodies the relative proportions of T-cells 3
"I:
and T-cell subsets in the lymph nodes of mice fed on ND,
SD, DD, and PE was studied. Figure 8 shows an example of ;
-i'ilymph-node cells positive for thy antigen. Similar
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-Ivi.
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Figure B ; A population of cells from mesenteric and peripheral 
lymph nodes of mice stained with monoclonal antibody 
to thy. antigen.
(a)
(b)
(a) Cells as seen under phase contrast (xl3D0)
(b) The same field as in (a) under U.V., showing thy^  ^
positive cells (i.e. T-lymphocytes). ’ 
The arrows in (a) point to non-T-lymphocytes 
which have not stained with the fluorescent 
antibody.
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Table 32; Iron status of mice on different diets used for T-cell 
and T-cell subset studies with monoclonal antibody to 
T-cell antigens.
Diet Normal
(ND)
Semisynthetic 
4- Fe (SD)
Semisynthetic 
- Fe (DD)
Serum iron'*' 197 -  32 219 i 18 55 i 7
('Hg/IGO ml) (3) (4) (4)
1 • * 4"Liver iron 1.80 i 0.80 2.02 i 0.07 0.51 i 0.03
(m/g) (3) (4) (4)
Figures in parentheses are number of animals. F or statistical analysis, 
see Table 33.
■‘Mean ± SEM.
Table 55; Analysis by Scheffe^s method of multiple comparisons of the 
iron status of mice on different diets used for T-cell 
studies with monoclonal antibody to T-cell antigens.
(Data from Table 32).
*1,2,3: mice fed on ND, SD and DD, respectively
V?::
s
SERUF IRON LIVER IRON %v:i
Groups
compared*
Simultaneous 
95% confidence 
limits
Significant
difference
Simultaneous 
95% confidence . 
limits
Significant
difference
1 and 2 50.14,-104.14 ns 0.09,-0.08 ns
1 and 3 59.85,224.14 S 0.16, 0.13 S
2 and 3 238.17,85.83 S 0.19, 0.15 S
«
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1
thy^ ly^ and ly^ did not differ significantly between 
any groups of mice (Tables 34 and 35)• This suggested 
that iron deficiency did not affect the mitogenic responses 
of T-lymphocytes by altering the relative proportions of 
different T-cell subpopulations.
I
f
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3*5 DISCUSSION
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Iron is an important requirement for metabolically
active cells especially those undergoing differentiation
in DNA synthesis. Lymphocyte transformation, a process 
of elevated metabolic activity leading to cell division,
and cell division, it being needed in particular for the 
synthesis of iron-containing proteins and enzymes involved
may also be associated with an increased requirement for 
iron.
Decreased lymphocyte proliferative responses in vitro 
in association with iron deficiency have been reported by 
many investigators using culture media supplemented with 
either autologous serum (Joynson ejt al » , 1972; Fletcher et al. , 
1 9 7 5) or foetal calf serum (Macdougall e_t al. , 1975; Sawitsky
et al. , 1 9 7 6; Soyano e_t al. , 1982; Kuvibidila _et al. , 1983a, b)
However, other authors have reported no effect of iron 
deficiency on the mitogenic response of lymphocytes using 
either autologous plasma (Kulapongs ejfc ad., 1974) or normal 
human serum (Gross at a^, , 1975; Gupta at al., 1982; Krantman 
et al., 1 9 8 2) in the culture medium. This controversy 
is probably due, at least in part, to lack of an experimental 
system which allows accurate control of iron supply during
the vitro culture of lymphocytes.
■
The work reported in this chapter has attempted to 
define more closely the effect of iron deficiency on 
lymphocyte transformation vitro using an experimental 
system in which the iron content of the culture medium was 
accurately monitored, taking advantage of the fact that
I
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mouse lymphocytes can respond to ConA in serum-free medium 
(Brock, 1 9 8 1). Furthermore, the use of an animal model 
has allowed variables which could complicate the interpretation 
of the results such as infections and other concomitant 
nutritional deficiencies to be eliminated.
In the present study, the mean weight-gain of mice fed 
on different semisynthetic diets was independent of the iron 
content of the diet or the amount consumed per day even 
when there was a day-to-day variation. However, the average 
weight-gain of the mice fed on iron-containing semisynthetic 
diet was significantly higher compared with that when normal 
laboratory diet was used (Fig. 7, Table 3). This may have 
been due to the fact that the semisynthetic diet had a higher 
carbohydrate content {6k»8fo) than the laboratory diet (48.4^^. 
Furthermore, although the mean weight-gain of mice fed on 
low-iron diet was slightly lower than that of the mice fed 
on iron supplemented diet or pairfed this difference was 
not statistically significant (Fig. 7, Table 6), These 
results differ from the observations of Kuvibidila et al. 
(1 9 8 3a) who at the end of their 32-day feeding period found 
a statistically significant reduction in the mean body 
weight of the iron-deficient mice and pairfed group in 
comparison with the control group. However, this difference 
was observed in of their animals only, as 759° of the
mice of each group had already been killed by this time, 
and they did not find a significant difference in the mean 
weight-gain of any mice during the first 25 days of feeding. 
They also used mice that were of a different strain and 
considerably older than those used in this study.
I
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A 6-week feeding period on low-iron diet was sufficient 
to induce iron deficiency in mice as indicated by the low 
serum and liver iron levels (< 95 p.g/lOO ml and < 0.75 pg/g, 
respectively) compared with- values obtained from the control 
group (> 180 pg/lOO ml and > 1.8 pg/g, respectively).
These results are comparable with values obtained by other 
investigators (Puschraann & Ganzoni, 1977; Kuvibidila e_fc al., 
1 9 8 3a,b). At the end of the 6-week feeding period, the 
haemoglobin levels of the iron-deficient group were lower, 
but not to a statistically significant degree than those of 
the control mice. The low liver iron and near normal 
haemoglobin level in the iron-deficient groups (Tables 24(a) 
and 3 0 ) indicated that latent iron deficiency had been 
established. However, after seven weeks of feeding on the 
low-iron diet, a statistically significant reduction in the 
haemoglobin levels in the iron-deficient group was observed 
(Table 24(b)). These results indicate that after 7 weeks 
on low-iron diet the mice become anaemic. However, although 
anaemia was not observed after 6-week feeding period on 
low-iron diet there was little difference in the level of 
liver iron between mice fed on low-iron diet for six weeks 
and those fed for seven weeks (see Tables 24(a) and 24(b)), 
so mice were normally fed for six weeks before being used.
As in the preliminary experiments (Chapter 2), the 
degree of transformation of lymphocytes from mice cultured 
in medium containing lO^^-iron-saturated transferrin was 
significantly lower compared with the responses of the 
cells cultured in medium containing 309o~iron-saturat ed
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transferrin or FCS. This applied to all groups, irrespective 
of diet and iron status. This result indicates that one 
of the important factors in controlling the proliferative 
responses of lymphocytes iu vitro is the content of 
transferrin-bound iron in the culture medium. "When transferrin 
partially saturated with iron is added to the culture medium, 
the amount of iron talc en up by cells from transferrin and 
hence the degree of cell proliferation, will depend on 
the percentage of apopnonoferric and diferric species of 
transferrin bound to the transferrin receptor on the cell 
membrane. The proportion of each species of transferrin 
bound will depend, in turn, on the saturation of transferrin 
with iron (Williams et ad., 1978). With rabbit reticulocytes, 
apotransferrin binds to the transferrin receptor with lower 
affinity than mono- and diferric transferrins, and their 
binding affinities are 4.6 x 10^ M ^, 2.65 x lo'^  M  ^ and 
1.1 X 10^ M ^, respectively (Young et al., 1984b)® At low 
saturation of transferrin with iron, therefore, the 
concentration of apo transferrin may be sufficiently high 
to counteract its relatively low binding affinity for the 
transferrin receptor. This could then lead to a significant 
blocking of receptors by apotransferrin and hence reduced 
iron uptake from the iron containing molecules. The 
proportion of apotransferrin, monoferric and diferric 
species of transferrin bound by the cells can be calculated 
using the affinity constants for these species as estimated 
for reticulocytes by Young e_t ad. (see above), together with the 
values for the distribution of iron between the binding
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sites in partially saturated transferrin as determined by 
Williams e^ (1978). The percentage of a particular
species of transferrin expected to bind to the transferrin 
receptor is equal to: proportion of the species present
multiplied by its affinity constant for the transferrin 
receptor. Thus, for lO^-iron-saturated transferrin, the 
proportion of apotransferrin, monoferric and diferric 
transferrin which would be expected to bind to the receptor 
are 3 1 ? 4l and 28% respectively, in comparison with 8, 55
and 37%, respectively, when 3 0%-i3?on-saturated transferrin 
is used. Thus, with 10 %-iron~saturated transferrin the 
proportion of apotransferrin bound would be high in 
comparison with that bound when transferrin 30% saturated 
with iron is used, and as a result, the interference by 
apotransferrin in the iron uptake process will be higher.
If these calculations are applied to the present study 
it can be proposed that transferrin at low iron saturations 
would not be as good an iron donor to cells as transferrin 
of higher iron saturation, and hence the lymphocyte 
proliferative responses would be reduced. Furthermore, 
although foetal calf serum containing medium had a higher 
saturation of (bovine) transferrin with iron (4l%; see 
3 .4 .2 .2 .2 ) than the serum-free medium, the degree of 
transformation in both media was not significantly
different (Table l4) indicating that under the conditions 
employed here, culture medium containing 3 0%“'i3ron-saturated 
transferrin is as good as medium containing 10% FCS in 
supporting and promoting lymphocyte transformation.
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Using serum from iron-sufficient and iron-deficient 
mice, it was also shown that sera from iron-deficient mice 
were unable to support optimum transformation of cells 
isolated either from iron-deficient mice or control mice, 
while serum from iron-sufficient mice permitted a normal 
response of lymphocytes from both iron-deficient and iron- 
sufficient mice. Supplementation of iron deficient sera 
with enough iron to bring the iron levels back to normal 
values (i.e. to increase the saturation of serum transferrin 
with iron) increased the lymphocyte mitogenic responses.
It seems, therefore, that the decreased lymphocyte proliferation 
associated with iron deficiency may be due to inadequate 
levels of circulating transferrin-bound iron. As previously 
explained, the apotransferrin present in the serum will 
interfere with the uptake of iron by the cells from mono­
ferric and diferric species of transferrin. The average 
percentage of saturation of transferrin with iron in the 
iron-deficient and iron-sufficient sera as calculated from 
Tables 8 and 12, is 15% and 82%, respectively. At 15% 
saturation of transferrin with iron, the theoretical 
proportions of apotransferrin, monoferric and diferric 
transferrins bound would be 19%, 52% and 29%, respectively.
When transferrin is 82% saturated with iron most of the 
transferrin bound would be in the diferric form (91*8%) 
and only 0.3% in the apo form. Therefore, in medium containing 
serum from normal mice, there is a large amount of iron 
available to the cells, this being the result of low
l 6 o
interference from apotransferrin and also due to the higher 
proportion of diferric to monoferric transferrin bound 
to the cells.
The observation that the degree of lymphocyte 
proliferation depends on the availability of transferrin- 
bound iron is supported by the work of other investigators.
It has been shown that lymphocytes isolated from iron- 
deficient individuals responded normally to mitogens when 
cultured in medium containing serum from normal individuals 
(Gross et al., 1975? Van Heerden et al., 1981; Krantman et al., 
1 9 8 2). Normal human serum contains approximately 2.4 mg/ml 
transferrin (Morgan, I98I) which is about one third saturated 
with iron (Fairbanks & Beutler, 1977) so that when serum 
is added to the lymphocyte culture medium at a normal 
concentration of 5-10%, there will, as explained above, 
be enough circulating transferrin-bound iron to permit a 
normal response of lymphocytes to mitogens (or antigens). 
Furthermore, the normal response to mitogens of lymphocytes 
isolated from iron-deficient subjects and cultured in 
medium containing serum from normal individuals also 
indicated that iron deficiency did not cause any intrinsic 
defects in lymphocytes and that these cells can respond 
normally if there is enough circulating transferrin-bound 
iron.
Decreased proliferative responses of lymphocytes 
associated with reduced levels of circulating transferrin- 
bound iron were also reported by Joynson at al. (1972), 
who cultured peripheral blood cells isolated from iron 
deficient anaemic patients in a medium containing autologous
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serum. The level of circulating iron in the deficient 
group (2 5*5 “ 3*68 iJg/lOO ml) was much lower than that of 
the normal individuals (ll5»3 ” 7*57 ^g/lOO ml). The 
reduced transformation observed by the above investigators 
might therefore have been associated with decreased levels 
of circulating transferrin-bound iron present in the culture 
medium. However, they also cultured cells in medium
y notcontaining 20% foetal bovine serum, and as it wasrgpecified 
in the results which of the two types of serum was used, it 
is not clear whether the decreased lymphocyte transformation 
was the result of low iron levels in the culture medium. 
Decreased lymphocyte proliferation du vitro not associated 
with decreased levels of transferrin-bound iron in the 
culture medium have also been reported. Kuvibidila _et ad. 
(1983b) showed that the response to ConA of spleen cells 
from iron deficient mice cultured in medium containing 
foetal calf serum was significantly lower than that of the 
control groups and that this difference was not eliminated 
by addition of ferric chloride or mouse transferrin 
(unspecified saturation with iron) to the culture medium. 
Their results indicated that the low lymphocyte proliferative 
response was probably the result of cell abnormalities 
caused as a result of iron deficiency, rather than the 
lack of adequate levels of transferrin-bound iron. However, 
it is difficult to compare their results with those 
presented here as spleen rather than lymph node cells 
were used. There was also an unexplained variation in the
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effect of vitro iron repletion according to the mitogen 
and source of iron employed. Fletcher ejfc ad. (l975) also 
observed decreased proliferation of lymphocytes isolated 
from iron-deficient individuals and cultured in medium 
containing plasma from iron deficient patients. The 
decreased response, though, was not due to low-levels of 
iron in the culture medium but probably due to intrinsic 
defects of the cells isolated from the iron-deficient 
patients, since cells from normal subjects cultured in 
"iron—deficient" serum produced a normal response. However, 
most of their patients had chronic Candida infections 
which might have affected parameters associated with 
lymphocyte function. On the other hand, it has also been 
reported that lymphocytes isolated from iron-deficient 
patients and cultured in medium containing autologous plasma 
could transform normally in response to mitogens, indicating 
that neither iron-deficiency nor availability of transferrin- 
bound iron affected lymphocyte transformation (Kulapongs 
et al., 1 9 7 4). However, all their patients had a concomitant 
hookworm infection, which may alter cell—mediated immune 
responses or enhance the production of factors which could 
balance out the negative effect of lack of iron. It should 
be noted that reports in the literature indicate that 
factors other than iron in the culture medium may affect 
lymphocyte transforraation. The presence of infection 
(Mendes and Raphael, 1971) influences cell-mediated immune 
responses and nutritional restriction in the diet causes 
damage of the lymphoid system and substantially alters the
I
I
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immune response (Faulk e_t aJ_, , 1975; Malave et al « , I98O).
The probable reason for the demonstration by many investi­
gators of a reduced mitogenic or antigenic response of 
lymphocytes isolated from iron-deficient individuals and
cultured in media without restriction of iron may have
been the presence of infections or nutritional deficiencies 
other than iron (Bhaskaram & Reddy, 1975; Chandra & Saraya, 
1975; Macdougall ejb aT. , 1975; Sawitsky aT. , 1976). It 
is important to note that investigators who failed to find 
abnormalities in lymphocyte transformation associated 
with iron deficiency using culture medium containing serum 
from healthy individuals were among those who documented 
the absence of infections or nutritional factors other than
iron (Gross et al. , 1975; Gupta _et al. , 1982; Krantman e_t al. ,
1982).
Furthermore, using sera from normal, iron-repleted 
and iron-deficient mice it was shown that sera from iron- 
sufficient mice were able to support optimum transformation 
of lymphocytes isolated from iron-deficient, iron-sufficient 
or iron-repleted mice, while serum from iron-deficient mice 
could not (Tables 20 and 29)* The observed increase in 
proliferative activity of lymphocytes cultured in medium 
containing serum from iron-repleted mice was probably the 
result of the in vivo restoration of normal levels of 
circulating transferrin-bound iron. The finding that 
decreased skin responses of iron-deficient mice (Kuvibidila 
et al., 1 9 8 1) or iron-deficient patients (Talwalkar e_t al. ,
1 9 8 2) were restored to normal values by iron administration,
37
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may also be explained by increased levels of circulating 
transferrin-bound iron.
Another observation in the present investigation was 
that the iron content of the medium did not affect the cells 
of the iron-deficient group differently from those of the 
other groups of mice. Cells from iron-deficient mice 
would transform as well as cells from iron-sufficient mice 
in all media. These results indicate that iron deficiency 
in mice does not cause any intrinsic defects in lymphocytes 
which affect proliferation and differentiation dni vitro.
This conclusion is supported by the work of Cummins et al. 
(1 9 7 8) who showed that immune lymph node cells obtained 
either from normal or iron-deficient donor rats failed to 
induce parasite rejection in iron-deficient recipients, 
whereas immune lymphocytes from deficient donors could induce 
rejection in normal recipients. However, abnormalities in 
lymphocytes as a result of iron deficiency have been reported. 
Kuvibidila e_t al. (1 9 8 3a) demonstrated a reduced blastogénie 
response of mouse splenic lymphocytes cultured with ConA 
or PHA in medium containing new born calf serum, which was 
restored to normal after in vivo iron repletion. They 
attributed the decreased mitogenic response to either 
increased numbers of undifferentiated or functionally 
inactive cells. Furthermore, Jarvis and Jacobs (1974) 
reported morphological abnormalities of the mitochondria, 
such as increase in size, degeneration of the cristae and 
vacuolation, in lymphocytes isolated from iron deficient 
and anaemic individuals. Similar observations were reported
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proportions of different lymphocyte subpopulations in the 
lymph nodes in mice. As iron deficiency affects cell
by Jimenez jet aT. (1 9 8 2) who in addition showed that the 
mitochondrial modifications were proportional to the degree 
of iron deficiency. It is possible, however, that the 
morphological abnormalities seen by these investigators 
may not affect transformation per s_e, or may only be found 
as a result of severe and prolonged iron deficiency, and 
do not develop in the comparatively short time for which 
the experimental animals were kept on low-iron diet in 
these experiments.
The proportion of T-lymphocytes in the mouse lymph 
nodes as indicated using monoclonal antibody to T-cell 
surface antigens and ANAE-stain was the same in normal and 
iron-deficient mice. This suggests that iron deficiency 
does not affect immune responses by altering the relative
division and differentiation it is to be expected that the 
population of lymphocytes with a high turnover rate (i.e. 
short-lived) would be more affected in iron deficiency than 
the long-lived cells. Since the lymph-node compartment is 
considered by represent a long-lived recirculating pool 
of lymphocytes (Zatz & Lance, 1970) such a difference in
:T-lymphocyte populations in lymph nodes in iron deficiency 
may not be present. In contrast to the above findings,
Bhaskaram & Reddy (l975)? Chandra & Saraya (l975), Srikantia 
et al. (1 9 7 6) and Krantman ejk al. (1 9 8 2) reported decreased
T-cell counts associated with iron deficiency. However, 
they all used peripheral human blood cells while mouse
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lymph node cells were used in the present study. Furthermore, 
a decreased proportion of T-cells in the spleens of iron 
deficient mice has also been reported (Kuvibidila _et al. > t 9P?j 
1983 a. ). However the spleens in the iron-deficient mice 
were very much enlarged so that the absolute number of 
T-cells per spleen in the iron-deficient mice might not 
have been very much different from the control mice. In 
the present study the proportion of T-cells using- ANAE-stain 
which was approximately 82-90% of the total lymph node cells 
(Table 34), was slightly lower (7-9%) than that demonstrated 
by Mueller jet al. (l975)* However, they used cells from 
mesenteric lymph nodes only while cells from mesenteric 
and peripheral lymph nodes were used in the present 
investigation and they also used BABL/c mice while C^H/BI 
mice were used in this study. The proportion of cells 
positive for thy^  ^cell-antigens was found to be about 
76-78% (Table 34). This value was lower than that estimated 
using ANAE-stain. However, results obtained using ANAE- 
stain cannot be compared to those obtained using monoclonal 
antibody to T-cell surface antigens because ANAE-stain 
involves the detection of a cytoplasmic enzyme activity
i.e. of a different cell marker to that detected by antibodies 
to T-cell surface antigens. The proportion of thy^  ^
positive cells which were also positive for either ly^ or 
ly^ cell surface antigens was approximately 74-83% and 
3 2-34%, respectively, (Table 34), indicating that the 
number of cells positive for thy^  ^ (i.e. T-lymphocytes) 
is less than the number of cells positive for ly^ (i.e.
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T“helper) and ly^ (i.e. T-suppressor). However sensitive ;
immunofluorescence techniques have shown that in mice ly^ 
is found in all T-cells although it is present in much 
higher levels on T-helper than on T-suppressor or cytotoxic 
T-cells (Ledbetter e_t aT. , I98O), so that some cells positive 
for ly^ may also be positive for ly^.
Although DNA synthesis is affected by the amount of 
transferrin-bound iron in the culture medium, in the present 
study protein synthesis by transformed cells was not affected 
by the availability of iron. Resting lymphocytes, like all 1
cells, possess the enzymatic apparatus required for oxidative 
metabolism and also other enzymes such as acid phosphatases 
and enzymes for the synthesis of DNA, RNA and protein 
(Elves, 1 9 7 2). T-cell activation and proliferation leading 
to cell division, involves increased cellular metabolic 
activity such as DNA, RNA and protein synthesis (Epstein & Stolmaq 
1964; Inman & Cooper, I9 6 5; Sell et al., 1 9 6 5)» Furthermore, 
it is well established that stimulated T-cells produce 
interleukin-2 (Smith, I98O; Smith e_t ed. , 1980b;¥agner ejt al. , 
1 9 8 0), a T-cell growth factor which plays a crucial role '[
in T-cell activation and proliferation and they also produce 
immune interferon (Perussia e^ al., I98O; Klein et al., I9 8 2), 
a polypeptide involved in immunity against viruses. T- 
lymphocyte transformation is therefore associated with 
increased production of various proteins. The process of 
protein synthesis requires DNA and since transferrin-bound 
iron as seen in this study affects DNA-synthesis, it could 1
be expected that availability of iron during proliferation
" 11 6 8  -
could also affect protein synthesis. However, from the 
results presented here, protein synthesis was not directly 
dependent on the levels of iron in the culture medium, and 
it seems, therefore, that iron deficiency did not cause 
any intrinsic defects in the ability of these cells to 
synthesise protein. It is important to note that under the 
conditions employed here for measuring total protein 
synthesis by transformed cells, the number of cells from 
each group was standardised to eliminate possible differences 
in protein synthesis arising from the presence of different 
number of cells. In general, it seems that, provided there 
is sufficient DNA to initiate translation, this and protein 
synthesis will proceed normally even in the condition of 
iron limitation.
In conclusion, a short term iron deficiency in mice
Î
does not affect the proliferative responses of mouse lymph 
node T-lymphocytes iji vi tro by causing intrinsic defects 
or by altering the relative proportion of different 
lymphocyte populations in the nodes. Furthermore, although 
protein synthesis seems to be independent of the iron level 
of the culture medium, cell transformation as measured by 
DNA synthesis depends on the availability of transferrin- 
bound iron. From the results presented in this chapter it 
is quite clear that proliferation of mouse lymph node 
T-lymphocytes in vi tro depends on the availability of 
transferrin-bound iron. However, it was not evident 
whether transferrin was important in proliferation only 
as an iron donor or whether it also has an effect on cell y
transformation unrelated to its iron-donating properties.
I
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In order to determine the exact role of transferrin in 
the proliferation and division of T-lymphocytes, another 
set of experiments was performed and these are discussed 
in more detail in Chapter 4.
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3.6 CONCLUSIONS
1, No intrinsic loss of ability of mouse lymph-node 
T-cells to transform is caused as a result of iron 
deficiency.
2. The iron content of the culture medium is important for
T-lymphocytes to transform in vi tro.
3* The in vi tro protein synthesis by transformed lymphocytes
is not directly affected by the iron content of the 
culture medium.
4. Under the conditions employed, serum from iron-deficient
mice has inadequate iron levels to permit optimum 
transformation.
5. In vivo iron repletion resulted in the re-establishment 
of normal iron status and also in restoration of the
■ >•in vitro mitogenic response of lymphocytes cultured 
in medium containing serum from iron-repleted mice.
6. Iron deficiency does not affect the proportion of T-cells 
or T-cell subsets in the mesenteric and peripheral 
lymph nodes of mice.
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3.7. SUMMARY
The in vitro response to ConA of lymphocytes from 
iron-deficient and control groups of mice in media containing 
either 10% FCS or 30%-Iron-saturated transferrin was the 
same for the iron-deficient and control groups. However, 
the degree of transformation in serum-free medium containing 
10%—iron-saturated transferrin was significantly lower in 
all groups of mice. The transformation of lymphocytes 
from iron-sufficient, iron-deficient and iron-repleted mice 
was lower in media supplemented with serum from iron- 
deficient mice than when serum from iron-sufficient or iron- 
repleted mice was used. Addition of sufficient iron to 
bring the iron level of the deficient serum to that of 
normal serum significantly improved its ability to promote 
transformation. In vivo repletion of iron-deficient mice 
resulted in a restoration of normal lymphocyte response to 
ConA which was associated with a return of serum iron levels 
to normal values. The proportion of cells positive for 
thy^ g, ly^ and ly^ antigens did not differ significantly 
between any groups of mice. Protein synthesis by cells 
transformed in serum-free medium containing 10%-or 30%— 
iron-saturated transferrin was the same in all groups of 
mice. These results indicate that the decreased lymphocyte- 
proliferative responses in iron deficiency may be due to 
inadequate levels of circulating transferrin-bound iron 
rather than to intrinsic defects caused as a result of 
iron deficiency or changes in the proportion of T-cells 
or T-cell subsets in the lymph nodes.
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THE ROLE OF TRANSFERRIN AND IRON
IN PROMOTING THE IN VITRO TRANS­
FORMATION OF MOUSE LYMPH NODE
LYMPHOCYTES
';î;
CH.A.PTER 4 —  -
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4.1. INTRODUCTION
I
Although- iron is an important requirement for 1
'7haemoglobin synthesis (Elder, I98O; Wrigglesworth & Baum,
1 9 8 0), small but significant quantities also are required 5
by cells other than erythroid precursors for the synthesis 7
of metabolically important metalloenzymes and cytochromes 
(Wrigglesworth & Baum, I98O). The transformation of 
lymphocytes to form blast cells, an important component of f
the immune response, involves increased metabolic activity 
(MacKinney et al., 1962; Epstein & Stohlman, 1964; Inman 7
& Cooper, 1 9 6 5; Sell et al., I9 6 5; Elves, 1972; Ling &
,7Kay, 1 9 7 5) and hence an increased requirement for iron- 4.
containing enzymes , It is possible, therefore, that in­
adequate delivery of iron may cause a decrease in the 
metabolic activity of lymphocytes which may result in
:reduced proliferative response.
■In the previous chapter it was shown that lymphocyte
Ïtransformation in serum-free or serum-containing medium, 
depended on the availability of transferrin-bound iron 
and that supplementation of iron-deficient serum with 
enough iron to bring the iron levels back to normal values 
significantly increased the degree of proliferation. Since
it was not clear whether transferrin was important in 3-;7transformation as an iron donor, or that transferrin also 
affects proliferation by means other than donating iron,
7it was decided to investigate further the role of transferrin
■ v-7in lymphocyte proliferation. The requirement of transferrin 3;
1 7 4
and iron in lymphocyte transformation has been reported
before . Tormey and Mueller (1972) showed increased
incorporation of labelled thymidine into DNA in human
peripheral blood lymphocytes when human transferrin was
added to the culture medium. The interpretation of their
results, though, is difficult since they cultured the
lymphocytes in medium containing foetal calf serum and
hence their results were complicated by the presence of
bovine transferrin. Lipsky & Lietman (1 9 8 0) showed that
stimulated murine lymphocytes accumulated ^^Fe during the
blastogénie process when cultured in medium containing
59serum which had been incubated with Fe as ferrous chloride
to allow oxidation and binding of the iron by the serum 
transferrin . Furthermore, mitogen-stimulated lymphocytes 
showed an enhanced incorporation of labelled thymidine
when cultured with transferrin in serum-free medium
,
(Phillips & Azari, 1975; Dillner-Centerlind e_t al. , 1979; 
Brock, 1 9 8 1, Tanno e_t aT. , I9 8 2). This ability of trans­
ferrin to promote lymphocyte transformation in vitro was 
shown to depend on its ability to bind iron since des- 
ferrioxamine, an iron chelator, added to the medium prior 
to transferrin prevented transferrin from potentiating 
the proliferative responses (Brock, I98I; Novogrodsky et al■, 
1 9 8 2). These workers also showed that the decreased 
proliferative response of lymphocytes in the presence of 
desferrioxamine (DFO) was not the result of modification 
of the mitogenic response by desferrioxamine itself but 
probably due to removing transferrin and hence depriving 7
175
lymphocytes 5 of iron. Similarly, Lipsky cl Lietman (1 9 8O) 
showed that the blastogénie response of murine lymphocytes 
cultured in serum-containing medium was decreased by about 
50% when desferrioxamine was added to the medium. Additionally, 
they reported that the percentage inhibition depended on 
the time for which the cells had been cultured before 
desf errioxamine was added. Brock (1 9 8 1) and Tanno ejt al.
(1 9 8 2) also reported that in serum-free conditions des- 
ferrioxamine inhibited the transformation-promoting activity 
of transferrin, and that the inhibition depended on the 
concentration of desferrioxamine.
Use of monoclonal antibodies to the transferrin receptor 
which blocks transferrin binding showed the need of 
transferrin-bound iron by proliferating cells in vi tro. 
Transferrin-mediated uptake of iron by murine tumour cell 
lines was inhibited by an antibody to mouse transferrin 
receptor (Trowbridge e_t aT. , I9 8 2). The inhibition of 
cell-proliferation by monoclonal antibody was not a direct 
result of its binding to the receptor, since a monoclonal 
antibody to transferrin receptor which did not block access 
of transferrin to the receptor did not have any effect 
(Trowbridge & Lopez, I9 8 2). Further evidence that the 
transferrin requirement for in vitro lymphocyte proliferation 
is related to a need for transferrin-bound iron, comes 
from the observation that the degree of transformation of 
lymphocytes depends not only on the presence of transferrin, 
but also on the level of transferrin-bound iron (Phillips & 
Azari, 1975; Brock, I98I) indicating that the levels of
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transferrin-bound iron are also important. This is 
confirmed by the work of Brock & Rankin (1 9 8 1) and Bomford 
et al. (1 9 8 3), who showed that mitogen stimulation resulted
in an increase in both binding of transferrin and uptake 
of iron by lymphocytes. Uptake of transferrin-bound iron 
and binding of transferrin by human lymphoblastoid cell 
lines has also been reported (Schulman ejt al. , I98I). During
transformation and cell division, when the requirement for
iron increases, there is also an increased expression of 
cell-membrane receptors specific for transferrin (Hamilton 
et al., 1979; Larrick & Cresswell, 1979&%Galbraith al,, 
1 9 8 0a,b,cj Brock & Ranlcin, 1 9 8I; Hammarstrom e_t aT. , 1982; 
Neckers & Cossman, I9 8 3).
Literature data, therefore, suggest that transferrin 
is important in lymphocyte proliferation as an iron supplier. 
However, it could also be proposed that the requirement 
for transferrin is not only related to the increased need 
of proliferating cells for iron, but may also result from 
cell proliferation being dependent upon a signal derived 
from the interaction of transferrin with its receptor. This 
would suggest that the importance of transferrin in 
lymphocyte transformation may be due to some effect on cell 
proliferation other than its ability to act as an iron 
donor. There are some literature data which support such 
a theory. Although iron from transferrin is important for 
lymphocyte proliferation, it is necessary to explain the 
fact that lymphocytes, in serum-free medium, also take iron 
from iron compounds such as nitrilotriacetate (Brock, I9 8 1)
I
,37
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or ferrous sulphate (Tantio ejb a^ . , I9 8 2) but these compounds 
do not substitute for transferrin as promoters of lymphocyte 
transformation. However, it should be remembered that 
iron uptalee from low molecular weight compounds is non- 
physiological since, under normal conditions, no low-molecular 
weight iron complexes are found in the plasma (Hahn & Ganzoni, 
1 9 8 0) and internal handling and utilisation is probably 
abnormal. Another point of consideration is that although 
desferrioxamine when added to cell cultures caused a marked 
inhibition of lymphocyte proliferation, it did not induce 
complete inhibition even at concentrations sufficient to 
chelate all the iron in the medium (Brock, I98I; Novogrodsky 
et al», 1 9 8 2). Furthermore, proliferating lymphocytes in 
contrast to erythroid precursors bind inappropriately large 
amounts of transferrin in relation to their iron requirements 
(Bomford e_b al. , 1 9 8 3)» Finally, lymphocytes possess storage 
iron (ferritin) which one might expect to be mobilised to 
meet increased needs during transformation if no exogenous 
iron is available, but seemingly ferritin cannot substitute 
for transferrin-bound iron (Summers & Jacobs, 1976). Taking 
these points into consideration, it could be argued that
Ithe binding of the iron-transferrin complex, or perhaps, 
transferrin alone, to the cell membrane receptor is, in 
itself, an important step in the sequence of events which 
lead to cell proliferation. Binding of transferrin to its 
receptor at physiological temperatures results in aggregation 
or patching of the receptors which is followed by endocytosis 
(Galbraith & Galbraith, I9 8 0). Patching has been observed
I
1 7 8
in other systems such as the binding of mitogens to 
specific receptors on cell membrane (Ling & Kay, 1975?
Stobo, 1 9 7 7) or the binding of antigens to immunoglobulins 
on B-lymphocytes (Taylor ejfc aT., 1971; Loor et aT. , 1972;
Raff & de Pétris, 1973)» The transferrin receptor is a 
major multi-subunit component in the membrane of transformed 
T-lymphocytes (Goding & Harris, I98I) and it is a bivalent 
molecule (Newman ejk ai., I9 8 2). Furthermore, transferrin 
probably acts as a divalent ligand since iron-binding half­
molecules produce no enhancement of lymphocyte proliferative 
responses (Brock, I98I). Patching of the immunoglobulin 
on B-lymphocytes which leads to cell activation, also 
requires a divalent ligand (Taylor et , 1971; Raff & 
de Pétris, 1973)« There is, therefore, a resemblance between 
the binding of transferrin to its receptor and other 
triggering systems such as the binding of antigen to surface 
immunoglobulin.
In conclusion, although transferrin is undoubtedly 
important for lymphocyte transformation as an iron donor, 
there are also data which suggest that the interaction of 
transferrin with its receptor on the membrane of stimulated 
cells may in itself trigger events leading to transformation. 
This study was performed in order to investigate this 
possibility, and four different approaches have been used 
to test this hypothesis.
S
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1. The effect of desferrioxamine on the proliferation of 
mouse lymph node lymphocytes in vitro 
One of the important factors which needs to be talc en 
into account while investigating the effect of transferrin i
or iron on lymphocyte proliferation in vi tro, is the level 
of endogenous iron or transferrin in the culture medium.
The interpretation, for example, of results concerning 
the effect of transferrin or iron on the proliferation of 
lymphocytes cultured in serum-containing medium are 
complicated by the presence of transferrin in the serum.
The use of serum-free medium overcomes this problem, but 
it has been found that RPMI-l640, the most commonly used 
culture medium for lymphocytes, contains a small but 
significant amount of endogenous iron (Brock, 1981) which 
is sufficient to saturate some of the transferrin added
'to the medium. This may therefore interfere with any■
attempt to study the role of apotransferrin. In order to 
determine whether transferrin is important in lymphocyte 
transformation as a membrane-triggering agent and not as 
an iron donor, it is necessary to determine whether apo-
Itransferrin promotes transformation. The problem of 
endogenous iron can, however, be overcome by adding a 
suitable iron chelator to the medium prior to the addition 
of apotransferrin. Desferrioxamine is an iron chelator 
with an iron-binding affinity constant greater than that 
of transferrin (Pollack e_t aT. , 1976). If DFO is used 
in the culture medium prior to the addition of apotransferrin
1 8 0
and the effects of transferrin on lymphocyte proliferation 
in the presence or absence of desferrioxamine are compared, 
the importance of transferrin as a membrane-triggering 
agent can therefore be demonstrated. However, this 
strategy would only work if the efficiency of apotransferrin 
as a trigger was similar to that of iron-containing trans­
ferrin. Some investigations along this line have already 
been reported, but they used either serum-containing medium 
(Novogrodsky at ad., I9 8 2) or a different culture technique 
(Brock, 1 9 8 1), hence it was felt desirable to carry out 
further experiments using the controlled conditions described 
in Chapter 2 of this thesis.
2. The effect of cobalt- and manganese-containing transferrins 
on lymphocyte proliferation
The use of desferrioxamine to investigate the possibility 
that lymphocyte proliferation vi tro depends on a signal 
derived from the interaction of transferrin with its 
receptor, and that transferrin is not important as an iron 
donor, will only provide useful results if both apo^ and 
iron containing transferrins could cause a signal for 
proliferation. However, it could be that the induction of 
the triggering effect requires the conformation of trans­
ferrin induced when metal is bound. In order to test this 
possibility transferrin which had bound either cobalt or 
manganese was used instead of iron-containing transferrin. 
Cobalt and manganese are metals of the same transition 
series as iron and therefore have similar physico-chemical
s
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properties. Since the ionic radii of cobalt and manganese 
o o(0 . 6 5 A and 0,62 A, respectively), do not differ much from 
that of iron (0 , 6 7 A), they should be able to substitute 
for iron in the transferrin molecule without greatly alter­
ing its configuration. Complexes of transferrin with 
manganese or cobalt have been prepared previously (Aisen 
et al. , 1 9 6 9; Tan & Woodworth, 1 9 6 9; Zweier ejk aT. , 1 9 8I),
Since Mn^^ and Co^^ hâve been shown to occupy the same■
binding sites in the transferrin molecule as Fe^^ (Aisen 
et al * , 1 9 6 9; Tomimatsu ejb aT. , 1976) it is physiologically 
feasible to use them instead of iron. By using cobalt- 
or manganese-containing transferrins instead of iron trans­
ferrin it may therefore be possible to show whether 
transferrin is important in lymphocyte transformation 
because of its ability to donate iron or because of a 
membrane triggering effect.
3• The effect of transferrin with abnormal iron-binding 
properties on lymphocyte proliferation
A variant transferrin has been isolated by Evans et al. 
(1 9 8 2) with an abnormal C-terminal iron-binding site. This 
transferrin also has a lower association constant with the 
transferrin receptor which is reflected in a reduced rate 
of iron-donation to transformed lymphocytes (Young et al., 
1984a). However these workers did not investigate the degree 
of transformation induced by the abnormal transferrin. The 
effect of the variant transferrin on lymphocyte proliferation 
could therefore be used to determine whether transferrin
1 8 2
enhances transformation by causing a triggering effect on 
the lymphocyte membrane. If the variant transferrin induces 
the same proliferative response as the normal transferrin, 
the triggering effect is probably not important , However, 
if the variant transferrin causes low proliferation, this 
could be due to either low membrane triggering effect or 
due to low iron uptake
4.» The effect of a monoclonal antibody to the mouse 
transferrin receptor on lymphocyte proliferation 
It is known that membrane receptors specific for 
transferrin are expressed on mitogen activated peripheral 
blood lymphocytes (Phillips, 1976; Galbraith et al., 1980b)
and that membrane binding of transferrin results in the 
delivery of iron to the metabolically active lymphocytes 
(Hamilton, 1983). However, if the interaction of transferrin 
with its receptor also causes a triggering effect leading 
to cell proliferation, then a monoclonal antibody to the 
transferrin receptor may, if an alternative source of iron 
is also provided, be able to mimic the effects of transferrin 
and induce the same proliferative response. The effects 
on in vitro lymphocyte transformation of a monoclonal antibody 
to the transferrin receptor in the presence or absence 
of chelated iron have therefore been compared with the 
effect of iron—containing transferrin.
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4.2. MATERIALS
4.2.1. Variant and normal human transferrins. Variant and
normal human transferrins isolated from the plasma of a
donor who is heterozygous for the variant were kindly
provided by Dr R.W. Evans, Guy’s Hospital Medical School,
London. Variant and normal transferrin preparations were
rendered iron free by dialysis against 0.02 M citrate
buffer at pH 5*1 for 24 h, and dialysed again against d-D¥
before being freeze-dried. Stock solutions (0 . 5 mg/ml)
of variant and human transferrins were prepared in PBS
(containing 1% NaHCO^). For different saturations of the
transferrins with iron, the appropriate amount of iron as
,ferric nitrilotriacetate complex was added (see 2.2,2.2).
Human control transferrin solution was prepared from 
Behringwerke transferrin as described elsewhere (see
2.2.2. 6) .
4.2.2. Monoclonal antibody to transferrin receptor. Monoclonal
antibody to the mouse transferrin receptor (Ab a TfR;
RI7 2 0 8) was kindly provided by Dr I. Trowbridge, Salk 
Institute, San Diego.
4 ,3 . METHODS
4 .3 *1 * Preparation of cobalt and manganese complexes of
transferrin — ---------
For the preparation of the cobalt transferrin complex 
(CoTf) the method of Aisen _e_t al. (1 9 6 9) was used. The IS1:1 complex of cobalt with citrate was obtained by mixing
iI
 -   --    . - ■ -* ■ —  -, -  . .1
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equal volumes of 0.01 M citric acid and 0.01 M cobaltous 
nitrate solutions (Analar grade, BDH) and then slowly 
adjusting the pH of the solution to 5*0 by careful addition 
of IM NaOH. A 3-fold excess of citrate-cobalt complex 
was added to a 5% (w/v) solution of human apotransferrin 
in 0.1 M KOI - 0 . 0 5 M Tris buffer, pH 7*5* The preparation 
was then made 0.04 M in NaHCO^ and allowed to stand for 
30 h at 4^0 in the dark. Increments of 2 pi of 0.6% (w/v) 
of hydrogen peroxide were then added until no further 
increase in the absorbance at 405 nm was observed. Since 
the absorbance at 405 nm was not further increased after 
the addition of 6 pi of peroxide solution to a solution 
containing 25 mg of transferrin in O . 9 ml medium, it was 
decided that the transferrin was fully saturated with iron.
The spectrum of this solution exhibiting maximum at 405 nm, 
was similar to that obtained by Aisen et al. (1 9 6 9)* Unbound
metal was removed by Sephadex G-25 gel filtration followed 
by passage of the preparation through a column of chelex-100 
(Bio Rad. Laboratory, Richmond, Co., U.S.A.) equilibrated 
with KCl-Tris buffer. The chelex-100 did not remove any 
of the metal from the transferrin complex as indicated by 
the ratio of the absorbance of the transferrin solution 
at 280 and 405 nm which were the same before and after 
passing through the column. The final concentration of 
the transferrin in the solution was estimated by measuring 
the absorbance at 280 nm against KCl-Tris buffer and using 
the extinction coefficient for human iron-saturated 
transferrin at 280 nm; = l4.1 (Aisen _et a^ . , I9 6 7),
"!{f1 8 5  -
since the extinction coefficient value for cobalt-saturated 
transferrin was unobtainable.
using the extinction coefficient values for iron-saturated 
transferrin at 280 nm l4.1; see above) and the
prepared as described above exhibited a maximum at 429 r.m 
and it was similar to the spectra obtained by other 
investigators (Feeney & Komatsu, I9 6 6; Aisen e_t ai. , 19^9) »
4.3 .2.1, Effect of desferrioxamine on the transformation of 
mouse lymphocytes in serum-free medium 
Cells were cultured with ConA (0 . 5 pg/ml; see 2,4.2) 
in serum-free medium to which apotransferrin (50 pg/ml) 
and increasing concentrations of DFO (25 to 250 ng/ml)
The manganese transferrin (MnTf) was prepared in the
same way as the cobalt transferrin using MnSO^'4HgO 
(ANALAR grade, BDH), and omitting the step of addition of 
peroxide. The concentration of transferrin in the solution 
and the percentage saturation with manganese were checked
I
extinction coefficient values for manganese-saturated
transferrin at 429 nm (E^ ^^  = 1.09, Feeney & Komatsu, I9 6 6),cm
The percentage saturation of the transferrin with manganese 
was calculated using the formula: ^^429 l4.1 ^^ - 100
The spectrum of transferrin saturated with manganese
4 .3 *2 . Lymphocyte transformation assay
Lymph node cell-suspensions were prepared and cells 
were cultured as described elsewhere (see 2.3*2). The 
proliferative responses were measured as in Section 2.3*2.
3':
i:
»
I
iron.
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were added. The DFO was added to the culture medium 20 min 
prior to the addition of apotransferrin and cells to allow 
complete binding of endogenous iron. Controls without 
ConA or without DFO, and also a positive control with 25%— 
iron-saturated transferrin, were included. The reason for 
using 25%—iron-saturated transferrin as a positive control 
instead of 30%—iron-containing transferrin was that, at the 
time of this experiment, a new batch of culture medium was 
used (see 2.3*l*l) without knowing the levels of endogenous
4.3*2.2. Culture of cells with cobalt- or manganese-containing 
transferrin
Cells were cultured with ConA (l pg/ml) in serum free 
medium to which transferrin saturated to varying degrees with 
iron, manganese or cobalt (see 4.3*1) was added.
4.3*2.3* Culture of cells with variant and normal human
■;transferrin
Lymphocytes were cultured with ConA (0,5 pg/ml) in 
serum-free medium containing either variant or normal human 
transferrin isolated from the same donor, or human control 
(Behringwerke) transferrin. Two different experiments were
performed depending on the concentration of the transferrin
.used (i.e. either 50 pg/ml or 5 pg/ml). Cultures were 
set up containing each transferrin as either apotransferrin 
or 30%-or 80%—iron-saturated transferrin. The cells were 
cultured in medium containing 80%-iron-saturated transferrin, 
because at this saturation both sites of transferrin will
187 -
contain iron and therefore it is ensured that the abnormal 
site will carry iron.
4.3*2.4. Effect of anti-transferrin receptor monoclonal
antibody on the transformation of mouse lymphocytes 
Cells were cultured with ConA (0 . 5 pg/ml) in serum-free 
medium containing either 7*5 ng/ml or 15 ng/ml of iron as 
Fe(NTA) in the presence or absence of Ab a TfR (50 pg/ml).
The amount of iron added as Fe(NTA) (i.e. 7*5 and 15 ng/ml) 
was equivalent to that of 10%-or 20%—iron-saturated transferrin, 
respectively. The monoclonal antibody was added to the 
medium prior to the addition of Fe(NTA). Controls consisting 
of cells cultured alone or with Ab <x TfR only and also 
with apotransferrin and 10%—or 20%—iron-saturated transferrins 
were included. In these experiments, cell-cultures were 
set up in octuplicate with triplicate ConA-negative controls.
4 .3 *3 * Manganese and iron uptake from doubly labelled 
transferrin by proliferating l3=rnphocytes
4.3*3*1* Adjusting counting windows in the ^-counter for 
dual counting of iron and manganese
54Examination of the range of energy emitted by Mn 
was found, using a spectral plot, to overlap the range of 
emission by ^^Fe (Fig. 9), so that in simultaneous counting 
of radiation emitted by the two metals, the counting of 
the energy emitted by one may also include energy emitted 
by the other. It is important, therefore, before measuring 
simultaneous uptake of manganese and iron to choose counting 
windows for each isotope which allow as much radiation as
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possible emitted by each isotope to be counted but at 
the same time giving minimum spill over from one channel 
to the other. For this reason, before proceeding to the 
experiments concerning manganese and iron uptake by 
proliferating lymphocytes, the counting windows in the  ^~ 
counter (LKB CompUgamma Model 1282 with 3" detector) were 
adjusted accordingly using a set of standards. The standards 
included: high and low activity (i.e. about 10,000 and 
1,000 c.p.m.jrespectively) of ^^Mn and ^^Fe, and a mixture 
of high activity of Fe and low activity of Mn, and 
vice versa. Figure 9 shows the energy spectra for iron 
and manganese at window range of 200-240. For simultaneous 
counting of both metals, the windows were adjusted to 
211-220 for manganese and to 222-233 for iron. The spillover
Iwhich was 0.2% for Mn in the iron-channel and 12% for
of 60%. However, the ratio of manganese to iron in each 
preparation was as follows: firstly, 3îlj secondly, 1:1
59Fe in the manganese-channel, was corrected automatically 
by the machine.
4.3'3'2. Estimation of manganese and iron taken up by 
proliferating lymphocytes 
Mouse lymph node cells were cultured with ConA (0 . 5 pg/ml,
see 2 .4 .2 ) in serum-free medium containing transferrin 
doubly labelled with ^^Mn (specific activity = 94pCi/pg Mn) 
and ^^Fe (specific activity 9-lOiiCi/pg Fe) (Amershajn) .
Three different preparations of doubly labelled transferrin 
were obtained, each one having a total saturation with metal Ii
and thirdly, 1:3, taking into account also the iron content
3
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of the medium (5 ng/ml). Preliminary work showed that 
24-0 nCi of •^ F^e and 800 nCi of ^^Mn per 3 . 6 x 10*^  viable 
cells gave adequate counts for measuring uptake of each 
metal by the cells after two days of culture. For the 
preparation of the double labelled transferrin, the radio­
active metal was diluted, appropriately, first with the 
cold metal, and then mixed with the correct amount of 
transferrin solution ( 30 pg of human transferrin/ml medium) 
for 1 0 - 1 5 min. before being added to the culture medium.
Ferric nitrilotriacetate was used as a source of cold iron, 
and MnS0^.4H^0 for manganese, prepared in citrate buffer 
(Mn: citrate molar ratio 1:1, pH 5 .0 ). The cells (2 x 10^ 
viable/ml) were cultured at 3 7°C in an atmosphere of 90% 
air, 1 0% 0 0  ^in 50 ml tissue culture flasks (see 2.3 »1 *2 ) 
in a total volume of culture medium of 18 ml. After 65 h 
of incubation the cultures, set up in duplicate, were spun 
(1200 r.p.m., 90 sec), the cells were washed three times 
in RPMI-1640 containing Hepes, and the ^^Fe and ^^Mn 
radioactivity associated with the supernatant^washes and 
the cells counted in the ^-counter using the windows described 
in Section 4.3*5*1* Finally, the percentage uptake of each 
metal by the cells was calculated. To determine whether 
different degrees of transformation took place at the three 
different proportions of metals, and because radioactive 
iron and manganese interfere with measurement of uptake of 
labelled thymidine, separate parallel cultures were set 
up in which the cells were cultured with transferrin 
containing cold iron and manganese at the three different
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ratios described above, plus control containing 60%— 
iron-saturated transferrin. After 65 h of incubation, 1 ml 
aliquots were taken and slides of the cells were prepared 
for differential staining (Leishman). The rest (l ml) 
was aliquoted into a microtitre plate (lOO pl/well), 
pulsed with thymidine for 4 h and the proliferative
responses measured as described elsewhere (see 2.3*2).
4 .3 *4 . Iron uptalce by proliferating lymphocytes in the 
presence or absence of monoclonal antibody to 
transferrin receptor 
Mouse lymph node cells were cultured with ConA (0 . 5  pg/ml 
see 2 .4 .2 ) in serum-free medium containing I5 ng/ml iron 
as Fe(NTA) with or without monoclonal antibody to transferrin 
receptor (50 pg/ml). The amount of iron added to the medium 
was equivalent to that of 20%—iron-saturated transferrin 
when the transferrin was used at a concentration of 50 pg/ml. 
Cells were also cultured in medium containing 25%—saturated 
transferrin (this amount of iron includes also the endogenous 
iron). The reason for using 25%^lron-saturated transferrin 
as a positive control instead of 30%, is explained in 
Section 4.3*2.1. Unlabelled Fb(NTA) was mixed with ^^Fe 
(specific activity: 10 pCi/pg Fe) and this labelled Fe(NTA) 
was either used as such in the culture media, or added to 
transferrin or to the monoclonal antibody before these were 
added to the medium. The final activity was 24o nCi/2 x 10 
viable cells, in a total volume of 10 ml. The cells were 
cultured in duplicate flasks as described in Section 4.3*3*2 
After 58 h of incubation, the cultures were centrifuged
■
I
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and the cells washed as described elsewhere (see 4.3,3*2). 
59Finally, the Fe-activity of supernatant, washes and cells 
was measured in the ^-counter and the percentage iron 
uptake calculated.
« 3 -
4.4. RESULTS
4.4.1. The effect of desferrioxamine on the response to 
concanavalin A of mouse lymph node lymphocytes in 
in serum-free medium
The degree of transformation of lymphocytes cultured 
in medium to which apotransferrin and DFO were added was 
significantly lower at all concentrations of DFO when 
compared with the responses of the cells cultured with 
transferrin hut in the absence of DFO (Fig. 10, Table 36).
The decreased proliferation may be due to DFO depriving 
transferrin and hence cells of the endogenous iron. However, 
the degree of proliferation at all concentrations of DFO 
was similar, and even the concentration which was enough 
to chelate only 50% of the endogenous iron (i.e. 0.025 pg/ml) 
caused the same reduction in transformation as higher 
concentrations of DFO sufficient to remove all the endogenous 
iron. It may be that at a concentration of DFO of 0.025 pg/ 
ml, the amount of endogenous iron available to transferrin 
is so small that it does not cause any marked effect on 
the proliferative response,
4.4.2. The effect of cobalt and manganese complexes of 
transferrin on the transformation of mouse lymph 
node lymphocytes in vitro
4.4.2.1. The effect of cobalt-transferrin on the transformation 
of mouse lymphocytes in vi tro
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Table 36; Analysis by Scheffe’s method of multiple comparisons of the 
effect of desferrioxamine on the transformation of mouse 
lymphocytes in serum-free medium (data from Fig. 10).
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 531.90,434.00 S
1 and 3 -26.80,-567.22 S
1: and 4 -165.34,-680.66 S
1 and 5 -65.34,-580.66 S
1 and 6 -147.80,-688.23 S
1 and 7 -58.80,-599.25 S
2. and 3 641.91,434.15 s
2 and 4 502.65,311.44 s
2 and 5 605.90,408.12 s
2 and 6 510.90,313.11 s
2 and 7 601.90,414.15 s
*1: cells cultured in absence of transferrin; 2; cells cultured in 
medium to which apotransferrin was added; 3,4,5,6,7; cells cultured 
in medium containing transferrin and DFO of concentrations of :
25, 50, 100, 150 and 250 ng/ml, respectively.
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¥hen mouse lymph, node cells were cultured in medium 
containing cobalt-transferrin, the incorporation of labelled 
thymidine was significantly reduced in comparison with the 
proliferative response of the cells cultured in medium 
containing 100, 30, or 10%-iron-saturated transferrin 
(Fig. 11, Table 37)* This result indicates that cobalt- 
containing transferrin does not promote lymphocyte 
proliferation as well as iron-containing transferrin, and 
that iron bound to transferrin is important for stimulated 
lymphocytes to proliferate in vi tro. However, since iron 
displaces cobalt from the transferrin molecule (Zweier 
et al., 1981), the iron present in the medium (see 2.3»l*l) 
will displace some cobalt from the cobalt transferrin. The 
decreased proliferation of lymphocytes in medium containing 
100%-cobalt-saturated transferrin may therefore be caused 
by free cobalt arising from the displacement of cobalt by 
endogenous iron. Also cobalt taken from transferrin by 
the cells may itself be toxic for the cells. To determine 
whether free cobalt was toxic, lymphocytes were cultured 
with ConA (0 . 5 pg/ml) in medium containing 100%-iron-saturated 
transferrin plus cobalt (as cobaltous chloride solution 
made in d-DW) to give 5 ng of cobalt/ml of culture, which 
was equal to that displaced by iron. Cells were also 
cultured in medium containing 30^ a n d  100%—iron-saturated 
transferrin. Although free cobalt slightly decreased 
the lymphocyte proliferative response (Fig. 12), the effect 
was not significant (Table 38). This would indicate that
197 -
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Figure 11; The effect of cobalt-transferrin and iron-transferrin 
on the transformation of mouse lymphocytes in serum- 
free medium.
Percentage 
saturation of 
transferrin 
in the medium
100
•H
EL
75
•H4J
to rH A O
A Cs g 50
>H
T3■H
25È+3
100% Fe 10% Fe 100% Co30% Fe 30% Fe
(+UB No ConA
control) (-VB
control)
Mean + S.D. (+ConA, n = 14; -ConA, n = B) 
For statistical analysis, see Table 37.
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Table 37; Analysis by Scheffe’s method of multiple comparisons of 
the effect of cobalt-transferrin and iron-transferrin
on the 
medium
transformation of mouse 
(data from Fig. 11),
lymphocytes in serum-free
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 -2301,-8719 S
1 and 3 10935,4517 S
1 and 4 -12022,-18440 S
2 and 3 5425,-993 MS
2 and 4 2930,6512 S
3 and 4 -4296,-10714 S
*1: cells cultured in medium containing 30% FeTf; 2: cells cultured 
in medium containing 100% FeTf; 3; cells cultured in medium with 
10% FeTf; 4: cells cultured in medium to which transferrin 
saturated with cobalt was added.
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reduced trausformation of lymphocytes cultured in medium 
containing 100%-cobalt-saturated transferrin was probably 
not the result of a toxic effect of cobalt released into 
the culture medium. In order for the preparation of 
cobalt-transferrin, to ensure oxidation of Co^^ to Co^^ 
and binding of the metal to the transferrin molecule, 
hydrogen peroxide was used. Since hydrogen peroxide is a 
strong oxidising agent which, therefore, may affect the 
structure of transferrin, it was decided to use another 
metal which binds to transferrins with the same configuration 
and at the same binding sites but does not require peroxide 
for its preparation. Since manganese complex of transferrin 
has been prepared before without the use of peroxide (Ulmer 
& Vallee, I9 6 3), it was therefore decided to use manganese.
4.4.2.2. The effect of manganese-transferrin on the trans­
formation of mouse lymphocytes in vitro 
Cells were cultured with transferrin fully saturated 
with iron or manganese, and also in medium to which 100%- 
manganese-saturated transferrin plus free manganese, the 
amount was equivalent to that displaced by the endogenous 
iron (i.e. 12.5 ng Mn^ "^  as MnSO^.^H^O solution, made in 
d-DW, per 1 ml of culture; this amount was added as the 
old batch of culture medium was used (see 2.3.1.1)}, As 
with cobalt, the degree of transformation of mouse lymphocytes 
in medium containing transferrin fully saturated with 
manganese was significantly lower than that when 100%—iron- 
saturated transferrin was used (Fig. 13&, Table 39)* This
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Figure 12; The effect of free cobalt on the transformation of 
mouse lymphocytes cultured in serum-free medium 
containing transferrin-bound iron.
Percentage 
saturation of 
transferrin in 
the medium
rHo
-Pcou
Ct-□
€0
CO
75-
co•tH
(0(H□CL(•iOÜc
•H
50,
mc
•H"O•HE
È4J
iU
25,
<3-iH
100% Fe 100% Fe30%30% Fe
(+ve No ConA 
control) (-VB
control)
Free Co (5 ng/ml)
Mean + SA (+ConA, n = 14; -ConA, n = 8) 
For statistical analysis, see Table 38.
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Table 38; Analysis by Scheffe*s method of multiple comparisons of 
the effect of free cobalt on the transformation of 
mouse lymphocytes cultured in serum-free medium containing 
transferrin-bound iron (data from Fig. 12).
Groups
Simultaneous 95% 
confidence limits
Significant
difference
compared*
1 and 2 5146.85,-2998.85 IMS
1 and 3 -1297.15,-10442.95 S
2 and 3 -2871.15,-12016.85 S
*1: cells cultured in medium containing 100% FeTf; 2; cells cultured 
in medium containing 100% FeTf and free cobalt (5 ng/ml); 3: cells 
cultured in medium with 30% FeTf.
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result indicates that manganese transferrin, like cobalt- 
transferrin, is not as good as iron-containing transferrin 
in promoting lymphocyte proliferation ija vitro, and 
furthermore, do not support the idea that the proliferative 
response may depend on a signal derived from the interaction 
of the transferrin with its receptor, rather than simply 
the donation of iron. However, the degree of transformation 
in medium containing 100^—iron-saturated transferrin plus 
manganese equivalent to that displaced by the endogenous 
iron, was significantly lower (Fig. 13a, Table 39) than 
when 100'^ —iron-saturated transferrin was used alone, 
indicating that free manganese may have some adverse effects 
on cell proliferation. The low proliferative response, 
therefore, in the presence of 100^—manganese-saturated 
transferrin might have been partly due to the toxic effects 
of manganese released into the medium after being displaced 
by the endogenous iron, and this might have masked any 
triggering effect of manganese-transferrin. To avoid this 
problem, the effect of partially saturated transferrins was 
investigated. Cultures were set up in medium containing 
30^-or 10^-iron-saturated transferrin, and also in medium 
to which apotransferrin and 100%-manganese-saturated 
transferrin were added in 4:1 ratio, respectively, so that 
the transferrin present in the medium had a saturation with 
metal of 20^0 manganese, 10^ iron (derived from the endogenous 
iron of the culture medium), and 70% remained iron-free.
This also compared the effect on cell proliferation of 
manganese-containing transferrin with a similar metal content
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Figure 13: The effect of manganese-transferrin and iron- 
transferrin on the transformation of mouse 
lymphocytes in serum-free medium.
Percentage saturation 
of transferrin in the 
medium.
100% Fe (+ve control)
100% Fe , no ConA (-ve 
control)
100% Mn
100% Fb + free Fin 
(12.5 ng/ml)
Incorporation of ^^C-thymidine 
as % of positive controls
0 50 100
(b)
30% Fe (+UB control)
30% Fe, no ConA (-ve 
control)
10% Fe
10% Fe, 20% Fin
50 100
/ / / / / / / / / ' / 77/777T
r n i m
mn
(a) Fully saturated transferrin (b) Partially saturated transferrin.
Mean + SID. (+ConA, n = 14; -ConA, n = 8),
F or statistical analysis, see Tables 39 and 40.
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Table 39; Analysis by Scheffe's method of multiple comparisons of the 
effect of free manganese on the transformation of mouse 
lymphocytes in serum-free medium (data from Fig. 13a).
Groups
Simultaneous 95% 
confidence limits
Significant
difference
compared*
1 and 2 18760,15226 S
1 and 3 14088,10692 S
2 and 3 -2636,-6370 S
*1; cells cultured in medium containing 100% FeTf; 2; cells cultured 
in medium containing transferrin 100% saturated with ; 3: cells 
cultured with 100% FeTf and free manganese (12.5 ng/ml).
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Table 40: Analysis by Scheffe's method of multiple comparisons of the 
effect on the transformation of mouse lymphocytes of 
transferrin partially saturated with manganese or iron 
(data from Fig. 13b).
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 15777,12413 S
1 and 3 19102,14518 S
2 and 3 5007,423 S
*lî cells cultured in medium containing 30% FeTf; 2; cells cultured 
with 10% FeTf; 3; cells cultured in medium containing 10% FeTf 
and 20% MnTf.
I
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to 30%—iron-saturated tratisferrin. The degree of transform­
ation in medium containing 10%-iron plus 20%-manganese- 
saturated transferrin was significantly lower than when 
cells were cultured in medium containing 30%—iron-saturated 
transferrin despite the fact that the content of metal- 
containing transferrin molecules was the same in both cases 
(Fig. 13b, Table 4o). These results again suggest that 
the function of transferrin is mainly to supply iron to 
transforming lymphocytes and that a signalling effect caused 
by transferrin is not essential to promote transformation. 
However, the data could, alternatively, suggest that 
transferrin-bound manganese may be inhibitory per se. 
Manganese-transf errin could inliibit transformation by blocking 
transferrin receptors and hence uptake of iron. On the 
other hand, since transferrin with 10% iron and 20% manganese 
was less effective than transferrin containing 10% iron alone 
even though it contained a higher content of metal-bearing 
transferrin molecules, manganese-transferrin may also result 
in uptake of inhibitory amounts of manganese by the cells.
In order to investigate whether the decreased proliferative 
response in the presence of manganese-containing transferrin 
might have been partly due to uptake of manganese by the 
cells, and also to determine whether the stimulated cells 
can distinguish between iron-containing and manganese- 
containing transferrin, studies of uptake of manganese and 
iron from transferrin by proliferating lymphocytes were 
performed.
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4.4.2.3* üptaice of manganese and iron from transferrin by 
proliferating lymphocytes vitro
At 1:3 ratio of iron to manganese, the amount of iron 
taken up by stimulated lymphocytes was as great as that of 
manganese, despite the greater quantity of manganese added.
At higher iron to manganese ratios, the proportion of 
manganese taken up was further reduced. It seems therefore 
that at all ratios of iron to manganese, the cells preferentially 
talce up iron (Table 4l). The degree of transformation of 
stimulated lymphocytes and the proportion of blast-like 
cells was the same in the three media containing transferrin 
of different ratios of iron to manganese, indicating that 
enough iron was taken up at all three ratios of iron to 
manganese to induce the observed response and that the 
availability of iron was not a limiting factor (Table 42).
However, the response of lymphocytes was much enhanced in 
medium containing 60%—iron-saturated transferrin (the 
saturation with iron was equivalent to the iron and manganese 
content of transferrins). Since cells take up manganese 
(Table 4l), it seems that the decreased response in the 
presence of manganese may be due to toxic effects of 
manganese rather than blocking of the receptors.
4.4,3" The effect of variant and normal human transferrins 
on the proliferation of mouse lymphocytes cultured 
in serum-free medium 
The degree of transformation of lymphocytes in medium 
to which variant transferrin was added either as apotransferrin i
- 2 0 8
CD
r—I H tH
CD M
- P l-H t - ! CM H
E CLo 3 r-C CM <3-A
Q - 4 -  C
O  S :
(0
Q] o  CD
4 J 'H  Lu> . - P
ü CD rH rH HO 0= t—1JZ O rH O -CL
E iH CM X
i—i
CL 1—1 X X fHa i 3 r - X X Mc
•H C "O
■P m c(0 CDA CD en(D -p  c tH4 -
•H ctH e: 1-4 X O H TJ
O ra X CDA E
CL Ac O> , •H Hc 4 -X I A n o X H AA CL H-1 CO iH < - CDm CD 3 iH H CLLi­ Cl­en eo C CDX C CD s ACD - y  O l CDTJ A CD C 3
C - P *P /m CO*o m Pc m Lu Cs: r~i CD<3- iH * X D~ C3 EX CD HH CD CM X *HX tH H A4- CD CDo rH
CD >% o XCD
H o  X  -H(0J3 VD - P  -P P-p 3 •H  CD CCL O te 3  A CD=) TJ •H AA  13 C CDA  CD *H c 4 -
M CD P e: X rH H C|_■V P  CO CO •rMCO A  rH CD rH rH X TJCD C  3  CD Lur - f CD P  P o
X I A  CD CD 3
CO h -  CO E H”
H
3
3i
S
209 -
Table 42; The effect on the transformation of mouse lymphocytes of 
transferrin doubly-labelled with ^^ Fln and ^^Fe.
Transferrin
saturation
^^C-thymidine 
incorporation (c.p.m.) 1+
Percentage 
of blasts
15% Fe + 45% Mn 789 i 197 65
30% Fe + 30% Mn 998 i 76 63
45% Fe + 15% Mn 954 i 98 73
60% Fe 1851 i 100 nd
"^ Flean - StQ; n = 10. Figures obtained using the same cells as in 
Experiment I, see Table 41.
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or 25%—i3?on~saturated transferrin was not significantly 
different from the response of cells cultured with normal 
human transferrin at the corresponding iron saturations 
(Tables 43a and 44a). These results indicate that at low 
iron saturations, variant transferrin is as good as normal 
transferrin in promoting transformation of lymphocytes 
in vitro and also that enough iron was taken up from the 
variant transferrin to induce the same response as with 
normal transferrin. However, at higher saturations with 
iron (i.e. 80%), the proliferative response induced by the
variant transferrin was significantly lower than the response 
induced by normal transferrin (Tables 43a and 44a), indicating 
that, at high iron saturations, the variant transferrin is 
not as good as normal in promoting transformation.
However, this experiment was performed only once due 
to lack of availability of the variant transferrin. Further-
Imore, since variant transferrin at 50 pg/ml is well above 
the amount required to saturate all receptors, abnormal
binding may become more apparent if the variant transferrin 
is used at lower concentrations. The same experiment was
therefore repeated using 5 ^g/ml transferrin instead of ■
50 pg/ml. At this low concentration, taking into account
.the amount of iron present in the culture medium (5 hg/ml,
see 2.3'i'l), transferrins when added to the medium as 
apo transferrin or 7 5 %“-Î3?on-saturated transferrin, become 
50 and >100 per cent saturated, respectively. The variant 
transferrin at both saturations caused a slightly lower I
proliferative response when compared with normal or control
I
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Table 44(a) : Analysis by Scheffe’s method of multiple comparisons of 
the effect of variant and normal transferrins (50 ^ g/ml) 
on the transformation of mouse lymphocytes in serum-free 
medium.
*1: cells cultured in medium containing variant transferrin;
2: cells cultured with normal transferrin isolated from the 
same donor as the variant transferrin;
3s cells cultured with control human transferrin (Behringwer'Ke)
Percentage 
saturation 
of trans­
ferrin in 
the medium
Groups
compared*
Simultaneous 
95% confidence 
limits
Significant
difference
1 and 2 356.0,-386.0 NS ■
5% FeTf 1 and 3 916.0,174.0 S
2 and 3 931.0,189.0 S
1 and 2 63.4,-48.3 NS
30% FeTf 1 and 3 14.8,-514.8 NS
2 and 3 224.8,-304.8 NS
1 and 2 -390.8,-1025.2 S
80% FeTf 1 and 3 -605.8,-1240.2 S
2 and 3 102.2,-532.2 ■ NS
I
.■:;V
«
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Table 44(b); Analysis by Scheffe's method of multiple comparisons 
of the effect of variant and normal transferrins. (5^g/ml) 
on the transformation of mouse lymphocytes in serum-free 
medium.
Percentage 
saturation 
of trans­
ferrin in 
the medium
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 0,3,-518.3 ns
50% FeTf 1 and 3 44.3,-474.3 ns
2 and 3 205.1,-293.1 ns
1 and 2 258.8,-1018.8 ns
>100% FeTf 1 and 3 56.0,-1636.0 ns
2 and 3 141.0,-1103.0 ns
i
*1: cells cultured in medium containing variant transferrin;
2: cells cultured with normal transferrin isolated from the same 
donor as the variant;
3; cells cultured with control human transferrin.
:
■ftI
■ftS
f
i
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transferrins but the difference was not significant (Tables 
43b and 44b). At low concentrations of transferrin, therefore, 
when less transferrin is available to interact with its 
receptor, the proliferative response induced by variant 
or normal transferrin was the same at either high (i.e.
> 100%) or lower (i.e. 50%) saturations with iron, i.e. 
the same result was obtained as when the variant and normal 
transferrins were used at concentrations of 50 pg/ral and 
lower iron-saturations.
4.4.4. The effect of monoclonal antibody to mouse transferrin 
receptor on the transformation of mouse lymph node 
lymphocytes ini vitro
The degree of transformation of lymphocytes in medium 
containing Ab a TfR was significantly lower than the response 
induced by apotransferrin (Tables 45 and 46). A lower 
proliferative response in comparison with that induced by 
15%or 25%~i3Ton--saturated transferrin was also observed with 
Ab a TfT plus Fe(NTA) of iron content equivalent to that of 
the corresponding iron-containing transferrin (Tables 45 and
46). It appears, therefore, that Ab a TfR cannot substitute 
for transferrin even in the presence of Fe(NTA). Furthermore 
the proliferative response in the presence of Ab a TfR was 
significantly lower than when the cells were cultured 
without transferrin indicating that Ab a TfR may actually 
be toxic to the cells. When both Ab a TfR and Fe(NTA) were 
used, the degree of transformation was also lower than that 
when Fe(NTA) was used alone. The reduction in transformation
216
4-ccp cQ OXC io•HP©EAOP©c©AP
©JZP
co
A 4-O cC•4^ cCL □© XU 4-©A
C•iH
AA©P©a©Ap
©©3O EE E3 CLo •tHp TJ Ü©
> • E OlTJ C  CO © O «Hn © •H  C•tH P4 P  •Hp © ©c 1 A  P© E o  c3 CL QtH A A  Q© © GC © U  Eo C  3tH C •pH ’HÜ •tH TJD © ©C © C  EO © •HE P TJ ©> • •rH AP © E  3O O "AJZ x : tHP CL P  3O E I O© > • XP iH Mi- CP tH  •H© ©©© 3J= □
1— E
XMl- © AtH  ©© CL XJtH E EJZ © 3© X  Zh -
*
X X CM CM m L rH tH X Ol
4-t 4-1 4-1 4-1 P 1 4* i PI PI PI
C3 □ m L X X CM ML X o
C - ML X X CM CM CM CM o
rH rH tH
□ cnCM CM CM CM CM X tH X H
4-1 4-1 4-1 4-1 PI P  1 PI P  1 P 1
X X o O CM CM cn C'­ X
ML X X X CM CM CD en cn
X ML
X o X l> C - m l X CM
ML CM X H iH O l O l rH H
4*1 4-1 4-1 4-1 PI PI Pi PI P 1
O l X ml X X ml c - X cn
X CM CJl r - O X X iH X
X X X iH tH cn ml MLtH tH
o O rH
o D - iH iH iH X X
X X X X O l X iH tH rH
4-1 4-1 4-1 PI P 1 PI P 1 PI P 1
X !>X CMX
+ +
>>r-l
CO
©Lu
Ol
C
X
r -
«C[—
z
mLu
ro mf—J (Hr—Im CDX  X
CM
cni>rH
CMO
■H*
0)
LuOl
C
XH
©
Lu
4*
©
( - 4iH
CDX
CCP
I—
%JZCC
m
H
©X
©
Olc
X
o
cch -
4-ccpl_.
%
ncc
©iH
©X
Mi-
r—I
■ra.
©
Lu
O l
C
XH
g
©
Xcc
©H
H©
X
CMXXtH
OlCMOltH
P*1_
Oacc
p%
;
H
© ©
rH tH© ©X  X
X
XXOltH
P[_»©
CM
4-
©rHtH©X
01
X  O l
© © tH rHII© ©
H  H
C  C  •H  *H5 a© © p  P  © ©
p  p
O O -p  -p
XMl-
©tHg
©
©•H©rH§
tH©O•HP©•HP©P©
AO
■§TJTJ©
pI
0  P
Pê
rH©>•p43O '©
c□A*H
PQ
P1 icC
grHO .i©iH
c
!S
p©
c cCf*»
H"
cCg
X
ITJ ©TJ A  TJ *  O ©  1—I P
P  XIs"C0 Mp  *  •' cCP  TJ CS I S1 ëZ3» C|re»AO
© X  ©g-ë "A  © C  •fH E •HCf.ri
D ©I-'
C  O © 3 ©
cc H -  s :  4-4- 4:4"
- - 1
217
Table 46; Analysis by Scheffe’s method of multiple comparisons of the 
effect of monoclonal antibody to transferrin receptor on 
the transformation of mouse lymphocytes in serum-free medium 
(data from Table 45).
Groups
compared*
Simultaneous 95% 
confidence limits
Significant
difference
1 and 2 1850.0, - 1 6 7 0 . 0 ns
1 and 3 200.0,-152.0 ns
1 and 4 373.0,121.0 S
2 and 3 191.0,-161.0 ns
2 and 5 547.2,182.8 S
3 and 6 557.0,205.0 S
4 and 5 259.2,-105.2 ns
4 and 6 2.8 , -68.0 ns
5 and 6 213.2,-151.2 ns
4 and 7 -120.7 ,-1559.0 S
5 and 8 -1644.8,-2009.2 S
6 and 9 -1734.8,-2099.2 S
7 and 8 -191.0,-543.0 S
7 and 9 -243.8,-608.2 S
B and 9 123.2,-241.2 ns
*1: cells only; 2: cells + Fb (NTA) (7.5 ng Fe/ml); 3: cells + Fe(NTA) 
(15 ng Fe/ml); 4; cells + AbocTfR; 5: cells + AbocTfR + Fe(NTA)
(7.5 ng Fe/ml); 6; cells + AbocTfR + Fe(NTA) (15 ng Fe/ml); 1% cells + 
ApoTf; B: cells + 15% FeTf; 9; cells p 25% FeTf.
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in the presence of Ab aTfR and Fe(NTA) compared with the 
response in the presence of Ab aTfR only, appeared to depend 
upon the level of Fe(NTA), but the counts were very low 
(Table 45)* Iron uptake studies showed that in the presence 
of Ab a TfR and Fe(NTA) a smaller amount of iron was taken 
up by the cells than in the presence of Fe(NTA) alone (Table
4 7). These results suggest that in the presence of Ab aTfR 
the amount of iron taken up from Fe(NTA), although very 
small, may, nevertheless, interfere with rather than promote 
cell proliferation. Furthermore, the degree of transformation 
of lymphocytes in medium containing iron as Fe(NTA) equivalent 
to that present in I5 or 25%—iron-saturated transferrin, was 
the same as the response of the cells cultured without iron, 
although the proliferative response was much reduced compared 
with that when I5 or 25%-lron-saturated transferrin was 
used (Table 47)* The percentage of iron taken up by 
proliferating cells from Fe(NTA) was similar to that taken 
from iron-containing transferrin (Table 47)* These results 
confirmed the earlier observations of Brock & Rankin (I98I) 
that, although, iron from Fg(NTA) is taken up by stimulated 
lymphocytes fn vi tro, it does not promote transformation.
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Table 47; Iron uptake by mouse lymphocytes cultured with concanaualin A 
in serum-free medium containing either transferrin or ferric 
nitrilotriacetate or monoclonal antibody to mouse transferrin 
receptor.
Culture medium 
containing
Percentage of iron uptake by 
proliferating lymphocytes
I* II*
Fe(NTA)+
(15 ng Fe/ml) 25.5 i 3.5^ 18.5 i 1.5
25% FeTf 25.5 i 1.5 23.8 - 0.2
Fe(NTA)(15 ng 
F e/ml)
+ 6.0 i 0.6 6,0 i 0.3
Ab^TfR
^Amount of iron equivalent to that of 20% FeTf 
iflean of two readings - SEM
*Two different experiments were performed, I and II
,.:ç,
■a'S
■S'a,rx%
t.
i
k
a
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4.5* DISCUSSION
It is now well established that transferrin is 
important for lymphocytes to proliferate in vitro (Tormey 
& Mueller, 1972; Dillner-Centerlind e^ al. , 1979; Larriclc & 
Cresswell, 1979a; Galbraith ejt al. , 1980a; Brock, I98I).
This requirement of transferrin in cell proliferation is 
known to depend on its ability to donate iron to the cells 
(hipsky & Lietman, I98O; Brock & Rankin, 1 9 8I; Boraford e_t al * , 
1 9 8 3)» However there are also literature data which suggest 
that transferrin may be required in cell proliferation 
because of a property unrelated to its iron-binding and 
donation (Brock, I98I; Tanno _et al. , I9 8 2). It may be 
that when transferrin binds to its receptor on the cell 
membrane of stimulated lymphocytes, it causes a signalling 
effect which then leads to the events of proliferation. 
Membrane-triggering mechanisms exist in many systems. The 
interaction of IL-2 with IL-2 receptors on the membrane of 
activated T-lymphocytes initiates proliferation (Palacios,
1 9 8 2a;Neckers & Cossman, 1983)* The mitogenic or antigenic 
stimulation of lymphocytes also depends on a triggering 
effect caused as a result of the binding of the mitogen or 
antigen to their receptors on the cell membrane (Chess 
et al. , 1 9 7 6; Crumpton e_t al. , 1976). It may be, therefore, 
that lymphocytes in order to proliferate also require a 
signal caused by transferrin interacting with the transferrin 
receptor on the membrane of stimulated lymphocytes.
221 -
The work reported in this chapter has attempted to 
define more closely the role of transferrin in the 
proliferation of lymphocytes vitro with particular 
reference to its role as an iron donor or as a possible 
membrane triggering agent. This has been achieved by 
investigating the effects on cell proliferation of:
1) apotransferrin;
2) transferrin containing metals other than iron which bind 
to transferrin specifically and induce a similar conformation 
of the transferrin molecule to iron-transferrin;
3) a variant transferrin which has abnormal iron-binding 
properties and a lower affinity for the transferrin receptor 
than normal transferrin;
4) a monoclonal antibody to the mouse transferrin receptor 
in the presence or absence of inorganic iron.
If a membrane triggering mechanism caused by transferrin 
is important in the proliferation of lymphocytes, the 
apotransferrin itself may induce some degree of transformation, 
assuming that the cells can utilise their own intracellular 
iron. However, since endogenous iron in the culture medium 
will saturate some of the transferrin, DFO was used in order 
to render this iron non-available to transferrin. The 
degree of transformation of lymphocytes when apotransferrin 
and DFO were added to the medium was significantly higher 
than the response observed in the absence of apotransferrin 
and DFO (Fig. 10, Table 3^). This suggests that lymphocyte 
transformation may depend on an interaction of transferrin 
with the cell-membrane which may then trigger events leading
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to proliferation. However, since the increased transformation 
in the presence of apotransferrin was only slightly (though 
significantly) higher than that observed in the absence of 
transferrin and lower than that observed in the presence 
of E5%»iron-saturated transferrin, it may be that apo­
transf errin is not as good a triggering agent as iron- 
containing transferrin because it does not possess the same 
configuration as transferrin with iron bound. However, 
this difference could also be due to the role of iron- 
containing transferrin as an iron donor, so that the above 
result is not conclusive. To avoid this problem, the 
effect of cobalt- and manganese-containing transferrins 
were investigated, since these complexes should permit the 
effect of transferrin in the metal-containing conformation 
to be studied. Transferrin fully saturated with cobalt or 
manganese caused a significant reduction in the proliferative 
response in comparison with that induced by iron-saturated 
transferrin (Figs. 11 and 13a)« However, culture medium 
to which transferrin 100% saturated with either cobalt or 
manganese is added will in fact contain transferrin which 
is 90% saturated with cobalt or manganese and 10% saturated 
with iron, due to endogenous iron displacing the cobalt or 
manganese. It will also therefore contain free cobalt 
or manganese (l2.5 ng/ml, see 2.3»l*l)» Since the response 
of lymphocytes in medium containing transferrin 100% 
saturated with cobalt or manganese was also significantly 
lower than that caused by 10%-iron-saturated transferrin, 
it may be that free cobalt or manganese are toxic to the
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cells, and that this may mask a possible triggering effect 
of transferrin. To test this, a further experiment was 
performed in which either cobalt or manganese was added 
to the medium containing 100%-âron-saturated transferrin, 
in an amount equivalent to that being displaced by the 
endogenous iron. The free manganese, and to a lesser extent 
cobalt, caused a reduction in the transformation-promoting 
activity of 100%—iron-saturated transferrin, thus indicating 
that the free metals themselves caused some reduction in 
proliferation (Figs. 12 and 13b). To avoid the problem 
of toxicity caused by the free metal, partially saturated 
transferrins were used. Transferrin saturated 20% with 
manganese and 10% with iron still significantly reduced the 
proliferative response of lymphocytes in comparison with 
that induced by 30%-iron-saturated transferrin despite the 
presence of the same number of metal-containing transferrin 
molecules (Fig. 13b, Table 4o). Furthermore, proliferation 
in medium containing 10% iron and 20% manganese was also 
significantly less than that observed when 10%—iron-saturated 
transferrin was used (Fig. 13b), despite the fact that both 
cultures contained the same number of iron-bearing transferrin 
molecules. This suggests that transferrin may not promote 
transformation by inducing a membrane signalling effect. 
However, the reduced response observed in the presence of
binding to the transferrin receptors and thus preventing
manganese-transferrin may be due to manganese-transferrin
«
binding of iron-transferrin or alternatively, to a toxic 
effect of manganese acquired by the cells from transferrin.
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Studies of uptake of manganese and iron by proliferating 
lymphocytes from transferrin doubly labelled with the 
two metals were therefore performed. These experiments 
showed that the cells can take up manganese from transferrin, 
suggesting that the low response of the cells in the presence 
of manganese-transferrin could be partly the result of 
intracellular toxic effects of manganese (Table 4l). The 
proportion of iron taken up at the ratio of FeîMn of 1:3 
was as high as that of manganese despite the fact that 
there was more manganese present, and at higher ratios of 
Fe:Mn, the iron taken up by the cells increased proportionally. 
It seems therefore that the cells take up iron preferentially. 
In addition, the percentage of blast cells, and the degree 
of transformation at all ratios of Fe:Mn was the same 
(Table 42), but reduced in comparison with that induced by 
transferrin 60%-saturated with iron. Talcen together these 
observations suggest that the impaired cell proliferation 
in the presence of manganese-transferrin was not the result 
of inadequate iron uptake due to blocking binding of iron- 
containing transferrin, but more likely due to a toxic 
effect of manganese-transferrin. Additionally, since iron 
was taken up preferentially at all ratios of Fe:Mn it may 
be that manganese-transferrin has a lower binding affinity
to the receptor than iron-containing transferrin. Although 
none of these experiments conclusively showed that transferrin 
does not act as a membrane triggering agent none gave any 
evidence that such an effect was occurring.
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Further evidence for this conclusion came from studies 
using the variant transferrin. This transferrin binds iron 
abnormally at the C-terminal site, the complex being less 
stable than normal transferrin (Evans ejb al. , I9 8 2) and 
in addition, variant transferrin saturated with iron binds 
to the transferrin receptor with an affinity of one order 
of magnitude less than that of normal transferrin (Young 
et al.. 1984a). If a membrane triggering effect is important, 
therefore, it would be expected that the reduced affinity 
of the variant transferrin for the receptor would result 
in reduced proliferation. At low iron-saturation, the 
variant transferrin caused a similar response to that of 
normal transferrin isolated from the same donor (Table 43a). 
This suggests that iron-availability was not a factor 
limiting cell proliferation in the presence of the iron and 
transferrin. However, at low saturation of transferrin 
with iron, it may be that no iron binds to the abnormal 
C-terminal site of the variant transferrin, and a difference 
between normal and variant might in consequence not be 
apparent. The experiment was therefore repeated using 
transferrin 80% saturated with iron, to ensure that some 
iron was bound at the C-terminal site of the variant 
transferrin, under these conditions. Since insufficient 
variant transferrin was available to repeat this experiment 
using 50 pg/ml of transferrin, a further experiment was 
carried out using the transferrin at 5 pg/ml. At this 
lower concentration, any effect of the lower affinity of 
the variant transferrin for the receptor should become more
ft:
■
226
apparent. At this condition, the proliferation of lymphocytes 
cultured in medium containing variant transferrin was
"patching" or "capping" leading to endocytosis. Patching 
of transferrin receptors on binding of transferrin to
significantly lower than that caused by normal transferrin 
(Tables 43a, 44a). However, at this concentration the 
variant transferrin also induced the same response as normal 
transferrin at high (> 100%) saturation with iron. The 
reduced response caused by variant transferrin at high 
iron-saturation and at 50 pg/ml in the previous experiment 
(see Table 43a) may have been an artifact. Nevertheless, 
since most results showed that the variant transferrin is 
as good as normal in promoting proliferation of stimulated 
lymphocytes it would appear that cell proliferation does 
not depend on a triggering effect caused by transferrin 
interacting with the transferrin receptor, and that the 
variant transferrin can, despite the lower affinity for
f
the transferrin receptor, donate sufficient iron to lympho­
cytes in promoting optimal transformation.
An alternative approach to the problem of whether 
binding of a ligand to transferrin receptor provides a 
signal to initiate cell proliferation, is to use a ligand 
other than transferrin to bind to the receptor. The effect 
on lymphocyte transformation of a monoclonal antibody to 
the transferrin receptor was therefore investigated. When
antibodies bind to specific cell receptors, they induce
%
Ï
lymphocytes and endocytosis of the transferrin receptor 
complex has also been reported (Galbraith & Galbraith, I980).
f
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Th.li s, if binding of ligand, or patching of the transferrin 
results in the induction of a membrane triggering effect 
which leads to endocytosis and to events of proliferation 
then a monoclonal antibody to transferrin receptor should 
also mimic the effects of transferrin# However, AbocTfR 
did not induce the same response as transferrin, at any
■
'
Î
iron saturation between 5 and 259 »^ even in the presence of 
a corresponding quantity of inorganic iron (Table 4^).
This result indicates that Ab d< TfR cannot substitute for 
transferrin in enhancing proliferation, which in turn 
suggests that binding of transferrin or patching of trans­
ferrin receptors is not in itself a membrane triggering 
mechanism# However, the Ab a TfR was not only unable to 
substitute for transferrin in promoting transformation but 
actually had inhibitory effects on proliferation compared 
with that observed when cells were cultured in the absence 
of transferrin. Possible mechanisms for this are discussed 
later.
In conclusion the results of experiments using cobalt 
or manganese transferrin, the variant transferrin and the 
monoclonal antibody to the transferrin receptor all suggest 
that the major role of transferrin is to donate iron to 
the cells. In no case was any evidence obtained to suggest 
that the interaction of transferrin causes a triggering 
effect leading to transformation which is independent of 
iron donation# However, in no case could it be unequivocally 
assumed that no triggering effect existed as other factors
S
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could have influenced the results# Furthermore, in contrast 
to the other results, it was shown that the proliferation 
of lymphocytes was significantly higher in the presence of 
apotransferrin than in the absence of transferrin even 
when DFO was added to prevent any binding of endogenous iron 
to apotransferrin (Fig. lo). This could suggest that 
transferrin may enhance proliferation by triggering membrane 
events even when it cannot donate iron# However,- some 
degree of proliferation was still observed even in the 
absence of (apo)transferrin. Sotys and Brody (l970) have 
shown that normal human peripheral lymphocytes synthesise 
transferrin. It may be, therefore, that transferrin is also 
required for some other function such as intracellular 
transport of iron, and that under adverse conditions when 
there is no extracellular transferrin-bound iron available, 
stimulated cells may be able to use endogenously synthesised 
transferrin to fulfil their needs, at least partially. 
Transferrin might be required intracellularly for the 
transport of iron from the labile pool to mitochondria, 
and it has been shown that isolated mitochondria talce up 
labelled iron from transferrin (Konopka, 1978; Konopka & 
Turska, 1979)» It may be possible, therefore, that the 
proliferative response observed when apotransferrin was 
used was not the result of a membrane triggering effect 
caused by the apotransferrin but that the (apo)transferrin 
is also required intracellularly, Although this is only 
a speculation, and the role of transferrin in the intra­
cellular transport of iron remains to be resolved, it does
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'imply that the ability of lymphocytes to proliferate in
the presence of apotransferrin may not necessarily be 
evidence for a membrane-triggering effect.
The effect of Ab <x TfR and Fe(NTA) in cell proliferation 
require some further discussion in addition to their in­
ability to substitute for transferrin in promoting trans­
formation.
It was found that in the absence of Abo? TfR, the same 
amount of iron was taken up by the cells from Fe(NTA) as 
from transferrin (Table 4-7) although the degree of prolifer­
ation of stimulated cells in medium containing Fe(NTA) .'1
was significantly lower than that induced by the transferrin
(Tables 45 and 46). Similar observations have been reported
before (Brock & Rankin, I98I; Tanno aJ^. , I9 8 2). Further-
,more, no significant difference in the degree of proliferation 
was observed between cells cultured with or without Fe(NTA). 
Taken together these observations indicate that Fe(NTA) 
cannot substitute for transferrin in promoting transformation. 
White and Jacobs (1978) showed increased uptake of iron 
from Fe(NTA) by Chang liver cells in comparison with that 
taken up from iron-containing transferrin. However, the 
iron taken up from Fe(NTA) was largely found to be membrane- 
associated and very little was incorporated into ferritin.
In contrast, iron taken from transferrin was found to be 
mostly incorporated into ferritin. This suggests that 
iron acquired from Fe(NTA) probably does not enter the 
normal intracellular metabolic pathways. Since the other 
experiments reported in this section suggest that transferrin
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does not promote proliferation by acting as a membrane
triggering agent, it seems likely that Fe(NTA) fails to
promote transformation not as a result of lack of a membrane
triggering effect, but due to inaccessibility of the iron
so acquired by cellular metabolism*
The fact that Ab et. TfR actually inhibited transformation
may be due to the fact that it is endocytosed via the same
route as transferrin (Enns e_t al. , I9 8 3) and once inside
the cell in the low pH of the endocytic vacuole, it may
become dissociated from the transferrin receptor and then
interfere with cell activity. Furthermore, the inhibitory
effect of Ab a TfR increased in the presence of inorganic
iron (i.e. Fe(NTA)) and although the counts of the incorporated 
l4C-thymidine were very low, the effect was reproducible 
and inhibition was proportional to the amount of inorganic 
iron added. Although the cells took up iron from Fe(NTA) 
in the presence of antibody, the quantity taken up was 
less than that taken in the absence of AbocTfR (Table 4-7) •
The interaction of the Ab cx TfR with the transferrin receptors
*
Î
may cause a reduction in membrane permeability in the
stimulated lymphocytes. Since Ab «x TfR plus Fe(NTA) is
more inhibitory than AbaTfR alone, and also since AbaTfR
is endocytosed via the same route as transferrin, it is
suggested that inorganic iron in the presence of AbaTfR is
taken up via the same route as AbaTfR rather than by
.diffusion across the membrane. Once inside the cell in 
the endocytic vacuole, the antibody, as explained above,
«
I I
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may become dissociated from the receptor and interfere 
with cell activity. The iron may or may not dissociate 
from NTA, but in either case the NTA may interfere with 
intracellular iron processing. To investigate such a 
possibility, it is necessary to study the fate of radio­
labelled NTA in the cell in the presence and absence of 
AbaTfR.
In conclusion, results presented in this chapter suggest 
that the importance of transferrin in the transformation of 
lymphocytes is not due to a membrane triggering effect 
which enhances proliferation as a result of interaction 
with receptors or inducing receptor patching. Transferrin 
is most likely required in cell proliferation solely for 
its iron-donating properties discussed in Chapters 2 and 3, 
possibly also for an undefined intracellular function.
I
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4.6. CONCLUSIONS
1. Apotransferrin has some transformation-promoting activity.
2. Transferrin containing either cobalt or manganese does 
not substitute for iron-transferrin as a transformation- 
promoting agent.
3 . Variant transferrin with an abnormal C-terminal iron 
binding site is as good as normal transferrin in enliancing 
lymphocyte proliferation.
4. Monoclonal antibody to transferrin receptor cannot 
substitute for transferrin in promoting transformation 
even in the presence of inorganic iron.
3 . The majority of these results indicate that transferrin
enhances lymphocyte proliferation solely as a result of
its ability to donate iron, and does not fulfil any
additional function by triggering proliferation through a
membrane signalling.
.
233
k-
h4.7* SUMMARY
!
Although it is now well established that transferrin 
is required by proliferating lymphocytes, it is not clear 
whether this is due only to a requirement for the cells to 
acquire iron or whether the interaction of transferrin 
with a membrane receptor also acts as a signal for triggering 
transformation. In an attempt to answer this question, 
desferrioxamine, an iron chelator, was used to remove 
endogenous iron present in the culture medium and allow the 
effect of apotransferrin on lymphocyte transformation to 
be investigated. It was found that when enough desferrio- 
Xamine to chelate the endogenous iron was added to the medium 
prior to addition of transferrin the degree of transformation 
was significantly reduced when compared with the response
■
■ 'of cells cultured in medium containing iron-transferrin.
However the proliferative response in medium containing
apotransferrin (i.e. in the presence of desferrioxamine)
was significantly higher than when cells were cultured in
the absence of transferrin indicating that transferrin
without iron does have some transformation-promoting activity.
In order to investigate further the relative importance of
iron and transferrin in lymphocyte transformation the effects
of transferrin containing iron (Pe^’*') or other metals (Co^^,
3 +Mn ) which form complexes with a similar configuration 
were compared. Transferrin 100^ saturated with manganese 
or cobalt was markedly less effective than transferrin 
100^ saturated with iron, but this was probably due to
"I
2 3 4
toxicity of free metal displaced from transferrin by
iron present in the culture medium. However, transferrin
■saturated 20^  ^with manganese and 10% with iron was also
less effective than transferrin saturated to either 10%
/ 59 54or 30% with iron alone. Studies using Pe and Mn bound
. ■
:,k:;to transferrin at different ratios showed that both 
manganese and iron were taken up by the cells, although 
iron was taken up to a greater extent, indicating that
toxicity of manganese was more likely to be responsible for
the low transformation-promoting ability of manganese 
transferrin than a blocking action of manganese-transferrin
■on iron uptake was more likely to be responsible® Nevertheless, 
these results do suggest that transformation-promoting 
activity of transferrin is dependent primarily upon its
role as a source of iron rather than as a membrane triggering 
agent. Further evidence for this conclusion was provided 
by experiments showing that a variant human transferrin 
which binds to lymphocytes with lower affinity than normal 
transferrin nevertheless promoted optimum transformation. 
Furthermore, a monoclonal antibody to the mouse transferrin 
receptor could not substitute for transferrin as a
provided in the medium.
receptor-triggering agent even when inorganic iron was
I
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GENERAL 5UMMAR1 AND CONCLUSIONS
Transferrin-bound iron is important for lymphocyte
proliferation. Evidence for this comes from the observations 
of the present investigation showing that the proliferation 
of mitogen-stimulated mouse lymph node lymphocytes depends 
on the availability of transferrin-bound iron both in 
serum-free, medium and in medium containing serum from iron- Îsufficient or iron-deficient mice. The reduced proliferative
response of lymphocytes cultured in medium containing serum
from iron—deficient mice was the result of low levels of
. .transferrin-bound iron since iron-repletion Jji vitro ^ iu vive 
corrected the defect. Furthermore, lymphocytes isolated 
from normal or iron-deficient and iron-sufficient mice
proliferated at the same degree irrespective of the iron 
availability in the culture medium, indicating that iron 
deficiency did not cause any intrinsic defects in the 
ability of the lymphocytes to proliferate. The proportion 
of T-cells and T-cell subsets was also not altered in iron 
deficiency. Taken together these observations suggest 
that the reduced lymphocyte proliferation and perhaps
I
’■i.
therefore, the impaired DTH responses associated with iron 
deficiency are the result of decreased levels of circulating 
transferrin-bound iron rather than of intrinsic abnormalities 
in the lymphocytes or altered lymphocyte-subpopulations.
In addition, the importance of transferrin in lymphocyte 
proliferation was shown to depend on its iron-donating
I
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properties, rather than on a triggering effect caused by- 
transferrin interacting with the transferrin receptor*
This was concluded from experiments showing that transferrin 
containing cobalt or manganese which has a similar 'configur­
ation to iron-transferrin did not enhance proliferation 
when compared with the response induced b-y iron-containing 
transferrin. Furthermore, a variant transferrin which has 
a lower receptor-binding affinity constant than normal 
transferrin induced the same response as normal transferrin, 
and a monoclonal antibody to transferrin receptor could 
not substitute for transferrin as a transformation-promoting 
agent even when inorganic iron was added. Thus, it can be 
concluded that the expression of transferrin receptors in 
proliferating lymphocytes is probably entirely related to 
the iron-requirements in the cells.
In conclusion, iron bound to transferrin is one of 
the controlling factors for the in vitro proliferation of 
lymphocytes. This is probably because iron is important 
for the activity of the enzyme ribonucleotide reductase 
which is required for the synthesis of DNA (Hoffbrand et al., 
1 9 7 6). How this compares with the vivo situation is 
difficult to predict. Under normal conditions, there is 
a constant supply of circulating transferrin-bound iron, 
but in iron deficiency, the saturation of transferrin with 
iron is very much reduced so that in a localised area, 
such as a lymph node, consumption of iron bound to transferrin 
may not be replenished fast enough resulting in impaired 
immune response.
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STATISTICAL ANALYSIS
In biological sciences unlike the more exact sciences 
of physics and chemistry, inherent variation is very high.
Since this variation can make numerical arguments more 
difficult and unreliable, it is necessary to describe the
basic variability by using appropriate statistical methods
■so that valid and objective conclusions are reached.
'The data presented in this thesis were analysed by 
methods appropriate to the experimental design and the 
problem to be resolved. The following methods have been 
used:
1. Student’s t-test  ; —------
This is a statistical method which is used to determine 
whether measurements on two samples taken from two populations 
are compatible with the null hypothesis that the two 
populations have the same mean, and it is achieved by 
comparing the difference between the two sample means with 
the estimated standard error of the difference. The test 
statistic t may be regarded as the difference between the 
two sample means divided by the standard error of the
\l^ ih
where 6*^= ^  + K X " \ 2  F and n, ,n_ are the number
of observations in samples and respectively.
The test is based on the following assumptions;
i) the observations in each sample are independent
ii) the samples show normal distribution
iii) the variability within each sample is the same (i.e. 
have the same variances).
I
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Suppose it is desired to know whether two populations
(from which two samples are drawn) are different. Using
t-test, the null hypothesis (H ) can be considered, ando
assuming this null hypothesis, the probability of obtaining 
a value of t equal or greater than the value actually 
observed can be calculated. If this probability is very 
small, (e.g. p < O.O5 ) we can reject the null hypothesis 
with reasonable safety. The probability (p) of obtaining 
or exceeding a given value of t with a particular sample- 
size can be most conveniently obtained from published tables. 
Alternatively, an acceptable level of uncertainty (a 
confidence criterion) such as p < O.O5 may be chosen in 
advance, and the critical value of t that would be required 
to satisfy this criterion may be obtained from tables.
If; t observed > t tabulated, then the null hypothesis 
is rejected in favour of the alternative hypothesis that 
the means are different at (say) 5% significant level 
(i.e. p < 0 .0 5 ). However, if t observed < t tabulated, 
then the null hypothesis is tenable and the means of the 
two populations from which the two samples are drawn may 
well be equal. This implies that there may be no difference 
between means of the two populations. It is important
to note that a lower significance level can be used such 
as 0.01 (i.e. 1%) or 0.001 (i.e. 0.1%), instead of 3% 
level, especially if the alternative hypothesis is 
particularly unlikely a priori.
:|
■ ■ .
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Tlie t-distribution can also be used to attach "confidence 
limits" to estimates, so that at the accepted significance
level (say 5%) it can be estimated that for (where
>^l’y*^ 2 the means of the two populations from which
the samples are drawn):
V ^ V ru u?
,  ,________where ± -2) ^  j ^  are the confidence limits
and tgi (Titi-n — 2I \/X the confidence interval.
Vn-i TIPh
Student’s t-test is used to compare the means of two
samples. If more than two samples are available it is 
unreliable to use the t-test because when the number of 
t-tests increases, the chance of an accidentally low p value 
increases proportionally.
-
w.2. Scheffe’s method of multiple comparisons
This is a statistical method which is used to compare 
simultaneously the means of more than two samples taken 
from different populations. The method, which is based 
on the same assumptions as the t-test, states that a set 
of simultaneous 95% confidence intervals for the I/ 2  K( K-1) 
pairs (k = number of samples to be compared) of means 
j j^ are given by:
X; - Xj ± y(K-l) F 0-05/K-1, N-K X  \j 5-4°°^  (-è/-^2)
I
where X; — is the difference of the estimated means ofj- J
the samples S., S., respectively, and
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z ^  (ui-l) (5-f1  )  6 "  p o o l  —  - i a l - - - 1 _ _ _ _ _ _ _  w h e r e :
N n. = number of observations ^ within S.
264 = variance within S.J- X
N = total number of observations
2) pO-Oy/K—1, N—K is the 5% points of variance-ratio (f )
distirubiton at (N-K) degrees of freedom 
(f^) and (K-1) residual (f^)
So, for the actual difference of means :
(i) X j - X j T 0-051X~1 jN~X X y 6‘^ p o o i ^
(rr)/'lyj +\/CX-l) F 0-05/X-l^  N-X X  \/6-^pool(x+^')
There are three possibilities;
1) If the first part of the inequation (i) above and the
second part of (ii) are both positive numbers, then;
> 0  or and therefore the null
hypothesis that the two means are the same, is rejected in 
favour of the alternative hypothesis that there is a 
difference between the means of the two parent populations*
2) Similarly, if the first part of the inequation (i) and 
the second part of (ii) are both negative numbers, then:
< 0 and therefore
In this case, as in the previous one, the null hypothesis 
is rejected and it is concluded that there is evidence that 
there is a significant difference between the means of the 
corresponding samples.
- '-'îg
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3 ) Either the first part of (i) is a positive number and 
the second part of (ii) is a negative number, or vice versa.
In this case:
nuSber^^ < positive number
This indicates that the difference is a small number
which may well be zero i.e = 0 or y-q =
In this case the null hypothesis is accepted and it 
is concluded that there is no evidence that the means of 
the samples are different.
Scheffe’s method of multiple comparisons has the property 
that, if the null hypothesis is true (i.e. all are equal) 
in only 5% of experiments will it be possible to find a pair 
of means which satisfy the confidence criterion by accident 
(e.g. random sampling error). Thus the 959^  confidence 
level applies to the experiment taken as a whole, and not 
to each pair of means taken separately.
3. Analysis of variance
This is a statistical technique in which the total 
variation of the numerical results about their mean is 
subdivided into components attributable to variations between 
the factor(s) (i.e. the variable(s) which is believed to
affect the outcome of the experiment) and the residual 
variation attributable to variations between individual 
animals, errors of measurements etc.
The two-way analysis of variance (two-way iUNOVA) is used 
to investigate the effect of two different factors; A and 
B, each one having a number of different levels, say h and g, 
respectively.
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The errors are assumed to be normally and independently
distributed, random variables with mean zero and variance 
2S . It can be shown that the total variation can be
subdivided into three parts; one for each of the two
factors and a third being the residual variation. Thus ;
Total sum of squares = factor A sum of squares + factor B
sum of squares + residual sum of squares.
OR: SST = SSA + SSB + SSEK gwhere SST = y V  y.. _ r TT C.F. (i.e. correction factor)
i--l h  ■ ' yVn
K c y = sum of all responses
1=1
SSB f  Y/-C.F. 5 ^ 'K j _ - i  ^
SSE = SST - SSA - SSB
There are three variances:
5^  = SSA/h - 1 , 6} ^  SSB/g - 1 , G] = SSE / (h-1 ) (g-1 )
Considering the null hypothesis of no difference between
the levels for factor A, there are two estimates of 
2 Zvariances; 6^  and <5^ . If the F estimated value for
Z I Ifactor A(F = ^  / <5^ ) is greater than the critical statistic
value F (obtained from tables for F-distribution) on j^ (h-l), 
(h-1)(g-1^ degrees of freedom and at a certain level of 
confidence (i.e. 0*95 or 0.99 or 0.999), then there is 
evidence to reject the null hypothesis of no difference
between any levels of factor A and to accept the alternative 
hypothesis of some difference. Similarly, if i®
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greater than F critical value at [(h-l), (h-1 ) (g-1 ^  degrees of
freedom, then the null hypothesis is rejected again in 
favour of the alternative hypothesis.
When several replicate samples have been tested with 
the same levels of factors A and B, it is also possible 
to separate the residual sum of squares further into two 
components; an error sum of squares arising from differences 
among replicates treated identically, and an interaction 
sum of squares arising from the interaction between factors 
A and B« If a significant interaction is observed this
implies that the effects of A and B are not simply additive;
the effect of A is increased at particular levels of B or 
vice versa. There may, for example, be synergy between 
A and B, or conversely, particular levels of one factor 
may inhibit the effects of the other factor. The analysis 
may be extended, in principle, to any number of factors, 
and the mathematics then become exceedingly complex. For 
these analyses the computer programmes MINITAB and RUMMAGE 
were employed, using a Northstar Advantage computer.
s
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